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Abstract
A number of AT-acetyl- '^-glycosyl cysteine derivatives have been prepared through the 
development of a general and simply applicable synthetic pathway, by modifying 
existing literature methods. The coupling of JV-acetyl-L-cysteine and a carbohydrate is 
desirable as it may improve the efficacy of the labile A-acetyl-L-cysteine as a drug. 
The 5'-glycosyl cysteines prepared are as follows: A-acetyl-6'-D-glucopyranosyl-L- 
cysteine, a and p-anomers, A-acetyl-,9-P-D-ribopyranosyl-L-cysteine, A‘-acetyl-<S'-a-D- 
mannopyi’anosyl-L-cysteine and A-acetyl-0-methyl-iS'-(2,3,4,6-tetra-0-benzoyl-P-D- 
galactopyranosyl)-L-cysteine. The coupling reaction was designed to yield both a and 
p-anomers in the same step, and this was observed in the synthesis of tire glucose 
derivatives. However, the other carbohydrates chosen appear to couple • more 
selectively. The preparation of V-acetyl-O-methyl-iS-a-D-glucopyranosyl-L-cysteine 
was also carried out by a different method, but this proved to be more involved and 
resulted in lower yields.
The stability of A-acetyl-jS-p-D-glucopyranosyl-L-cysteine towards the 
thioglycosidase enzyme myrosinase was studied. V-acetyl-5-P-D-glucopyi'ano,syl-L- 
cysteine was found to be stable to hydrolysis by myrosinase, but some inhibition of a 
standard sinigrin-myrosinase hydrolysis was observed.
The thioglycosidic linkage (-SH) of iV-acetyl-*S'-p-D-glucopyranosyl-L-cysteine is 
stable to hydrolysis in acidic media, which is contrary to previous work reported in 
the literature. However, the hydrolysis of the amide gioup of the cysteine side chain 
occurred in acidic solution giving the apparently acid-stable 6"-P-D-glucopyranosyl-L- 
cysteine. A kinetic study of this acetyl cleavage was undertaken and a second order 
rate constant of 5.96 ± 0.24 x dm^  moT  ^hours’  ^was obtained.
Whenever you are asked if  you can do a job, 
tell ‘em, 'Certainly I  can!'
Then get busy and find out how to do it
Theodore Roosevelt
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Chapter 1
Introduction
1.1 Aims of research
Glycosylation of amino acids and peptides is desirable for a number of reasons. 
Peptides and proteins are potentially useful as drugs, but administration can prove 
difficult, and they are often rapidly removed from the body before reaching the target 
site. One drug that would perhaps benefit from glycosylation is iV-acetyl-L-cysteine or 
NAC. NAC is the A-acetylated derivative of the amino acid L-cysteine and is used as 
an antioxidant for the treatment of things such as paracetamol poisoning and as a 
precursor to glutathione, the body’s powerful antioxidant. NAC is rapidly nietabolised 
and as a result its use is limited. Glycosylation of NAC could improve its 
effectiveness as a drug. Some glycosylated cysteine derivatives have been prepared 
but no clear practical method is apparent in the literature.
Generally — To develop a simple and generally applicable synthetic route to a range 
ofN-acetyl-S-glycosyl cysteines and to explore their chemical and enzymic reactivity.
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1.2 Backaround and literature review
1.2.1 Carbohydrates1-3
Carbohydrates are ubiquitous in nature, occurring in every living organism, therefore 
being an essential part of life. There are many uses for carbohydrates, from the 
starches and sugars in food, to the cellulose present in plants. Carbohydrates are so 
common that it has been estimated that 50 % of the dry weight of the earth’s biomass 
consists of glucose polymers.^ Upon metabolism, carbohydrates provide the major 
source of energy required by organisms. Glucose for instance is metabolized in the 
body to provide instant energy or stored in the foim of glycogen for later use. There 
are two groups into which carbohydrates ai*e generally classed: simple and complex. 
Monosaccharides are carbohydrates like glucose that cannot be hydrolyzed into 
smaller molecules; these are refen*ed to as simple sugars. Complex carbohydrates are 
made up of one or more single sugars. Classification of some of the more common 
simple carbohydiates is as follows: aldopentoses/aldohexoses and
ketopentoses/ketohexoses; aldo represents the aldehyde, pento or hexo representing 
the number of consecutive carbons, i.e. a five or six carbon chain with either an 
aldehyde or ketone as the final functional group. Sucrose 1, fig 1.1, for example is a 
disaccharide as it is composed of one glucose molecule, an aldohexose linked to a 
fructose molecule, a ketohexose.
OH
O
CHoOH
Fig 1.1 -  Sucrose: P-D-finctofuranosyl-a-D-glucopyranoside.
In the late nineteenth centmy, Emil Fischer published work on the structure and 
stereochemistry of glucose; the convenient way in which Emil Fischer represented his
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cai'bohydrates is called the Fischer projection. In scheme 1.1 we can see the Fischer 
projection (2a) of D-glucose 2. As well as Fischer projections, carbohydrates can also 
be represented as Haworth projections. Neither the Fischer nor the Haworth projection 
is strictly accuiate; this is because pyranose rings are actually chair shaped like 
cyclohexane and because the open chair Fischer form comprises typically 0.0026 % 
of D-glucose in aqueous solution at pH 7.0. Scheme 1.1 shows the conversion o f D- 
glucose from a Fischer projection 2a into p and a-D-glucose in the form of Haworth 
projections 2b and 2c respectively.
Carbohydrates form cyclic hemiacetals via facile nucleophilic addition of a hydroxyl 
group to the aldehyde group. Generally hemiacetals are formed by the reaction of  
ketones or aldehydes with alcohols, and as both functional groups are present in the 
carbohydi'ate, an mtramoleculai* nucleophilic addition occurs, resulting in cyclisation. 
The five and six membered rings, furanose and pyianose respectively, form quite 
easily and carbohydrates usually exist in equilibrium between the cyclic and open 
chain forms.
CHO
H-
HO-
H-
H-
-OH
-H
-OH
-OH
CH2OH
2a
Turned on 
tlie side
CH20H_
Ring closme
p-anomer
CH2OH
a-anomer
CH2OH 
O , OH J  H
OH OH
OH H OH" OH
2 b OH 2c OH
Scheme 1.1 -  The formation of the cyclic hemiacetal of D-glucose.
As mentioned previously the prefeiTed conformation o f the pyranose rings o f  
carbohydrates is actually chair-shaped, like the conformation o f cyclohexane. The 
substituents around the carbohydrate ring are positioned axially and equatorially. 
Upon cyclisation o f a monosacchar ide to form a hemiacetal, a new stereogenic centre
_________________________________________________________________ Chapter 1
is formed at the carbon where the carbonyl was once positioned. Two diastereomers 
are produced, these are called anomers, and the C-1 on the pyranose ring is designated 
the anomeric carbon or centre marked in red in scheme 1.2.
,OH
H2O
.OH 
4 <5
a -D -g lu c o p y r a n o s e  p -D -G lu co p y ra n o se  
(36% ) (64% )
Scheme 1.2-C hair conformations of a  and P-D-glucose in aqueous solution.
In aqueous solution, D-glucose cyclises reversibly, giving a 36:64 mixtme of a and P 
anomers respectively. The a and P-anomers are classified as follows: an a-anomer has 
the hydroxyl group pointing downwards in a Haworth projection, which is trans to the 
CH2OH group, and vice-versa for the p-anomer. For the purpose of scheme 1.2, the a- 
anomer has the hydroxyl group positioned axially at the anomeric centre and the P- 
anomer has the hydroxyl group positioned equatorially at the anomeric centre. P-D- 
Glucose is the most common monosaccharide in free form on earth, and it has all the 
hydroxyl groups around the pyianose ring equatorially positioned, which is the most 
stable ar rangement. The chair* conformation o f cyclohexane, in neat liquid or solution, 
is in rapid equilibrium with another chair form thr ough other intermediates. The two 
chair conformations of a six-membered pyranose ring structur e ar e shown in fig 1.2
'•c i ‘C4
Fig 1.2 - '*Ci and ‘C4  chair conformations.
In fig 1.2, the O, C-2, C-3 and C-5 provide the reference to the plane of the chair, and 
if C-4 is above this plane and C-1 is below it, the conformation is designated '^ Ci; the
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alternative is C^4 ^ In the pyranose forms of the D-aldopentoses and D-aldohexoses it 
is generally the "*Ci conformation that is preferred; but for D-iibose, D-arabinose and 
D-lyxose contributions of the inverted chair form are present.
1.2.2 The anomeric effec&'^
The anomeric effect is an important phenomenon in carbohydrate chemistry. 
Substituents on a six-membered ring typically prefer the equatorial position to 
minimize steric interactions around the ring, but the tendency for the formation of an 
axial anomeric substituent over that which would normally be expected was first 
recorded by Edwards,  ^ and named the anomeric effect by Lemieux.^ This effect 
makes an equatorially attached group on the anomeric carbon, less stable than it 
would be at other positions on the ring. The anomeric effect virtually ensures the axial 
configuration of an electronegative substituent on the anomeric carbon, (see fig 1.3).
OAc
AcO I AcOBr
a-anomer p-anomer
Common Less common
Fig 1.3 - a  and P-anomers of 2,3,4,6 -tetra-O-acetyl-D-glucopyranosyl bromide.
The anomeric effect is responsible for stabilisation of confoimations that seemingly 
lead to other unfavouiable interactions, (see scheme 1.3).
C l
Scheme 1.3 - Distribution of chair conformation due to the anomeric effect.
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One explanation o f this effect is the unfavourable interaction between the equatorial 
dipole and the dipole formed by the resultant of the lone electron pairs on the ring 
oxygen atom. A small angle is formed when the substituent (X) is equatorial and a 
large one when it is axial, (illustrated in fig 1.4 below).
/  /
X
Î
Fig 1.4 -  An explanation of the anomeric effect relating to dipole-dipole interactions.
More common and more accepted is the explanation that requires the interaction 
between a lone pair o f electrons located axially in a non-bonding orbital (n) on the 
ring oxygen and an unoccupied, anti-bonding molecular orbital (o*) o f the C -l-X  
bond.^
n
D ^  A n t i-p e r ip la n a r  to  axia l
'' p o la r is e d  C - 0  b o n d
 A n t i-p e r ip la n a r  to
^ p o la r is e d  r in g  C -O  b o n d
:X 6%
Two possible stabilisations if the group on C-1 is axially positioned 
OH
Q
H
Anti-periplanar to polarised 
't )  ring C-O bond
One possible stabilisation if the group on C-1 is equatorially positioned
Scheme 1.4
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The “anti-periplanar” arrangement found in the axial anomer favours this “back- 
bonding.” This produces a slight shortening of the ring 0->C -l bond, a slight 
lengthening of the C-1->X bond and an increase in the electron density at X.
The anomeric effect increases with the electronegativity of the substituent and also as 
the dielectric constant of the solvent decreases. One way in which the solvent could 
affect the conformation is to do with hydrogen bonding. Although intiamolecular 
bonding is negligible in hydrogen bonding solvents, it is not the case in non-bonding 
solvents. If a partially substituted sugar is dissolved in a non-hydi'ogen bonding 
solvent, intramolecular hydrogen bonds may form, and the resultant energy may 
stabilise a confoimation which would otherwise be less favoured.  ^ The extent o f the 
anomeric effect decreases down the series:
Halogen > OCOPh > OCOCH3 > OMe >0H  > NH2
The reverse anomeric effect^’^  is when an electropositive group at the anomeric 
carbon (C-1) prefers a nonnally unfavoured ^ 0 4  conformation. This is shown below in 
scheme 1.5. The (tetra-0-acetyl-a-D-glucopyranosyl)-4-methylpyridinium bromide 
switches from the ^Ci 3a to the C^4 3b conformation, because of the electropositive
OAc
AcO OAc OAc
" C L . . .CH3 Cancelling of opposing dipoles
3a 3b
Scheme 1.5 -  The reverse anomeric effect.
The explanation for this reverse anomeric effect is also illustrated in scheme 1.5, the 
simple and favourable cancelling of opposing dipoles, although some discussion 
continues as to whether the reverse anomeric effect actually exists at all.^ ®'^  ^Lemieux 
and others also discussed the “exo-anomeric effect.”^^’^^
Chapter 1
H
.R HOR OR
01-01
Fig 1.5 -  The exo anomeric effect.
In a simple carbohydrate acetal, there operates the “normal anomeric effect,” 
stabilising the axial anomer over the equatorial anomer. However, in the appropriate 
conformation of the exocyclic alkoxy group, there is another anti-periplanar 
anangement of a lone-pair on oxygen (of OR) and the C l-05 bond. This is the “exo- 
anomeric effect,”  ^fig 1.5. As the normal anomeric effect and the exo-anomeric effect 
operate in different directions, the exo-anomeric effect is not considered important 
with such axial acetals. This is not the case in an equatorial acetal, where there is no 
contribution from a normal anomeric effect; it is the exo-anomeric effect that is 
dominant and dictates the conformation of the alkoxy group at the anomeric carbon, 
(shown below in fig 1.6).
2
0 5 .
R'&
H
Fig 1.6 -  The exo anomeric effect with respect to an equatorial acetal.
The exo-anomeric effect appears to be responsible for the helical shape of many 
polysaccharide chains and it is important in determining the shape of many 
biologically important oligosaccharides.^
“ The anomeric effect or the “normal anomeric effect” is now sometimes referred to as the ^^endo- 
anomeric effect.
 ^The general term for small chains of monosaccharides with up to ten "sugar” residues in the chain.
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1.2.3 Protecting groups in carbohydrate chemistry^’ ’^ ^
The study of cai'bohydrates is not confined to the abundant and natural sugars. So if  
synthesis o f modified monosaccharides or oligosaccharides is required, the other 
problems of organic synthesis become apparent. Protection of the reactive hydi'oxyl 
groups of the carbohydrates may be necessary, and perhaps the coupling of two 
monosaccharides at the anomeric (C-1) centre. Many functional gr oups can be applied 
for the protection of carbohydrates, but for the purpose of this project it is sufficient to 
talk about the ester and ether functional groups.
Esters and ethers
Esters and ethers were introduced into carbohydrate chemistry primarily to protect the 
hydroxyl groups. Ethers are useful as they are inert and are generally found at the 
non-anomeric positions, i.e. C-2“>5, around the ring of the sugar.° Esters have a dual 
role in that they can affect reactions at both the anomeric and non-anomeric carbons. 
This is explained in section 1.2.5. The attachment of esters and ethers greatly reduces 
the polarity of the carbohydrate, therefore allowing solubility in organic solvents.
Acetates
The acylation of D-glucose was originally carried out in the mid nineteenth century. 
Three sets of conditions can be used; these are shown below in scheme 1.6.
OH OAc
q  a) AC2O, pyridine
HO -O H  b )A c.O .N .O A c
c) AC2O, HCIO4
Scheme 1.6 -  Acétylation of D-glucose.
‘ An ether protecting group at the anomeric centre would technically be a more reactive acetal.
Chapter 1
The reaction with acetic anhydride and pyiidine is the most general and convenient, 
and with careful temperature control, the original anomeric configmation is 
r e t a i n e d . A n  acid catalysed reaction could operate under greater theimodynamic 
control and yield the more stable anomer.
Removal of the acetate once it is attached is straightforward and it leads to 
regeneration of the hydroxyl group. This is acliieved by dissolving the protected 
carbohydrate in methanol and then addition of a small amount of sodium metal.^°
OAc. OH
Q MeOH, Na metal
OAc OH
Scheme 1.7 -  Deprotection of “acetylated” sugar using sodium metal in methanol.
Benzoates
The benzoate is a stronger protecting group than the acetyl in that it is less easily 
removed in basic conditions. Added advantages are the extra crystalline derivatives 
that are produced from using benzoates to protect the hydroxyl group of the 
carbohydrate, and also the absorbance of UV light. Preparation is simple as with the 
acetates, benzoyl chloride and pyridine; as before, careful temperature control retains 
the anomeric configuration.^^
OH O B z
B zC l, pyridineH
HO
O OH
Bz
Scheme 1.8 -  Protection of a-D-glucose using benzoyl chloride and pyridine.
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Benzyl ethers
Benzyl ethers can be used to protect the hydroxyl groups situated on non-anomeric 
carbons on the ring of a sugar. Attachment of the benzyl group can be carried out in 
different conditions: basic (benzyl bromide, sodium hydride and DMF; benzyl 
bromide, sodium hydride, tetrabutylammonium iodide, THF^ ’^^ )^, acidic (benzyl 
trichloroacetimidate, triflic acid^ '^ ’^  ^ ; phehyldiazomethane, tetrafluoroboric acid^ )^ or 
neutral (benzyl bromide, silver triflate) conditions.^^
OH OBn
Bn
Scheme 1.9 -  Protection of the hydroxyl groups of methyl-a-D-glucopyranoside as benzyl ethers.
Deprotection can be carried out in various ways: hydrogenolysis (H2 , Pd-charcoal, in 
the presence of acid), catalytic transfer hydrogenolysis (ammonium formate, Pd- 
charcoal, m eth anol),reduction  under Birch conditions^® (Na, liquid ammonia) or 
treatment with anhydrous ferric chloride.  ^^
1.2.4 Formation of the glycoside linkage^
A glycoside linkage is the alteration of a carbohydrate at the anomeric centre. It can 
be the linkage of a carbohydrate to another carbohydrate to form a disaccharide such 
as trehalose or a-D-glucopyranosyl-a-D-glucopyranosyl 4, seen in fig 1.7, or the 
synthesis of the acetal methylglucoside, in scheme 1.10.
OH ,OHpH
HO 'OH
Glycoside linkage
4
Fig 1.7 -  Trehalose.
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In scheme 1.10, glucose 2 is the glycosyl donor and the methanol the glycosyl 
acceptor.
OH OH
HO I HClOH O M e
2
c :
HO
54-
OH G lycosid e  linkage
HO
Scheme 1.10 -  The formation the glycoside linkage of a and ^-methyl glycoside.
X OR
OR
Scheme 1.11 -  A 1,4-glycoside linkage.
The glycoside linkage shown in scheme 1.11 is a 1,4-linkage. Condensation of the 
glycosyl donor, shown in scheme 1.11 with the glycosyl acceptor forms the glycoside 
Ihikage. The configuration at C-1 could be a or p and is dependent upon reaction 
conditions, there will be no change in conhgui ation at C-4 of the glycosyl acceptor. 
Formation o f specific glycosidic linkages is complex and poses several difficulties: 
activation o f the glycosyl donor, if the glycosyl acceptor is also a carbohydrate then 
caiTying out the reaction at the specific hydroxyl group causes problems. There are 
also the problems o f stereochemistry. Will the a or p-anomer form?
In forming the glycosidic linkage, the substituent at C-2 plays an important role in the 
stereochemistry o f the product at C-1. The hydroxyl group at C-2 requires protection 
prior to the actual glycosidation step. No protection could lead to inter or intra 
molecular- side reactions. The choice o f protecting group at C-2 can affect the 
stereochemistry of the glycosidic linkage.
12
_________________________________________________________________ Chapter 1
The most common groups for protection of the hydroxyl group at C-2 are esters and 
ethers; acetates and benzoates are common, as are benzyl ethers. The presence of an 
ether group at C-2 sterically hinders the nucleopliile during the glycosidation reaction. 
An ester can also give rise to steric hindrance, but it can also participate in the 
reaction, this will be discussed in more detail in the next section.
1.2.5 Glycosyl halides^
1.2-tmns glycosides are generally easier to prepare than 1,2-cis glycosides. This 
section will explain how it is possible to use a glycosyl halide to synthesise both.
1.2-tmns products OHOH
OR
OHOne of the best known uses for a glycosyl - -
halide in carbohydrate chemistry is that _ _ , , _P-D-gluco, galacto a-D-raanno
developed by William Koenigs and Edward
Knorr in 1901.^  ^The treatment of acetobromoglucose 7 with alcohols in the presence 
of silver (I) carbonate is known as the Koenigs-Knorr reaction and it gives \,2-trans 
glycosides seen in scheme 1.12.
OAc OAc
A cp lV —coA - . - - 7 ^
AcO AcO
Scheme 1.12 - The Koenigs-Knorr reaction.
The use of glycosyl clilorides and bromides is now standard practice in carbohydrate 
synthesis. Other salts such as HgBr2 and HgO have been used as catalysts. Insoluble 
salts are thought to give rise to an Sn2 mechanism resulting in inversion of the 
stereochemistry. Where soluble silver (I) and mercury salts are used the mechanism is 
said to be an SnI type with ester group pailicipation from the acetyl group at C-2, 
shown in scheme 1.13, which also results in an inversion of stereochemistry.
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An ester at C-2 can affect the reaction in two ways: firstly, it provides some steric 
hindrance during the glycosidation reaction. Secondly, the ester group can participate 
in the glycosidation reaction, thus affecting the stereochemical outcome of the new 
substituent at C-1. This is illustrated in scheme 1.13. According to Paulsen, for 
reactions with even moderately reactive alcohols, an anomeric mixture of a and p can 
form,^  ^although it is unclear as to why this is.
OAc OAc
AcOAcO
OAc OAc
O
AcO Br
O
Nu
AcO
Nu
OAc
AcO \ Nu
anomer
0
Nu
AcO 
8 p-anomer
Scheme 1.13 - Ester group participation.
1.2-cM products f  f  OH
a-D-gliico, galacto P-D-mamio
Lemieux carried out the synthesis of 1,2- 
cis glycosides using an a-glycosyl halide 
with a benzyl ether at C-2.^ "^  Lemieux 
gives a reason for the formation of an a-anomer as the product. He states that the a- 
glycosyl halide 10 is in rapid equilibrium with the conesponding p-anomer 11. Use of 
a solvent of low polarity such as dichloromethane allows production of an ion pair 
10a from 10. Another ion pair l i a i s  also produced from 11 through conformation
14
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l ib.  Equilibrium is then established between ion pairs 10a and 11a through the 
conformation 10b. As 10 is more stable at equilibrium, the proportion of 10 is greater 
than 11, 11 being destabilised by an anomeric effect. The energy barrier for the 
reaction of 10, 11 and R’OH is greater for 10-^10a->12a->12, formation of the p- 
anomer, than the other route of ll-> lla -> 13a-> 13 , which gives the a-anomer. 
Production of the 13 is therefore faster than that of 12, allowing control of the reaction 
to yield only the a-anomer. The equilibrium between 10 and 11 must be readily 
established to allow constant production of 11a.
o:
BnO
10 b7 )
+
%
Br
OBn
OR'
BnO 
1 2 b
Br
+P
1 1 a OBn
R'OH
BrOBn
1 2 a
+
%
Br
OBn
1 0 b
Br
1 1 b OBn
r Br
R'OH
OBn
13a
BnO OR
13
Scheme 1.14 - The formation of a 1,2-cis glycoside linkage via an a-glycosyl halide.
This interpretation appears somewhat convoluted. A simpler explanation is perhaps 
the lack of ester group participation. As is seen in scheme 1.13, the use o f an ester 
group at position C-2 of the carbohydrate facilitates formation of the P-anomer, but as
15
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can be seen in scheme 1.15 if no ester gi'oup is present at C-2, there is a route for 
foimation of the a-anomer.
BzO i-N BzO o' \= 0
o
BzO
Nucleophile
Orthoester facilitates the formation o f  the 6 -anomerP
BnO I- Br
— BuO
Ortho ester unable to form
Scheme 1.15
Glycosyl halides can be used to synthesise both 1,2-trans and 1,2-cis products 
effectively. Other methods of the formation of a glycosidic linkage are available, but 
the method used in this project will involve a glycosyl halide, and therefore other 
methods will not be discussed in detail. It is worth mentioning the use of the 
glycosylated trichloroacetimidate in the formation of the glycosidic linkage. The 
glycosylated-TCA intermediates can also be used to synthesise both 1,2-tmns and
1,2-cis products with the con*ect reaction control.^
1.2.6 Amino acids and peptides'’ -
Amino acids are essential in all forms of life as they are the building block for all 
proteins. Amino acids are difunctional containing a basic amino group (-NH 2), and an 
acidic carboxylic acid group (-COOH), shown in Fig 1.8.
16
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S c1
H '" " /
H3 C
OH
NH,
Fig 1.8 -  L-Alanine, an amino acid.
Amino acids are highly valuable as biological building blocks due to the fact that they 
form amide or peptide bonds, which enable them to link together. A peptide bond is 
the result of an amide bond between the “NH2 o f one amino acid and the -COOH of a 
second amino acid. This is shown in scheme 1.16. A tripeptide is the linkage of three 
amino acids etc. If there is a linkage of less than 50 amino acids then it is referred to 
as a polypeptide, above 50 then the term protein is used.
o
HoN CH— C OH
R
Amide bond
O
R
O
H2 N-CH— C—  CH— C-------------OH
H
R
Scheme 1.16 — An example of a dipeptide.
There are 20 essential amino acids, all of which are crucial for protein synthesis. 
Amino acids generally exist in the form of a dipolar ion, a zwitterion, shown in 
scheme 1.17; this is because of the acid and base group which are present.
R O
H N------ CH— C
H
■OH
Scheme 1.17 -  An example of a zwitterion.
H R O
H  N-------CH— C----- O
H
Zwitterion
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The amide bonding mentioned previously is one kind of covalent bonding that occurs 
between amino acids. L-cysteine, one of two sulfui* containing amino acids, can bond 
through the sulfur atom of the thiol, RSH, the amino nitrogen and the oxygen of the 
carboxyl group. Furthermore a disulphide linkage, can occur between two cysteines. 
Disulphide bonds are formed by oxidation of thiols, and can be cleaved by mild 
reduction. If cysteine is present in two different peptides, it can link the separate 
chains together via the disulphide bond, (shown in scheme 1.18). If two cysteines aie 
present within the same peptide chain a loop occurs. The disulphide linkage is 
extremely important in protein structure.
CO2 H CO2 H Oxidation
H2 N — — HS ^ N H 2 Reduction
Y
cystmeTwo cysteines
Scheme 1.18 -  Formation of a disulphide bond through two cysteine residues.
1.2.7 Sulfur containing amino acids and peptides
There are two essential sulfur containing amino acids, L-cysteine and L-methionine. 
The focus of this project will generally be upon cysteine which plays an important 
role in protein and peptide chemistry. L-Cysteine, and some of its derivatives, have 
medicinal applications. However, the lability of the thiol group poses problems, 
(discussed later). iV-Acetyl-L-cysteine 14, (NAC), fig 1.9, still has many uses despite 
the problems of lability.
HS
NHCOCH3
14
Fig 1.9 -iV-acetyl-L-cysteine.
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The ability of cysteine to chelate through the nitrogen of the amino group and the 
sulfur of the thiol means it has a strong affinity for heavy metals. NAC has been 
found to be effective in the elimination of mercury from the body, and the antioxidant 
effects produced by NAC have been seen to aid against mercury induced damage to 
the lungs."'* NAC has also been used in experimental chelation therapy, promoting 
urinary excretion of boron and chromium.^  ^ It has been found to reverse oliguria 
which is associated with chromic and boric acid intoxication, although the reasons 
behind this effect are not certain .N A C  is also used in the treatment of “dry eye”, 
helping reduce the levels o f excess mucus, and it is used as a mucolytic agent to treat 
paracetamol poisoning."*" Importantly NAC is a precursor for the powerful natural 
antioxidant glutathione 15, GSH, fig 1.10. It can be used to replenish depleted levels 
of GSH, which can occur during Interleukin 2, IL-2, therapy. IL-2 therapy induces 
marked oxidative stress, from reactive oxygen and nitrogen intermediates. The natural 
antioxidant GSH is the primary source to deal v/ith the oxidative stress; NAC is 
therefore used to increase intracellular levels of GSH.^  ^Research has been carried out 
with a view to using NAC as a treatment for viruses, such as HIV infection,"*® NAC 
again being used to replenish GSH levels.
Despite its many uses the lability of the thiol gioup continues to causes problems for 
the use of NAC as a dmg. It is relatively acidic and when it comes into contact with 
ah* or rubber, oxidation of the thiol occurs, leading to inactivation. L-Cysteine 
stimulates biosynthesis of GSH in the liver. It is however, readily metabolised."** NAC 
itself is metabolised and deacetylated quite quickly after intake. However, it is more 
stable to oxidation than L-cysteine due to the acetyl substituted amino group, but after 
oral ingestion, no NAC is detectable in blood plasma after 10-12 hours."*^  Attempts 
have been made to “protect” the thiol gi'oup and these will be discussed later.
NH2 H o
O O HS*^  OH
IS
Fig 1.10 -  Glutathione (reduced form).
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Glutathione is ubiquitous in plants, animals and microorganisms. Due to its water 
solubility it is mainly found in the cell cytosol as well as other aqueous phases of 
living systems.'*  ^ As mentioned previously GSH, seen in fig 1.10, is a powerful 
antioxidant. It is also an essential cofactor for antioxidant enzymes and an important 
antitoxin.'*'* GSH has a good electron donating capacity, and as a result o f this, when it 
is present in high concentrations it is an extremely effective reductant."*^  As would be 
expected, the reducing power of GSH is most effective in the liver where its 
concentrations aie at their highest. This reducing power is also a measuie o f thiol 
donating and free radical scavenging ability. GSH is also used by the cell to protect 
the mitochondi’ia from endogenous oxygen radicals. The reduced form of GSH is 
made up ofthiee amino acids, cysteine 16, glycine 17 and glutamic acid 18, which aie 
joined together covalently end to end, with the exception o f glutamic acid 18, which 
uses the CO2H of its side chain to form the peptide link; this is illustrated in scheme 
1.19.
N H .
18
SH
O H ,N O
O
16
H 3N  ^
O
.0
17
NHj
HO
Scheme 1.19 -  The different amino acids making up the tripeptide glutathione.
The thiol group, which comes from the cysteine residue, gives the molecule its 
reducing power. GSH is present inside most cells in this electron rich reduced form. 
There is an oxidised form, which is known as glutathione disulphide or GSSG 19, fig 
1.11. This oxidised form however generally does not exceed 10 % of total cell 
glutathione.'*^
20
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Fig 1.11 -  Glutathione disulphide (GSSG).
The amount and type of intracellular glutathione present appears to reflect the health 
of the cell in question. Experimental GSH depletion has been known to trigger cell 
suicide by a process called apoptosis."*^ '"^  ^As far as the essentiality of glutathione for 
survival of the whole organism, information is available from studies on hereditary 
GSH depletion in humans."^  ^ GSH depletion is said to be an important factor in liver 
diseases such as cirrhosis. Studies have indicated a 4 to 8  fold decrease in plasma 
GSH in 48 cirrhotic patients against 18 healthy volunteers.A  significant decrease in 
cysteine was also obseiwed in cases o f severe cirrhosis. It has also been postulated that 
a decrease of GSH and/or an increase of GSSG can alter other fundamental cell 
processes such as protein synthesis and enzyme activities.^° GSH and its related 
enzymes are present in the epithelial lining fluid of the lower respiratory tract, and 
these are thought to be the first line of defence against such things as cigarette smoke, 
which can cause oxidative damage.^  ^ Also chronic viral infections have been known 
to trigger GSH depletion. Patients chronically infected with the hepatitis C virus were 
found to have low GSH in their circulating monocytes.^^ The GSH levels in 
monocytes were also observed to be abnormal in ear ly HIV-1 disease, as the disease 
became more advanced GSH levels became normal; however the GSH/GSSG ratio 
became abnorm al.It is clear that the cellular functions of GSH are very important, 
this is backed up by how cellular GSH levels are affected in the conditions mentioned 
above. The level of GSH in a cell is perhaps therefore an accurate indicator of cell 
health. Therefore GSH repletion in the diet is perhaps useful for assisting the body in 
conibating chronic viruses, liver and lung disease.
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1.2.8 Glycosylated amino acids and peptides
In a review of developments in glycoconjugates, Davis^ '^  stated that glycosylation can 
be thought of in two ways; the introduction of carbohydrates to structures, or the 
formation of a glycosidic bond. The formation of a glycosidic linkage was discussed 
in section 1.2.4 and 5. This section aims to focus upon glycosylated amino acids and 
peptides. The two main classes of glycoproteins involve linkages of carbohydrate to 
protein via an oxygen atom or a nitrogen atom; other linkages such as the sulfur of 
cysteine are much rarer and will be discussed later. In the case o f oxygen linked 
glycoproteins, the link is generally through the O containing side chains of serine, 
threonine or hydroxylysine; nitrogen linked glycoproteins are bonded to the 
carbohydrate through the N of asparagine, examples are shown in fig 1.12.
HoN COiH
CO O H  G lu co se  linked through the n itrogen  o f  
an asparagine residue
P eptide chain  exten sion  cou ld  ocCur here
G lu cose  linked through the o x y g en  
o f  a serine residue
Fig 1.12 - Examples of carbohydrate amino acid linkages.
The glycosylation of amino acids and peptides is desirable to scientists for many 
reasons. Peptides and proteins are potentially useful as drugs but prove difficult to 
administer and are rapidly cleared from the body. Although carbohydrates can be 
present in living organisms without being attached to another molecule, the majority 
of carbohydrates present in cells are attached to either proteins or lipids, hence the 
terms, glycoproteins and glycolipids. The presence of a carbohydrate in such 
structures can modify the chemical, biological and physical properties of the 
molecule. There are many types of modifications to the proteins synthesised in living 
organisms. None, however, are as common as glycosylation, it being the most diverse 
with respect to the amino acid modified and also the structure attached. 
Glycoproteins are fundamental to many important biological processes such as
22
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fertilization, immune defence, viral replication, parasitic infection, cell growth, cell­
cell adhesion, degradation of blood clots and inflammation. Glycoproteins, along with 
glycolipids, are major components of the outer surface of mammalian cells. Over half 
of the biologically important proteins are glycosylated.^^ There is a high sensitivity 
involved in glycosylation of proteins and peptides which are involved in cellular 
functions. Any abnoraial glycosylation can be diagnostic to a number of diseases such 
as cancer and rhemnatoid arthritis. The majority of secreted and cell surface proteins 
are glycosylated. The carbohydrate part of the molecule has a number of functions. It 
may participate in recognition e v en ts .A lso  it can modify the properties of the 
protein; this is probably due to the large size of the carbohydrate attached.^ '^^  ^
Research into the development of glycoproteins has been earned out intensively for 
some time, and a few studies have indicated that glycosylation can be used to 
overcome the intrinsic shortcomings in using peptides as drugs, i.e. poor transport 
across membranes such as the blood brain barrier.There are many developments 
with medicinal purposes, such as drug delivery and targeting. Covalent attachment of 
drugs through various degradable linkers to lactosaminylated and galactosylated 
human serum albumin has allowed the targeted deliveiy of the anti-inflammatory drug 
Naproxen,and anti-virals such as arabinoside-AMP.^^
COOH
H3 CO 
Fig 1.13 -  Naproxen.
These dings are absorbed into the hepatic cells through receptor mediated 
endocytosis. This process is used by all cells. It is an internalisation of receptors such 
as lectins, glycoproteins, and is unlimited in its targeting potential.^  ^ Glycoproteins 
are also being researched to assist in the field of infection and pathogenesis control. 
Proteins that bind to pathogens are generally termed adhesions; these adhesions are 
mostly lectins and bring about the infection and colonisation of a host by binding to 
ligands on the host cell surfaces.^  ^ The research into glycoconjugate anti-adhesives 
has yielded anti-influenza drugs. Influenza infection involves the binding of cellular 
a-sialic acid residues with viral haemaglutinin lectins, and a number of sialic acid
23
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modified glycopolymers have been synthesised as potential anti-infectives to inhibit 
this binding.^ "^  Effective compounds have also been used to combat gastric ulcers. The 
bacteria that cause gastric ulcers, helicobacter pylori, attach themselves to gut cells by 
binding to the extracellular sialylated glycoproteins. Inhibition of the adhesion has 
been effectively remedied by albumin, which has been glycosylated with 3’- 
sialyllactosyl residues.Research into the usage of glycoproteins in immunotherapy 
and vaccines dates back to 1929, when it was discovered that oligosaccharides 
become immunogenic when attached to a p ro te in .In  1930 they were used as a 
strategy to combat pneumococci.^^ A potential anticancer vaccine has also been 
synthesised by Danishefsky.®  ^ Glycosylation of the anti-diuretic drug, [l-desamino,8 - 
D-arginine]vasopressin improves the bioavailability of the drug on intra-intestinal 
administration.^  ^ Another report describes how the attachment of glucose to an 
enlcephalin analogue, which is an endorphin, enables transport o f the neuropeptide 
across the blood brain barrier.^ ®
711.2.9 Glycosylation of amino acids
The synthesis of glycoproteins can be challenging. The formation of a glycosidic 
linkage has several difficulties; protection and deprotection of the carbohydrate 
hydroxyl groups and the stereochemistry of the resultant linkage being the two main 
problems. In the case of glycopeptide synthesis there is the added difficulty of amino 
acid protection and deprotection and the acid/base lability of glycosylated amino acid 
residues. Due to the amount of work published on the glycosylation o f amino acids 
and proteins, what follows is a summary o f the synthesis of some glycosylated amino 
acids with examples and discussion.
The préparation of 3-0-(2-acetamido-2-deoxy-P-D-glucopyi'anosyl)-L-serine 23, 
scheme 1.20, was achieved by Jones et al. in 1961.^^
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AcO
H O . 21 OAc OH
ZHN COgMe . i) deacetylation--------------   '^ T o o X -r ^ O ., —— ------- *  %
HjN 'CO2H
AcHN' I Ag,CO , AcHN ! ii) hydrogenation AcHN
Cl " Z H N -^ C O a M e
20 Z = CgHsCHjOCO 22 23
Scheme 1.20 -  The synthesis of 3-0-(2-acetamido-2-deoxy-p-D-glucopyranosyl)-L-serine.
Koenigs-Knorr style reaction conditions were employed, the use of a glycosyl 
chloride 20 and A-(benzyloxycarbonyl)-L-serine methyl ester 21 in the presence of 
silver carbonate salts to give 2 2  which was then deacetylated with ammonia in 
methanol, and the amino acid deprotected by hydrogenation to give 3-0-(2- 
acetamido-2-deoxy-p-D-glucopyranosyl)-L-serine 23.
The synthesis of 0-glucopyranoside-D/L-serine 26 was carried out by Kochetkov and 
co-workers.^  ^This again involved the use of a glycosyl halide, this time 2,3,4,6-tetra- 
0-acetyl-a-D-glucopyranosyl bromide 7 and iV-(benzyloxycarbonyl)-D/L-serine 
methyl ester 24 in the presence of silver carbonate salts to give O-glucopyranoside- 
D/L-serine 26.
HO. 24
OAc ZHN COjMe 9^® - 9^
AcO I Ag^ CO) AcO I ii)hydrogenation HO I
ZHN COzMe HgN COzH
y Z = CgH5CH20C0 25 26
Scheme 1.21 -  The synthesis of O-glucopyranoside-D/L-serine.
Kunz and Buchholz^  ^ used 7V-(benzyloxycarbonyl)-L-serine 2-bromoethyl ester in a 
coupling reaction with 2,3,4,6-teti*a-0-benzoyl-a-D-glucopyranosyl bromide and then 
deprotection to give O-glucopyranoside-L-serine 26. The advantage of the bromoethyl 
protecting group is that it can be removed selectively without hydrolysis of the 
carbohydrate-amino acid bond. Fmoc (9-fluorenylmethoxycarbonyl) has also been 
used as an amino acid protecting group by Kunz in preparing a glucosylated L- 
asparaginyl-L-leucyl derivative.^  ^ As discussed in the earlier section on formation of 
the glycosidic linkage, with the use of Koenigs-Knoir conditions with a glycosyl 
donor having a participating group at C-2, the product obtained is solely the \,2-trans
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isomer. As some naturally occurring glycopeptides often have the 1,2-cis 
configuration at C-1 it is necessary to use a glycosyl donor with a non-participating 
group at C-2 in the synthesis of such compounds. The synthesis of 3-0-a-D- 
glucopyranosyl-L-serine 29 was carried out by Kum.’  ^ The synthesis of this 
compound was carried out by the condensation of A-(benzyloxycarbonyl)-L-serine 
benzyl ester 28 with 3,4,6-tri-0-acetyl-2-0-nitro-P-D-glucopyranosyl chloride 27 in 
the presence of silver carbonate, silver perchlorate and “Drierite”, then hydrogenation 
and then de-acetylation to give 3-0-a-D-glucopyranosyl-L-serine 29.
OAc ' ? ”
O2NO Ag2 C0 3 ,Aga 0 4  Q2NO ^  Ii)hydrogenation HO ^
Drierite
Z = q6H5CH2000 ZHN COzBn 29 HjN CX^H
Bn = CgHgCH227
Scheme 1.22 -  The synthesis of 3-O-a-D-glucopyranosyl-L-serine.
Similar conditions were employed in the synthesis of glycosylated L-threonine 
derivatives. Vercellotti and co-workers,carried out the condensation of 2,3,4,6 -tetra- 
0-benzyl-a-D-glucopyranosyl chloride 30 with A-(2,4-dinitrophenyl)-L-threonine 
methyl ester 31 in the presence of silver carbonate and drierite to give AT-(2,4- 
dinitrophenyl)-3-0-(2,3,4,6-tetra-0-benzyl-a-D-glucopyranosyl)-L-threonine methyl 
ester 32.
OBn OBn
-O H O ^
1 C
30 31 32
BnO DnpHn CO2 MG Drierite BnO ^
O^ N DnpHN*^  ^C02Me
Dnp = y —NO2  = 2,4-dinitrophenyl
Scheme 1.23 -  The synthesis of A/-(2,4-dinitrophenyl)-3-0-(2,3,4,6-tet^a-0-benzyl-a-D-
glucopyl■anosyl)-L-thIeonine methyl ester.
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Vercellotti also carried out the synthesis of 3-0-(2,3,4-tri-0-acetyl-p-D- 
xylopyranosyl)-L-threonine by the reaction of 2,3,4-tii-O-acetyl-a-D-xylopyranosyl 
bromide with A-(benzyloxylcarbonyl)-L-threonine /j-nitrobenzyl ester under the same 
conditions/^
The use of glycosyl halides to form the glycoside linkage is evident in the examples 
of the synthesis of the glycosylated amino acids above. Other methods are available, 
but the aims of this PhD do not require them to be discussed in detail.
The synthesis of a glycosylated peptide could be carried out by the preparation of one 
of the compounds above and then an extension of the peptide chain. Alternatively, the 
structure of the protein can be prepared and then the glycoside linkage made at that 
stage.
1.2.10 Glycosylated cysteines and S-containing peptides.
As mentioned earlier there are many glycosylated peptides and proteins. However the 
linkage of carbohydrate to peptide in the majority of these glycoproteins, involves 
bonding through the nitrogen (of asparagine) or oxygen (of serine or threonine). S- 
glycosylated peptides and proteins, where the link between carbohydrate and peptide 
is via the S of cysteine, are much less frequent in nature. Several have been identified 
but their origin and function are not well known.^  ^ The benefits of glycosylation of 
peptides were previously discussed in section 1.2.8, and it has many merits. The idea 
of using glycopeptides as therapeutic agents is of particular interest as far as S- 
containing amino acids and peptides are concerned. Cysteine and derivatives such as 
iV-acetyl-L-cysteine have properties as drugs, but the lability of the thiol group causes 
problems as it is oxidised easily. Attempts have been cairied out to “protect” the thiol; 
these include the use of 2-substituted thiazilidine-4-carboxylic acid 33 and 2-oxo 
thiazilidine-4-carboxylic acid 34, fig 1.14, with the “pro-drug” strategy in mind. 33 
being opened by “chemical” reactions and 34 being opened by the enzyme 5- 
oxoprolinase.'^ ’^^®
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H H
33 34
R = alkyl .
Fig 1.14 -  An example of thiazilidine-4 carboxylic acids, used as “pro-drugs”.
1.2.11 Synthesis of S-glycosylated cysteines
In 1971 Lote and Weiss^  ^ identified a novel glycopeptide extracted fi-om urine. 
Interestingly the linkage between carbohydiate and protein was through digalactose 
linked to the thiol group of the cysteine residue. Their analysis of the protein structure 
led to the discovery that the galacto-cysteine linkage could be cleaved by mild acid 
hydrolysis. The workers reported that no linkage of this type had been described 
before. Monsigny et reported the synthesis of 6 "-P-D-glucopyranosyl-L-cysteine 
in 1977. A glycosyl donor of an acetylated glucosyl isothiouronium salt 35 coupled 
with a protected 3-iodo-L-cysteine derivative 36 to form 6'-(3-glucosyl-L-cysteine 37 
after deprotection. A very good yield of 72 % was achieved but a large amount of 
work was necessary to prepare the adducts. This is shown in scheme 1.24.
CO2B11
^NHOCOPh Q 36 .
^AcO^
AcO
35
11+ AcO INH2 PhOCOHN-^COjBn
Br
Bn = C6H5CH2 i) Hydrogenationii) Deacetylation
OH
"Q
HO ]H2N-^C02H
37
Scheme 1.24 -  Synthesis of iS-p-glucosyl-L-cysteine derivative.
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Baxan and Drabarek^  ^ carried out the synthesis of jS-glucosyl and galactosyl cysteine 
in a Koenigs-Knorr style reaction. “Acetobromoglucose” 7a and 
“acetobromogalactose” 7b were reacted with iV-Z-O-methyl-cysteine 38 in the 
presence of a silver carbonate salt, scheme 1.25. The removal of the acetyl groups was 
caiTied out with 10 % TEA in methanol. It is important to note that no NMR 
characterisation was carried out, so characterisation and isomeric purity are in doubt. 
A study was also carried out on the hydrolysis of the jS-glycoside bond at various pH 
and temperature. The results were obtained after paper chromatography. They report a 
high lability of the 5'-glycosidic bond, with a decrease in stability as a result of an 
increase in temperature; this concurs with the work of Lote and Weiss.^  ^ As the 
method of detection in these studies was quite crude, it would be interesting to carry 
out these experiments with the more reliable technique of NMR, to see exactly 
what occurs.
r^AcOAc
NHZ ' AcO !
ZHN'^COzMe
7a 7b 38 39a, 39b
7a: R^  = AcO, R  ^= H Z = CgHsCHzOCO 39a; R^  = AcO, R  ^= H
7b:R^=H,R^ = AcO 39b: = H, R  ^= AcO
o h  i)HBr/AcOH OH
TEA/M eOH T ^ 2 _ - 0  W O H /M e O H39a, 39b ------------\   ^  R*" ----HO I HO 1
ZHN^^COiMe HgN COgH
40a, 40b 37,41
40a: R  ^= OH,R^ = H 37: R^=OH,R^ = H
40b: = H, R^= OH 41: R  ^=H,R^ = OH
Scheme 1.25 -  A Koenigs-Knoiï style synthesis of an iS-glucosyl derivative.
In a partial route to 5-galactosyl cysteine, Eloffson et a lP  replaced the silver 
carbonate catalyst with the Lewis acids, BFs-EtaO and SnCU, in a coupling reaction of 
Fmoc-serine, threonine, homocysteine and cysteine 42 to p-D-galactose pentaacetate 
43 in dichloromethane or acetonitrile. Acetonitrile was preferred as it dissolved the
29
_________________________________________________________________ Chapter 1
Fmoc acids, but it was found that the combination of dichloromethane/SnCU gave the 
best yields of thioglycosides, 59 %, as opposed to BF3 -Et2 0 /dichloromethane which 
gave a yield of 34 %. No deprotection of the acetyl groups was reported. The 
synthesis is shown in scheme 1.26.
OAc OAc OAc.OAc
^ — R 9 ° ° ^  SnCl4 ,DCMA cO X -r-V -O A c +
AcO SnCl4 , CH3 CN AcO !
FmocHN COOH
43
Fmoc =
Scheme 1.26 -  The synthesis of an 5-galactosyl-L-cysteine derivative.
In another partial route to a glycosylated cysteine, Kasbeck and Kessler synthesised 
A^-phthaloyl-iS'-(l,3,4,6-tetra-0-benzyl-D-fi.*uctofuranosyl)“L-cysteine benzyl ester, 
both a and P-anomers 44a and 44b.^ "^  They used octa-O-benzylsucrose 45 and the 
corresponding cysteine derivative in the presence of BFg EtzO. The reaction yielded 
both 44a and 44b and 2,3,4,6-tetra-O-benzylglucose 46 in a one pot reaction, shown 
in scheme 1.27, the products being separated by column chromatography. The 
treatment of octa-O-benzylsucrose 45 with a Lewis acid produced a 1,3,4,6-tetia-O- 
benzyl-D-fructofuianosyl cation 47 which was then trapped by the cysteine derivative 
to produce 44a and 44b.
CH2 OCO
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OBn
BnO OBn OBn
BnO I BnO—I fv O
OBn
Bn(
Bn(
Bi3OBn BnO•-O Bn OHOBn-O B n
44n 44b
Pht =BnO
Bnî
OBn
OBn
47
Scheme 1.27 -  Synthesis of i'/-phthaloyl-5-(l,3,4j6-tetra-0-benzyl-D-fructoftiranosyl)-L-cysteine 
benzyl ester, a and P-anomers.
The first reported synthesis of 5'-a-D-glucosyl-L-cysteine was by Kdsbeck and 
Kessler in 1997.^ '" The earlier work of Schmidt and Stumpp showed that the Lewis 
acid catalysed reaction of 2,3,4,6-tetra-O-benzyl-a-D-glucopyi'anosyl 
trichloroacetimidate with various thiol glycosyl acceptors gave only 5-a-D-glucosides 
in a temperature range of -42 °C to room temperatme.^  ^ Kessler et al. used N~ 
phthaloyl cysteine esters coupled with 2,3,4,6-tetra-O-benzyl-a-D-glucopyranosyl 
trichloroacetimidate 48 in the presence of Bp3 -Et2 0  to give the a-anomer, the benzyl 
groups being removed by hydrogenation with Pd/C.
OBn HS-
PhtN - ^ C O iB n
OBn
BnO
BnO ^ B Fj-E tjO .D C M
"ecu
48
BnO
Pht =
Bn = CsHsCH2
XPhtN-^COîBn
i)Hydrogenation
ii)N2H4, E ton
OH
HO I S
XH ,N    CO,H
Scheme 1.28 -  Synthesis of ■S'-a-D-glucopyranosyl-L-cysteine.
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More recently, studies of the synthesis of a range of glucoconjugates was published 
by Uhrig and co-workers in 2000.^  ^ They carried out the glycosylation of ibuprofen, 
a-tocopherol, gentsic acid, gallic acid, 2,6-bis(?er^butyl)-4-thiophenol and 7V-acetyl- 
L- cysteine. The carboxylic acid group of the A^-acetyl-L-cysteine was protected by 
the formation of the ethyl ester 49. p-D-glucose pentaacetate 50 was used as the 
glycosyl donor in the coupling with 49 in the presence of BF3*Et20 in 
dichloromethane to give A/'-acetyl-0-ethyl-iS-(2,3,4,6-tetra-0-acetyl-p-D- 
glucopyranosyI)-L-cysteine 51 in a yield of 45 %. Deprotection was carried out using 
10 % TEA in methanol, and during the deprotection racemization at C-2 of the 
cysteine moiety was observed by NMR. It is interesting that these are the same 
reagents employed in the deprotection of A-Z-0-methyl-<S'-(2,3,4,6-teti'a-0-acetyl-p- 
D-glucopyranosyl)cysteine 39a by Baran and Drabarek,^  ^ casting doubt on the 
isomeric purity of their products.
OAc OAc
so 49 51 A cH N '^C O .Et
OH OH
10 % TEA, MeOH
----------------------- hoX - - ^ V ^ s^,2 hoX - - - ^ ^ s^ 2OH W  OH 3 J 1
AcHN-^COjCHjCHj HaCHzCOzC^NHAc
4
52a 52b
2-R (derived from L-cysteine) 2-5 (derived from D-cysteine)
Scheme 1.29 -  The synthesis of a diastereomeric mixture of 5-glucosyI-cysteine ethyl ester.
Other work has been carried out in the formation of the iS-glycosidic linkage of 
various carbohydrates and c y s t e i n e . S o m e  of the work is incomplete in that it 
provides only evidence of the coupling reaction and the deprotection of the 
carbohydrate moiety has not been carried out. It could be that the difficulty in 
deprotection of the hydroxyl groups of the carbohydrate is great in certain cases, or 
that was never the main purpose of the work in the first instance. With this in mind 
and the methods previously discussed, it is evident that there are a number of ways to
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form the glycosidic linkage between carbohydrates and the thiol group of cysteine. 
However there is no efficient, simple and general method for the production of fully 
deprotected »S-glycosyl cysteines or iV-acetyl-iS'-glycosyl cysteines. Modifying and 
adapting the methodology in the literature, it should be possible to suggest a new 
route to these producing good yields.
It is the proposal of this project to use a carbohydrate as the protecting group for the 
thiol, e.g. 5'-(P-D-glucopyranosyl)-L-cysteine 37 and its A-acetyl derivative 53; this is 
shown in fig 1.15. This protecting group has distinct advantages in that it is non toxic 
and its metabolic pathway is well established.
OH OH
HO y HO 1
H jN ' ^ C O j H A cHN CO^H
37 53
Fig 1.15 -5-(a-D-glucopyranosyl)-L-cysteine.
It is also worth noting that whilst few thioglycoside derivatives of cysteine have been 
synthesised, thioglycoside derivatives of non-amino acids and thiols are a lot more 
common, but again their chemical and enzymatic reactivities are still not yet 
completely cleai*.
1.2.12 Chemical and enzymic reactivity of S-glycosyiated 
cysteines
From the literature reviewed it can be seen that the reactivity and stability of S- 
glycosylated cysteines and ^'-glycosylated cysteine-containing peptides towards 
enzymes is unclear and not well documented. It is commonly agreed that the 
thioglycosidic link (glyc-5 -^R) for simple thioglycosides such as the one seen in fig
1.16 is less easily “chemically” hydrolysed than its O or N derivatives.However it is 
quite unclear as to the situation with 5"-glycosylated cysteines; some research has lead 
to conclusions such as “easy ^'-cleavage” in the case of S-glycosylated cysteines and
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peptides/ '^^  ^ whilst some research is found to say “high chemical and enzymic 
stability
OH
»°H 0
HO I
54
Fig 1.16 -  An example of a thioglycoside non-amino acid derivative.
The O- and ^/-glycosidic links are cleaved in v/vo by various glycosidase and 
aminidase enzymes, but it is not known whether the ^'-glycosylated cysteines and 
peptides will act as substrates, as is the case with the O- and AT-glycopeptides, Also 
unclear is the nature and degree of reactivity if such behaviour is observed. One area 
that has been looked at is the possibility of iS'-glycosylated cysteines and peptides 
being substrates for the thioglycosidase enzymes (such as thioglucosidase also known 
as myrosinase). These are found in many biological systems including man. The 
thioglycosidase enzymes are known to act on the simpler thioglycoside derivatives, 
such as phenyl thioglucoside 54 (fig 1.16), but not much is known about their 
behaviour towards glycosylated cysteines.
1.2.13 Enzymes^^
Enzymes are proteins that act as biological catalysts. They affect the rate of many 
reactions throughout nature, including in the human body. A more traditional 
explanation of a catalyst is an agent that speeds up a chemical reaction without itself 
being consumed. For a simple reaction such as A + B Products, the reaction occurs 
by going through a transition state. Once the transition state is reached the reaction 
then proceeds to products. The energy required to convert the reactants A and B to the 
transition state is called the activation energy. It is the size of this activation energy 
which determines the rate of the reaction. A catalyst, in this case the enzyme, works 
by lowering the activation energy. This is carried out by stabihsing the transition 
state.
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Catalysts (enzymes) can work in a number of ways. Firstly, they can provide a surface 
for the reaction to take place; this surface could hold the reactants in the correct 
position to allow them to reach their transition state. It could also keep a reactant in a 
position to allow another reactant to reach it. Secondly, a catalyst can weaken bonds; 
this could be the case in a reaction such as AB -> A + B. Thirdly, the catalyst could 
also participate in the mechanism.
In the case of enzymes, substrates react and bind at a specific area called the active 
site. This is illustrated in scheme 1.30. The enzyme substrate fits into the active site 
where it binds and the reaction takes place, which is followed by a release of product. 
The active site is far more complicated than shown in scheme 1.30; generally there 
are many amino acid residues present at the active site that are responsible for the 
binding and sometimes the bond breaking/forming mechanism of the reaction.r
n
Enzyme
substrate
“Key”
Binding
Product Product
( T Reaction Release r
I/
Enzyme 
active site 
“Lock”
Scheme 1.30 -  The “lock and key” mechanism.
This is commonly known as the “lock and key” mechanism. Originally it was thought 
that the enzyme substrate fitted perfectly into the active site, and both were thought to 
be quite rigid. Some enzymes, however, catalyse a range of substrates so this analogy 
is not strictly valid. What is now proposed is that when the substrate enters that active 
site it forces it to change shape to accommodate it. This is known as Koshlands theory 
of induced fit.
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1.2.14 Inhibitors'^
There are other components which affect the rate of reaction between the enzyme and 
the substrate. These are called inhibitors. Inhibitors can be classified into two types: 
reversible and irreversible. An irreversible inhibitor will bind to the enzyme using 
covalent bonding thus binding pennanently. Amino acids such as serine and cysteine 
have nucleophilic groups, OH and SH respectively, and are often present at the active 
site of an enzyme. The nucleophilic natiue means that they can be alkylated and the 
active site is blocked permanently. This is classed as iiTeversible inhibition. No 
amount of extra substrate added will affect the rate of the reaction.
There are three type of reversible inhibitor: competitive, non-competitive and 
allosteric. Those that bind at the active site are called competitive inhibitors and 
they slow down the rate of catalysis of the reaction, they bind using non-covalent 
bonding and as a result they are reversible. The teim competitive inhibition comes 
from the substrate and inhibitor competing for the active site, so the effect of the 
inhibitor can be negated by the addition of more substrate. Non-competitive inhibitors 
bind close to the active site on the protein. The presence of the bound inhibitor 
disguises the active site thus hindering the passage of the substrate. Allosteric 
inhibitors bind on the enzyme further away from the active site. Such binding then 
brings about a conformational change in the active site and the substrate cannot bind 
correctly. These different types of inhibition can be determined thiough their kinetic 
plots. The Lineweaver Burk plot is distinctly different for each type of inhibited 
enzyme-substrate reaction.
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INHIBITOR
Binding
Active site 
conformation 
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Scheme 1.31 -  Allosteric inhibition (reversible).
1.2.15 Myrosinase and Glucosinolates92
Myrosinase is a p-thioglucosidase enzyme. The natural substrates for the myrosinase 
enzyme comprise a class o f compounds known as the glucosinolates, which are 
naturally occurring plant metabolites, shown in scheme 1.32.
OH
O
HO ri
55
R = Allyl
O3SO
HS
;
OSO1
56
Myrosinase
OH
I
HO ^OH
2
HS OSOi 
^  '
56
R - N = C = S  + HSO.
57
Scheme 1.32 -  The myrosinase catalysed hydrolysis of a glucosinolate.
Myrosinase catalyzes the hydrolysis o f the sulflir-glucose linkage o f a glucosinolate 
55 to produce D-glucose 2 and an aglycone fragment 56 which rapidly rearranges to 
form an isothiocyanate 57; it is unknown whether this second stage is enzyme 
catalysed. In the biological plant system, the glucosinolate and the myrosinase are
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separated from each other. In the process of cell damage caused by insect or pathogen, 
the enzyme and glucosinolate come together and the isothiocyanate is formed after 
hydrolysis of the glucosinolate. The isothiocyanate can then combat the pest. Over 
100 glucosinolates have been isolated. The side chain R can be a number of different 
groups including benzyl and indoyl. Allyl glucosinolate, where R is the allyl group, is 
known as sinigrin. Myi'osinase has been isolated from a many plant sources such as 
Brassica napus (rapeseed), Sinapis alba (white mustard), and Lepidium sativum L, 
(light grown cress).
Studies have been caiTied out using many different (3-glycosides as a substrate for the 
myrosinase enzyme."" Of the 29 different glycosides used, only four were found to be 
good substrates, shown in fig 1.17, sinigrin 58, benzyl glucosinolate 59, p- 
nitrophenyl-p-D-glucoside (PblPG) 60 and o-nitrophenyl-P-D-glucoside (ONPG) 61.
OH
Q
OH
HO
58
-  N O3 SO
hq: sHO
HO
OH OH NO
^ N O HO \\ ^
60 61 
Fig 1.17 -  Substrates for the myrosinase enzyme.
These studies revealed that p-D-glucose could not be replaced by any other 
carbohydrate; a-glucosides were inactive, as were simple p-glucosides such as methyl 
or phenyl. In the case of the reaction with glucosinolates, myrosinase is specifically 
activated by ascorbic acid, rates of hydrolysis being improved when ascorbic acid is 
present. However in the case of the reaction of PISIPG with myrosinase, no increase in 
rate was observed in the presence o f ascorbic acid.
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Despite the many glycosides tested, there is no information relating to thioglycosides 
where the S is par t of an amino acid or peptide. A comparison of the structure of N- 
acetyl-*9-P-D-glucosyl-L-cysteine 53 with that of sinigrin 58 is shown in fig 1.18.
«%0
OH
O
58 53
HO _
O O C  NHAc
Fig 1.18 -  A comparison of the structure of sinigrin against A-acetyl-iS'-P-D-glucosyl-L-cysteine.
The similarities structurally can be seen quite clearly. There is a P-configuration at the 
anomeric centre in both molecules. The carboxylate anion of iV-acetyl-5'-P-D- 
glucosyl-L-cysteine 53 is the charge equivalent of the sulphate anion in sinigrin. As 
mentioned previously, the nature of the R group in the side chain of the glucosinoates 
is not important. With this in mind, the lack of an equivalent "R group” for 53 may 
not be important in terms of the binding at the active site of the enzyme. Dotting et 
hypothesised that the presence of an anion in the substrate is important in the 
binding of the substrate to the active site, and so W-acetyl-*S-p-D-glucosyl-L-cysteine 
53 is preferTed in this work to the zwitterionic de-acetylated iS-P-D-glucosyl-L- 
cysteine 37. The enzymic activity of PNPG and ONPG towards myrosinase is 
incongiarous, as these two substrates are not “structurally” close to the glucosinolates, 
but they both contain a very good leaving group.
In the same study,^  ^ the enzyme activity o f myrosinase was tested for inhibition by a 
glucono-5-lactone 62, which is a known competitive inhibitor of P-glucosidase. The 
experiments carried out did not show the normal competitive inhibition which is 
generally observed with glucono-ô-lactone and P-glucosidase. Instead non­
competitive inhibition was observed, at a poor rate.
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OH
“So' HO ^'O
62
Fig 1.19 -  Glucono-5-lactone.
As mentioned previously, the reaction of myrosinase-sinigrin is accelerated by 
ascorbic acid. It is thought that ascorbic acid binds at a different site on the 
myrosinase enzyme, so the glucono-5-lactone could be binding this site. This is an 
example of non-competitive reversible inhibition that was discussed previously in this 
section. It may be that the aglycone fragment of the substrate is required to be a good 
leaving group for hydiolysis of the sulfur-glucose linkage to occur.. Just how good a 
leaving group A-acetyl-L-cysteine would be is unknown, but certainly the agylcone 
fragment of the glucosinolate has good leaving group qualities in that the subsequent 
rearrangement to a more stable species occius readily.
If binding at the active site of myrosinase is achieved then hydrolysis could occur, or 
perhaps inhibition of the enzyme.
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1.2.16- Methods of synthesis
The proposed general route to *S'-glycosylated cysteines will be based upon the 
adaptation and modification of known methodologies accessible via literature. 
This is illustrated in scheme 1.33, for the novel thioglycoside A -^acetyl-5'-(p-D- 
glucopyranosyl)-L-cysteine 53 and its a-anomer.
CO2 H acetyl chloride/MeOH CO2CH3 
'NHAc
OH
«So
OBz OBz
PhCOCl BzO HBr/HOAc
HO I pyridine OH BzO OBz
BzO I Br
SnCL
CO2 CH3
OBz
BzO I and/or
OBz
BzO X
AcHN CO2 CH3
AcHN CO2 CH3
P-anomer
OBz OH
2MHC1 BzO _______. BzO NaOMe/MeOHBzO HO(H+)
AcHN CO2 H
Scheme 1.33 -  Synthesis ofiV-acetyl-<S'-(P-D-glucopyranosyl)-L-cysteine.
The compounds as far as the tetrabenzoylglucosyl bromide are accessible via 
literature.  ^^ The coupling reaction, although not common in the literature for the 
glycosylation of thiols via glycosyl bromide is based upon the efficient SnCU 
catalysed coupling reaction used by Eloffson for the coupling of Fmoc-cysteine to p- 
D-galactose pentaacetate.^  ^Preliminary studies showed that this catalyst is capable of 
such a coupling.^ Kessler and Kâsbeck found for a related Lewis acid catalysed 
coupling, that a intermediate resulted in both a and p products being formed, so
I. Cunningham, Personal Communication.
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again a Lewis acid coupling seems sound assuming facile chromatographic 
separation, (aided by the benzoyl groups). Should the methodology prove limited in 
scope, other routes will be attempted. One such method involves the use of benzyl 
protecting groups, and has been successful in synthesis of &(a-D-glucopyranosyl)-L- 
cysteine. This is particularly attractive at the deprotection stage and deprotection of 
benzyl groups has been applied successfully to benzylated substrates using catalytic 
hydrogenation in the presence of palladium on charcoal.^^
However, despite rather limited literature references to benzoyl or acetate 
deprotection of similar coupled products, standard methodology^^ will be tried to 
yield the target A^-acetyl-P-D-glucopyranosyl-L-cysteine and its a-anomer. Similarly 
for other objectives, i.e. the galacto, manno, ribo and lactose analogues, the above 
route is proposed. This will test the scope of the route as a general route to glycosyl 
cysteines.
Therefore to summarise -  The aim of the project is to develop a simple and generally 
applicable synthetic route to *S'-glycosylated cysteines and to explore their chemical 
and enzymic reactivity. The synüietic objectives set at the start of this project were the 
preparation of glycosylated A -^acetyl cysteines from glucose, mannose, galactose, 
ribopyranose and lactose (as a representative disaccharide).
1.2.17 S-glycosylated peptides
The range of glycosylated peptides is enormous, so at the start it was envisaged that 
this project would attempt the synthesis of a glucosylated peptide only, e.g. S- 
glucosylglutathione (y-Glu-(gluc)Cys-Gly) 63, fig 1.20. Further synthetic targets 
might be an «S-glucosylated derivative of the commercially available His-Cys-Lys- 
Phe-Trp-Trp peptide as this peptide is an HIV inhibitor.^^
OH
HO
HO
NHz
63
Fig 1.20 -  iS'-glucosylglutathione.
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1.3 - Objectives
The research towards the specific objectives on a chapter by chapter basis are:
• The synthesis of a and P A^-acetyl-iS-D-glucopyranosyl-L-cysteine via a glucosyl 
bromide and V-acetyl-L-cysteine coupling reaction.
• Extension of the methodology to yield the analogues based on mannose, 
galactose, libose and lactose, and also glucosylated glutathione.
• Assess the reactivity of V-acetyl-6'-D-glucopyranosyl-L-cysteine towards acid 
hydrolysis, and as a substrate or inhibitor for the myrosinase enzyme.
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Chapter 2
S y n th es is  of /V-acetyl-S-glucosyl-L- 
cyste ine, a  and  (3 an o m ers
2.1 Introduction
2.1.1 Rationale
In chapter 1, the medicinal properties of iV-acetyl-L-cysteine (NAC) were discussed. 
Many uses were outlined: the removal of heavy metals such as Hg from the body/'^ as 
a mucolytic agent in the tieatment o f paracetamol poisoning,^ and as a precursor to 
glutathione/ the body’s major souice of countering the oxidative stress impacted 
upon cells during times of severe illness, such as cancer.
The problems of using NAC were highlighted in chapter 1; the lability and acidic 
nature of the thiol group means that NAC is rapidly oxidised to the disulphide bonded 
cystine. Although the iV-acetyl substituted amino group means that NAC is less prone 
to side-reactions than L-cysteine, no NAC is detectable in blood plasma after 12 
hours,  ^indicating fast metabolism of the drug.
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. de-glycosylation _
in vivo CO2  CO2 H
^ - ^ N H A c  
Scheme 2.1 -  Cleavage of iS-glucosyl cysteine.
The main focus of this chapter will be the protection of the thiol gioup of NAC with 
D-glucose in what is known as a “prodrug” approach. This was discussed in chapter 1. 
By masking the thiol group of NAC with a car bohydrate such as glucose, the drag has 
a greater chance of surviving oxidation prior to administration and premature 
metabolism as seen for NAC. Glycosylated ammo acids and peptides are already 
common throughout many biological systems including man; in this respect the 
glucosyl protecting gr oup of the active site is conventional and well understood.
2.1.2 Aims and Objectives
The aim of the research described in this chapter was to develop a novel and 
convenient synthetic route to a and P-V-acetyl-iS-glucosyl-L-cysteines.
The following key features were considered in designing the novel route:
• The preference of the benzoyl group as protection of the carbohydrate hydroxyl 
groups during synthesis. The benzoyl group is thought to give better crystalline 
products than acetate groups. It is reported to be more robust and it is UV active 
allowing easier chromatography. The benzyl group was also to be avoided as 
removal of the benzyl ether requires hydrogenation and the presence of sulfur* in 
the substrate may lead to poisoning of the catalyst.
• A route that can yield both a and (3-anomers.
• Improved yields and fewer steps compared to literature methods.
5'-|3-glucosyl-L-cysteine has been prepared previously by only two routes, '^  ^ S-a- 
glucosyl-L-cysteine by one route,  ^ other derivatives such as V-Fmoc-5'-(2,3,4,6-teti'a-
0-acetyl-p-D-galactosyl)-L-cysteine have been synthesised but no deprotection of the
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hydroxyl groups is reported.  ^ A^-acetyl-iS-P-D-glucosyl cysteine ethyl ester has been 
prepared but only as a 50:50 diastereomeric mixture/^ All these routes are discussed 
in detail in chapter 1. The route proposed here for the synthesis of A-acetyl-p-gluco- 
L-cysteine 7 and its a-anomer is based upon modified literature methods and is 
outlined in scheme 2 .2 .
acetyl chloride/MeOH I  ^ ^
“So
OH OBz
HO pyridine BzO Jt
OBz
SnCL BzO'
HS
% 0
C O 2 C H 3  BzO
OBz
0  HBr/HOAc B z O ^ ' X ^ ^ ^  BzO-X--^
iBz Br
OBz
NHAc
and/or
1AcHN "COzCH) 
4
OBz
2M HCI
BzO :x NaOMe/MeOHAcHN COjH
BzO %
AcHN CO 2CH3
5
OH
HO
AcHN
Scheme 2.2 -  Proposed synthesis of A^’-acetyl-jS-p-D-glucosyl-L-cysteine.
The coupling of a protected glucose moiety to NAC is to be canied out using Lewis 
acid catalysis similar to that used by Elofsson et al? However, where Blofsson 
employed galactopyranose pentaacetate as the glycosyl donor and coupled this 
directly with Fmoc protected L-cysteine using various Lewis acids, in this work it was 
decided to use tetrabenzoyl glucopyranosyl bromide 1  as the glycosyl donor to couple 
with iV-acetyl-L-cysteine methyl ester 2, in the presence of SnCL. The benzoyl group 
has been chosen for the protection of the hydroxyl gi'oup of the carbohydrate for a 
number of reasons. Firstly, the ease of preparation; the reaction of D-glucose with 
benzoyl chloride in the presence of pyridine is well established and is known to give 
good yields. Secondly, the benzoyl group is more robust than the acetate group and 
better crystalline products are often obtained. Thirdly, upon protection with the
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benzoate group, the presence of a chromophore means that the compoimd is UV 
active, making chromatography, i.e, separation of products, easier. The further 
activation of C-1 by subsequent conversion of glucopyranose pentabenzoate 3 into the 
glycosyl halide is also well established. It was intended to use tetrabenzoyl 
glucopyranosyl bromide 1 as the glycosyl donor; the Br gioup in the C-1 position of 
protected glucose will act as a better leaving group than a benzoate ester, possibly 
leading to better yields in the coupling reaction. This bromide can be prepared by the 
reaction of 3 with HBr in glacial acetic acid. For the important carbohydrate to 
cysteine coupling, SnCU was selected as the catalyst following the work of Elofsson  ^
who found SnCU to give the best yield when tested against BF3 .Et2 0  in a range of 
solvents. Preliminary studies at SuiTey supported this.  ^ Originally it was planned to 
remove the benzoate groups before hydrolysis of the methyl ester (see later), but this 
lead to racemization of the cysteine part. So it was decided that removal of the methyl 
ester on the carboxylic acid of the NAC moiety of 5 would be carried out using 2M 
aq. HCI to give A-acetyl-5'-(2,3,4,6-tetra-0-benzoyl-p-glucopyranosyl)cysteine 6 , 
followed by removal of the benzoate groups with sodium methoxide in methanol to 
give V-acetyl-»S'-P-glucopyranosyl-L-cysteine 7. This methodology will then be 
extended to prepar ation of the a-anomer 4.
An alternative route was also considered, via benzyl protection. It is a modification of 
a route via 2,3,4,6-tetra-O-benzyl-a-D-glucopyranosyl trichloroacetimidate and 
various protected cysteine derivatives to the protected Bn-a-glucosyl cysteines, which 
are then to be deprotected by hydrogenation with a Pd/C catalyst.  ^This route contains 
more steps as the protection is more complex and is outlined in scheme 2.3.
The benzyl protection of the hydroxyl groups of the carbohydrate is more difficult and 
requires the synthesis of methyl glucoside 8 . Then the subsequent benzylation 
reaction is carried out under standard conditions with benzyl bromide and sodium 
hydride to give tetrabenzyl methyl glucoside 9. The anomeric carbon C-1 must then 
be deprotected by acid hydrolysis, using the method of Aner et al.}^ to give 
tetrabenzyl glucoside 10. Due to the unstable nature of the desired glycosyl halide, it 
is necessary to further react at the anomeric centre with j9 -nitrobenzoyl chloride in the 
presence of pyridine to give the p-nitrobenzoyl-tetrabenzyl glucopyr anoside 1 1 , which 
facilitates the formation of the glycosyl halide, this is an adaptation o f the preparation
I. Cunningham, Personal Communication.
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of benzylated fucopyranosyl bromide. Tetrabenzyl glucopyranosyl bromide 12 is 
prepared in the same manner as the benzoyl eq u iva len t/b y  reaction of 11 with HBr 
in glacial acetic acid. The coupling reaction with 2 is to be carried out as before with 
SnCU in DCM. It is not known whether both a and p anomers will be obtained, it is 
reported in the literature that only the a-anomer is obtained with the benzyl protecting 
groups/ but the glycosyl donor used in that paper was different to 12. Removal of the 
benzyl groups will be by hydrogenation with palladium on carbon to produce 15, 
followed by hydrolysis of the methyl ester to give 17.
OH OH OBn
MeOH/HCl BoBr/NaH gnO O
DMP B„0 0M=OH
8
OBn OBn
2M HCl/AcOH _ 0  p-NOgBzCl/py / J ^ ^ O
OH O^ _10 11 I fo
OBn OBn
HBr/AcOH ^  2, SnCU ^  | q
BnO 1 IBr S. ^12 1 3  1  AcHN X O 2 CH3
AcHN CO2 CH3  14
OH OH
Pd/C/HCI MUHO
HO 1,AcHN CO,CH.
ho-a—T  HOMeOH/H2 0 /Toluene g
" ,AcHN COOH
Scheme 2.3 -  Proposed synthesis of A/^acetyl-^-a-glucopyranosyl-L-cysteine via Bn route.
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2.2 Results and Discussion
2.2.1 The amino acid portion: N-acetyi-O-methyl-L-cysteine
COOH
H N 2 H
Scheme 2.4 -  The synthesis of //-acetyl-O-raethyl-L-cysteine.
The reaction of iV-acetyl-L-cysteine with acetyl chloride in methanol at 0 °C, shown in 
scheme 2.4, gave after work up #-acetyl-0-methyl-L-cysteine 2 as a white solid in 
approximately 90 % yield, which was homogenous by NMR. The NMR 
experiment, caiTied out in CDCI3, after comparison with literature values showed the 
required compound had been synthesised.^  ^ A singlet at 3.80 ppm showed the 
presence of the necessary CH3O-, and also a broad peak at 6.38 ppm was indicative of 
the NH group. The melting point obtained 76-77 °C was the same as the literature 
value.
2.2.2 The Glucosyl donor: 2,3,4,64etra-0-benzoyi-a-D-glucosyl 
bromide
Hn
HO PhCOCl/py
BzO BzO
BzOBzO HBr/AcOH
BzOBzO DCM BzOBzO BrOBz
H O - X - - - 7 ^  DCM
OH
Scheme 2.5 -  The synthesis of 2,3,4,6 -tetra-O-benzoyl-a-D-glucosyl bromide.
The reaction of a-D-glucose with benzoyl chloride in dichloromethane in the presence 
of pyridine, led after workup and recrystallisation to a-D-glucose pentabenzoate 3 in 
63 % yield, which was homogenous by NMR. A NMR experiment, carried out 
in CDCI3 showed the required peaks were present. In particular, a peak at 6 . 8 6  ppm is 
assigned to H-1 and it appears as a doublet of V =  3.9 Hz; this is typical of an axial-
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equatorial coupling constant/^ indicating the a-anomer has been synthesised. The p- 
anomer with an axial H-1 would be expected to show an axial-axial coupling constant 
of ca. 10 Hz. The melting point of 178-180 °C, is also characteristic o f the expected 
product."^ In some cases when further batches were prepared with poor temperature 
control an anomeric mixtur e of a and p-anomers was obtained. However, use of such 
material did not affect the efficiency of future steps, as was expected.
The reaction of a-D-glucose pentabenzoate 3 with hydrogen bromide in glacial acetic 
acid (45 % w/v HBr) in dichloromethane, after work up and recrystallisation gave 
2,3,4,6-tetra-O-benzoyl-a-D-glucopyranosyl bromide 1 in approximately 8 6  % yield. 
The material was seen to be homogenous by H^ NMR. Identification of the product 1 
is supported by comparison with the literature melting point 148-149 
As with the H^ NMR spectrum of a-D-glucose pentabenzoate 3 a peak at 6.5 ppm is 
assigned to H-1 and has a coupling constant of V  = 4.2 Hz, this is typical of axial- 
equatorial coupling^ ^  which is indicative of the a-isomer.
The a-anomer was the only product obtained in this reaction, even if  an anomeric 
mixtiu'e of 3 was used, as mentioned in the previous section. This is due to the 
anomeric effect, discussed in section 1.2.2. The electronegativity of the Br substituent 
means the axial conformation is favoured. This is due to the interaction between the 
lone pair of electrons located axially on the ring oxygen and the anti-bonding 
molecular orbital of the C-Br bond. An axial substituent on C-1 favours this 
interaction. The tendency for the group to be axial is greater with an increase in 
electronegativity.
As with 3, further batches of this compound were often obtained in a crude form, with 
recrystallisation again proving difficult. However as with 3 the use of crude 1 did not 
significantly affect the outcome of further steps.
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2.2.3 Coupling reaction: N-acetyl-0-methyl-S-(2,3,4,6-tetra-0- 
benzoyl-D-glucopyranosyl)-L-cysteine, a and p-anomers
OBz
2 SnCk ^
^ o \ - — ^ B zO ~X --7 '‘^ - \ —S -^  a-anomer
Br ^ AcHN-^COzCHa ^
Scheme 2.6 -  The synthesis of7V-acetyl-C)-methyl-5'-(2,3,4,6-tetra-0-benzoyl-P-D-gliicopyranosyl)-L- 
cysteine and a-anomer.
Reaction of 2,3,4,6-tetra-O-benzoyl-a-D-glucopyranosyl bromide 1 with 7/-acetyl-0- 
methyl-L-cysteine 2, in dichloromethane in the presence of a SnCU catalyst led, after 
workup and column chromatography, to the isolation of iV-acetyl-O-methyl-5'- 
(2,3,4,6-tetra-0-benzoyl-P-D-glucopyranosyl)-L-cysteine 5, in 48 % cmde yield and 
7V-acetyl-0-methyl-5'-(2,3,4,6-tetra-0-benzoyl-a-D-glucopyranosyl)-L-cysteine 4, in 9 
% crude yield. The a-anomer 4 will be discussed in section 2.2.4. After 
recrystallisation of 5 fi*om ethanol, the yield decreased to 32 %. Several NMR 
experiments were carried out, (^H, COSY, HMQC, ^^ C and ^^ C DEPT), to
determine the structure, assess purity and assign signals. The material was seen to be 
homogenous by NMR and gave a satisfactory microanalysis and accurate mass. 
The identification of 5 is discussed below and the NMR assignments are given in 
table 2.1. The assignments are based on 2-D and ^^ C NMR experiments; these 
spectra are shown in figures 2.1-2.4. In particular, the peak at 4.91 ppm is assigned to 
H -r and it appears as a doublet of V =  10.0 Hz, coupled to H-2’; this shows axial- 
axial coupling,confiiming the p-stereochemistiy at C-T.
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Fig 2.1 - ‘H NMR spechum ofiV-acetyl-0-methyl-iS'-(2,3,4,6-teti*a-0-benzoyl-p-D-glucopyranosyl)-L- 
cysteine carried out in CDCI3 at 500 MHz.
m m # m m m
150 100 50 PPM
Fig 2.2 -  NMR specti um ofiV-acetyl-0-methyl-jS'-(2,3,4,6-tetra-Obenzoyl-P-D-gIucopyranosyl)-L-
cysteine canied out in C D C I 3  at 125 MHz.
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Fig 2.3 -  ‘H-'H c o s y  NMR spectrum of yV-acetyl-0-methyl-S-(2,3,4,6-tetra-0-benzoyI-P-D- 
glucopyranosyl)-L-cysteine carried out in CDCh at 500 MHz.
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Fig 2.4 -  'H- '^ C HMQC NMR spectrum of /V-acetyl-0-methyI-5-(2,3,4,6-tetra-0-benzoyl-p-D-
glucopyranosyl)-L-cysteine carried out in CDCh at 500 MHz.
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Assignment ÔC (ppm) ÔH (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
CH3-CO 2 2 . 8 1.96 8 3H
C-3 32.0 3.15 dd IH 13.9 and 6.0
C-3 32.0 3.25 dd IH 13.9 and 5.0
CH3-OC 52.7 3.70 s 3H _
C-5’ 76.6 4.24 m IH -
C-6 ’ 62.9 4.46 dd IH 12.4 and 4.9
C-6 ’ 62.9 4.72 dd IH 12.4 and 2.7
C-2 51.6 4.84 m IH -
C-1’ 83.8 4.91 d IH 1 0 . 0
C-2’ 70.4 5.51 t IH 9.7
C-4’ 69.1 5.68 t IH 9.8
C-3’ 73.8 5.93 t IH 9.5
Ni7 - 6.45 d IH 7.9
AiCH 128.5-130.2 7.27-8.06 m 20H -
Ar-C-CO 133.5-133.8 - - - -
AiC-CO- 165.4-166.4 - - - -
CH3-CO-N,
CO-OCH3
170.0 and 
171.0 .
Table 2.1 -  and "C  NMR assignments of A''“acetyl-0-meth.yl-5-(2,3,4,6-tetra-0-benzoyl-p-D-
glucopyranosyl)-L-cysteme carried out in CDCI3 at 500 MHz for *H and 125 MHz for
2.2.3.1 Explanation of the NMR assignments
BzO
BzO
OBz
HN
CH-
Fig 2.5 - iV-acetyI-(9-metliyl-5'-(2,3,4,6-tetra-0-benzoyl-P-D-glucopyranosyl)-L-cysteine.
Assignment of the peaks in the NMR spectrum involved interpretation of the
COSY, HMQC, ^^ C and ^^ C DEPT spectra.
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Firstly, the DEPT NMR spectrum identifies the two CH2- carbon signals present in 
the molecule. Consideration of fig 2.5 of A-acetyl-0-methyl-iS'-(2,3,4,6-tetra-0- 
henzoyl-(3-D-glucopyranosyl)-L-cysteine shows that these are C-3 o f the cysteine 
moiety and C-6 ’ of the glucose ring. The assignment of the corresponding signals in 
the NMR spectnim is obtained via the HMQC and with the aid of the ^H-^ H COSY 
it is seen that a pair of double doublets centred at approximately 3.20 ppm represents 
one CH2- group and a pair comprising a double doublet at 4.46 ppm and a doublet at
4.72 ppm is the remaining CH2- gioup. On closer examination the doublet at 4.72 
ppm is most likely a poorly resolved double doublet. The COSY spectrum shows the 
peaks at 3.20 ppm to couple directly to only one other peak at approximately 4.84 
ppm, a possible quartet, this peak is shown to couple to a doublet at ca. 6.45 ppm. 
Examination of the stmcture of the molecule suggests that the peaks centred at 3.20 
ppm can be assigned to H-3, with the peak at 4.84 ppm being assigned to H-2, 
meaning that the doublet at 6.45 ppm is that of the NH of cysteine, this signal shows 
no coupling to carbon in the HMQC. This is further proved by the COSY as the peaks 
of the other CH2- group at 4.46 and 4.72 ppm couple to a multiplet at ca. 4.24 ppm, 
which in turn couples to a tiiplet at 5.68 ppm. The peak at 5.68 ppm couples to 
another triplet at 5.93 ppm that couples to a triplet at 5.51 ppm. Finally the peak at 
5.51 ppm is coupled to a doublet at 4.91 ppm. This sequence of six couplings points 
to the pyranose ring structure observed in fig 2.5. Stalling fiom the peak at 4.46 ppm, 
this is a double doublet exhibiting large geminal coupling to the peak at 4.72 ppm, 
and vicinal coupling to the multiplet at 4.24 ppm; this is also the case with the peak at
4.72 ppm. The peaks at 4.46 and 4.72 ppm are assigned to H-6 ’. Proton H-5’ is 
assigned as the peak at 4.24 ppm; it is a multiplet because of coupling with the two 
protons of H-6 ’ and the peak at 5.68 ppm which is H-4’. The signal for H-4’ appears 
as a triplet due to its axial orientation. It couples to H-5’ at 4.24 ppm and H-3’ at 5.93 
ppm which are both positioned axially. It is because of this axial-axial-axial system 
that a triplet with large coupling constants of V =  9.8 Hz is present. H-4’ couples to 
H-3’, which is a triplet at 5.93 ppm. The same axial-axial-axial system is observed 
once more with H-3’ coupled to H-2’, which is also positioned axially, at 5.51 ppm. 
The presence of a triplet similar to those of H-4’ and H-3’ for H-2’ is noted, pointing 
to an axial configuration of the proton at H-1’. The proton H-2’ is vicinally coupled to 
a doublet at 4.91 ppm, this can only be H-1’ with a coupling constant of 10.0 Hz, 
which is indicative of axial-axial coupling, showing ^-configuration. The a-anomer
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would have a much lower coupling constant of ca, 5 Hz, due to axial-equatorial 
coupling ,see section 2.2.4. The signal H-2’ of the a-anomer would also be a double 
doublet as opposed to the triplet observed due to the axial-axial-equatorial system 
present. Two singlets can be seen in the H^ NMR spectrum at 1.96 and 3.70 ppm. The 
integration for both peaks shows three protons. These are the CHg-groups of the N- 
acetyl and the methyl ester of the cysteine residue. As the CHg-group of the iV-acetyl 
is adjacent to a carbonyl group, it is likely to be far more shielded and is therefore the 
peak at 1.96 ppm, leaving the more deshielded methyl ester CHg-group as the singlet 
at 3.70 ppm. A complex series of multiplets from 7.27 to 8.08 ppm is seen and can be 
assigned to the aromatic protons. The integration for this range shows twenty protons 
which is correct for the four benzoyl groups around the carbohydrate ring. No further 
assignments were made because of the complexity of these multiplets.
2.2.4 Coupling reaction: N-acetyi-0-methyi-S-(2,3,4,6-tetra-0- 
benzoyi-a-D-giucopyranosyi)-L-cysteine
OBZ OBZ
+ p-anomer
BzO DCM s
1 J L  5 ^ AcHN-^COzCHa
Scheme 2.7 -  The synthesis of//-acetyl-0-methyl-iS-(2,3,4,6-tetia-0-benzoyi-a-glucopyranosyl)-L- 
cysteine and P-anomer.
Reaction of 2,3,4,6-tetra-O-benzoyl-a-D-glucopyranosyl bromide 1 with A-acetyl-O- 
methyl-L-cysteine 2, in dichloromethane in the presence of a SnCl4  catalyst led, after 
workup and cohunn chromatography, to the isolation of A-acetyl-O-methyl-jS'- 
(2,3,4,6-tetra-0-benzoyl-a-D-glucopyranosyl)-L-cysteine 4, in 9 % crude yield, which 
was homogenous by ^H NMR, and A-acetyl-0-methyl-5'-(2,3,4,6-tetra-0-benzoyl-(3- 
D-glucopyranosyl)-L-cysteine 5, in 48 % cmde yield, the p-anomer 5 is discussed in 
section 2.2.3. Several NMR experiments were carried out: ^H, ^H-^ H COSY, HMQC, 
^^ C and ^^ C DEPT. The identification of 4 is discussed below and the H^ NMR 
assignments are given in table 2.2. The assignments are based on 2-D H^ and ^^ C
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NMR experiments; these are shown in figures 2.6-2.9. In contrast to the p-anomer 5, 
the peak assigned to H-1’ is now at 5.8 ppm rather than 4.91 ppm, and it appears as a 
doublet with a smaller coupling constant of = 5.5 Hz; this shows axial-equatorial 
coupling, showing that the a-anomer has been isolated.
H OBz
H o
BzO
3 ' H
A
u i
Fig 2.6 -  NMR spectrum of A'-acetyl-0-methyl-iS'-(2,3,4,6-tetra-0-benzoyl-a-D-glucopyianosyl)-L- 
cysteine carried out in CDCI3 at 500 MHz.
150 100 60 PPM
Fig 2.7 -  NMR spectrum o f A'-acetyl-0-methyl-iS'-(2,3,4,6-tetra-0-benzoyl-a-D-glucopyranosyl)-L-
cysteine cairied out in C D C I 3  at 125 MHz.
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Fig 2.8 -  'H-'H c o s y  NMR spectrum of Y-acetyl-0-methyI-5-(2,3,4,6-tetra-0-benzoyl-a-D- 
glucopyranosyI)-L-cysteine carried out in CDCI3 at 500 MHz.
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Fig 2.9 -  'H-'^C HMQC NMR spectrum of Y-acetyl-0-methyi-5-(2,3,4,6-tetra-0-benzoyl-a-D- 
glucopyranosyl)-L-cysteine carried out in CDCI3 at 500 MHz.
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Assignment 5c (ppm) 5h (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
CHs-CO 23.0 2.03 s 3H -
C-3 34.7 3.08 dd IH 14.5 and 2.3
C-3 34.7 3.25 dd IH 14.5 and 5.0
CHs~OC 52.7 3.75 s 3H _
C-6 ’ 62.4 4.50 dd IH 12.5 and 4.1
C-5’ 69.2 4.77 m IH -
C-6 ’ 62.4 4.92 d IH 12.5
C-2 52.3 5.03 m IH -
C-2’ 71.6 5.45 dd IH 9.3 and 5.5
C-4’ 69.0 5.75 t IH 9.8c-r 84.7 5.86 d IH 5.7
C-3’ 70.5 5.99 t IH 9.5
- 6.79 d IH 7.6
ArCH 128.6-130.3 7.29-8.14 m 20H -
ArC-CO 133.5-133.9 - - - -
ArC-CO 165.4-166.4 - - - -
CH3-CO-N,
CO-OCH3
170.0 and 
170.7 .
\
Table 2.2 -  *H and NMR assignments of/i/-acetyl-0-methyl-^-(2,3,4,6-tetra-0-benzoyl-a-D- 
glucopyranosyl)-L-cysteine carried out in CDCI3 at 500 MHz for and 125 MHz for
2.2.4.1 Explanation of the NMR assignments
BzO
BzO
OBz
HN
CH-
Fig 2.10 - N-acetyl-0-metliyl-iS-(2,3,4,6-tetra-0-benzoyl-a-D-gIucopyranosyl)-L-cysteine.
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As with the P-anomer assignment of the peaks in the NMR spectrum involved 
interpretation the COSY, HMQC, ^^ C and ^^ C DEPT spectra.
Again, the DEPT NMR spectrum identifies the two CH2- carbon signals present in the 
molecule; C-3 of the cysteine moiety and C-6 'of glucose. Using the rationale behind 
the assignment of the H^ NMR spectrum of the P-anomer it is easy to assign the peaks 
of H-3 and H-6 ’ firom the HMQC spectrum as it follows the same pattern. A pair of 
double doublets is centied near 3.08 ppm and this can be assigned to H-3’ this is 
reinforced by the COSY spectrum, which shows this peak coupled to a multiplet at 
5.03 ppm which in turn is coupled to a doublet at 6.79 ppm. From the HMQC 
spectrum it can be seen that the other CH2- signal gives peaks in the *H NMR 
spectrum at 4.50 and 4.92 ppm, these are assigned as H-6 ’ and both appear as double 
doublets, although the peak at 4.92 ppm is poorly resolved. As with the H-6 ’ of the P- 
anomer, the double doublet at 4.50 ppm shows a large geminal coupling to the peak at 
4.92 ppm. The COSY spectrum shows vicinal coupling to a multiplet at 4.77 ppm. 
Coupling with this peak is observed for the H-6 ’ peak at 4.92 ppm. The proton H-5’ is 
assigned as the peak at 4.77 ppm. The multiplet comes from the coupling with the two 
protons of H-6 ’ and with one other peak, shown as the peak at 5.75 ppm by the COSY 
spectrum. This triplet is assigned as H-4’, as for the p-anomer. The same axial-axial- 
axial system is present, accounting for the large coupling constant o f V =  9.8 Hz. Use 
of the COSY allows the rest of the carbohydrate protons to be assigned as this peak 
further couples to a peak at 5.99 ppm which can only be H-3’. This peak is a triplet as 
it is positioned axially on the carbohydrate ring and it is adjacent to the axially 
orientated H-4’ and H-2’. Proton H-3’ couples to a double doublet which is assigned 
as H-2’. Unlike the p-anomer, H-2’ is adjacent to the axially positioned H-3’ and the 
equatorially positioned H-1’, and so H-2’ appears as a double doublet rather than the 
triplet of H-2’ of the p-anomer. The doublet at 5.86 ppm can be seen to couple to H-2’ 
from the COSY and is assigned as H-1’ with coupling constant of V =  5.7 Hz, smaller 
than the 10.0 Hz of H-1’ of the P-anomer, confirming the compound as the a- 
anomer as shown in fig 2.10. The singlet showing thr*ee protons by integration at 2.03 
ppm is the CH3 of the A-acetyl group of the cysteine residue, while the three proton 
singlet at 3.75 ppm is the more deshielded CH3 of the methyl ester, also of cysteine. 
The peaks from 7.29-8.14 ppm are assigned to the aromatic protons of the benzoyl 
groups around the glucose ring, the integration of twenty protons is correct. Again as
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with the p-anomer, no particular aromatic peaks can be assigned due to the 
complexity of this region.
2.2.4.2 Discussion
An SnI mechanism is suggested for the coupling reaction of 2,3,4,6-tetra-O-benzoyl- 
a-D-glucopyranosyl bromide with A-acetyl-O-methyl-L-cysteine and is shown in 
scheme 2,8. The Br-group at C-1 coordinates to the SnCU and a C-1’ carbocation is 
formed. This carbocation is stabilised by resonance of the lone pair o f electrons on the 
ring oxygen of glucose. Attack of the iV-acetyl-O-methyl-L-cysteine nucleophile can 
then occur ‘above’ and ‘below’ to give the anomeric a/p mixture.
Slow
OBz 
BzO
OBzOBz I B
BZO-V— \B z O -X -" 7 '* * '^ S -^  BzO \  )  IBzO } %  \AcHN'^COjCHj /-CO2CH3
HN\+ a-anomer COCH3
Scheme 2.8 -  Proposed SnI mechanism for the coupling of 2,3,4,6-tetra-(9-benzoyl-a-D- 
glucopyranosyl bromide with A'-acetyl-O-methyl-L-cysteine.
An Sn2 mechanism is imlikely. The sulfur nucleophile would attack the a- 
bromoglucose compound at C-1 with inversion, and only the p-anomer would be 
formed. A subsequent equilibration is unlikely given the poor nucleofiigacity of ‘S’. 
Synthesis of 4 and 5 was generally carried out with stirring at room temperatiue over 
a period of 24 hours. If the mixture was stirred for longer, no a-anomer was isolated.
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2.2.5 Hydrolysis of the methyl ester: N-acetyl-S-(2,3,4,6-tetra-0- 
benzoyi-p-D-giucopyranosy!)-L-cysteme
OBz OBz
BzO I BzO 1
A cH N -^ C O jC H a A c H N '^ C O O H
Scheme 2.9 — The synthesis ofiV-acetyl-iS'-(2,3,4,6-tetra-0-benzoyl-p-D~glucopyranosyl)-L-cysteme.
The reaction of A’“acetyl-0-methyl-5'-(2,3,4,6-tetra-0-benzoyl-P-D-glucopyranosyl)- 
L-cysteine 5 with 2M HCl at 90 °C for 144 hours with workup and purification by 
column chromatography gave A-acetyl-6'-(2,3,4,6-tetra-0-benzoyl-P-D- 
glucopyranosyl)-L-cysteine 6  as a white powder in ca. 52 % cmde yield which was 
homogenous by NMR. The reaction was monitored by TLC, using 
dichloromethane: ethyl acetate 7:3, appearance of a spot on the baseline indicating 
product formation. A range of NMR experiments was carried out, ^H, COSY, 
HMQC, *^ C and *^ C DEPT, to confirm the structure. Solvent choice for the NMR was 
difficult, because although the product appeared soluble in CDCI3 the H^ NMR 
spectrum was never fully resolved. Solvent CD3 OD gave good resolution but some 
peaks are grouped together in the H^ NMR spectrum.
The H^ NMR spectrum (fig 2.11) is similar to that of the precursor 5, Most noticeable, 
is the absence of the methyl peak. The large singlet at ca. 3.3 ppm is residual 
methanol present in the CD3 OD. The large triplets, all showing large coupling 
constants, of H-2’, H-3’ and H-4’ are present at 5.53, 5.99 and 5.73 ppm respectively, 
as is the doublet of H-1’ at 5.17 ppm, the slight shift changes relative to 5 are 
attributed to the change in solvent fi'om CDCI3 to CD3 OD since the structural change 
in the molecule is so small. The other NMR experiments confirm the assignment of 
each peak, reasoned analogously to the cases of 4 and 5. LRMS was carried out but 
the molecular ion could not be identified. This was surprising since the precursor 5 
gave a good LRMS and accurate mass.
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Fig 2.11 -  *H NMR spectrum of A^-acetyl-iS'-(2,3,4,6-tetia-C?-benzoyI-p-D“glucopyranosyl)-L-cysteine 
carried out in CD3OD at 500 MHz.
Assignment ÔC (ppm) ÔH (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
CH3-CO 22.9 1.81 s 3H -
C-3 33.4 3.05 dd IH 13.6 and 8.3
C-3 33.4 3.38 dd IH 13.8 and 4.7
C-5’ 77.2 4.37 m IH -
C-6 ' 64.5 4.51 m IH -
C-6 ’ 64.5 4.62 dd IH 12.4 and 3.2
C-2 55.4 4.51 m IH -
C -r 84.5 5.17 d IH 1 0 . 0
c-2’ 72.4 5.53 t IH 1 0 . 0c-4’ 71.2 5.73 t IH 9.8
c-3’ 75.9 5.99 t IH 9.5
AxCH 128,1-129.8 7.16-7.99 m 20H -
ArC-CO 133.2-133.5 - - - -
ArC-CO 165.5-166.4 - - - -
CH3-CO-N,
CO-OH
173.4 and 
177.7 .
Table 2.3 -  'H and NMR assignments ofA^-acetyl-5'-(2,3,4,6-tetia-0-benzoyl-p-D-
glucopyi'anosyl)-L-cysteine canied out in CD3OD at 500 MHz for *H and 125 MHz for
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The removal of the ester was achieved in reasonable yield and to give adequate 
product purity. After ca. 96 hours an additional product was visible by TLC, this was 
never isolated but it could have been the de-acetylated product »S-(2,3,4,6-tetra-0- 
benzoyl-P-D-glucopyranosyl)-L-cysteine.
2.2.6 Hydrolysis of the methyl ester: N-acetyl-S-(2,3,4,6‘tetra-0- 
benzoyl-a-D-glucopyranosyiyL-cysteine
OBz OBz
2MHC1 „  q
 —  ---
BzO I BzO
S
1  ' XA cH N -^C O jC H s AcHN' COOH
4 16
Scheme 2.10 - The synthesis of A -^acetyi“y-(2,3,4,6-tetra-0-benzoyl-a-D-glucopyranosyl)-L-cysteine.
The reaction of iV-acetyl-0-methyl-*S'-(2,3,4,6-tetra-0-benzoyl-a-D-glucopyranosyl)- 
L-cysteine 4 with 2M HCl at 90 °C for 96 hours after workup and puiification by 
column chromatogiaphy gave iV-acetyl“5'-(2,3,4,6-tetra-0-benzoyl-a-D- 
glucopyranosyl)-L-cysteine 16 as a white powder in ca. 75 % crude yield. As with the 
p-anomer, the reaction was monitored by TLC, using dichloromethane; ethyl acetate, 
7:3, with the appearance of a spot on the baseline again indicating product formation. 
The ^H, ^H-^ H COSY, HMQC, ^^ C and ^^ C DEPT NMR experiments were carried out 
in CD3OD. Examination of the H^ NMR spectrum showed trace impurity peaks at 2.5 
and 2.8 ppm and it was estimated hat the material was ca. 93 mol % pure. The ^^ C and 
2-D NMR experiments allow assignment of each peak, and as with the p-anomer 6  
reasoning was as for 4 and 5. It is clear fi:om fig 2.12 that the signal of the methyl 
ester is no longer present. As with the P-anomer, the tall singlet at 3.3 ppm is residual 
methanol present in the CD3OD. Mass spectroscopy gave no clean spectrum as with 
the P-anomer 6 . Like previous reaction of the p-anomer, the first spot isolated was 4, 
No third spot was present on the TLC as there was for the p-anomer.
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Fig 2.12 -  *HNMR spectrum of A^-acetyl-iS-(2,3,4,6-tetia-C>-benzoyi-a-D-glucopyranosyl)-L-cysteine 
carried out in CD3OD at 500 MHz.
Assignment ÔC (ppm) 6 h  (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
CH3-CO 2 2 . 8 2.03 s 3H _
C-3 34.3 3.07 bt IH 14.1
C-3 34.3 3.25 bt IH 13.2
C-6 ’ 64.2 4.58 dd IH 12.3 and 4.0
C-2 56.2 4.64 m IH 4.0
C-6 ’ 64.2 4.70 d IH 12.3
C-5’ 69.8 4.93 m IH -
C-2’ 73.1 5.64 bt IH 9.4 and 5.5
C-4’ 70.9 5.82 t IH 9.8
C-3’ 72.6 6.03 t IH 9.7
C -r 85.4 6.07 bs IH -
AxCH 128.3-129.7 7.30-8.13 m 20H -
AiC-CO 133.2-133.7
Ai'C-CO 165.4-166.5 - - - -
CH3-CO-N,
CO-OH
173.6 and 
177.0
Table 2.4 -  ‘H and NMR assignments of A'^acetyl-0-methyl-5-(2,3,4,6-tetia-C>-benzoyl-a-D-
gIucopyranosyl)-L-cysteine carried out in C D 3 O D  at 500 MHz for ‘H and 125 MHz for
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2.2.7 Deprotection of the glycosyl portion: N-aoetyi-p-D- 
glucopyranosyl-L-cysteine
OBz OH
NaOMe/MeOII HO'HO
BzO HO
COOHAcHN AcHN-^ COOH
Scheme 2.11 - The synthesis ofiV-acetyl-P-D-glueopyranosyl-L-cysteine.
Reaction of iV-acetyl-S'-(2,3,4,6-tetra-(9-benzoyl-p-D-glucopyranosyl)-L-cysteine 6  
with freshly prepared sodium methoxide in methanol at room temperature, gave after 
workup and column cliromatography iV-acetyl-P-D-glucopyranosyl-L-cysteine 7 as a 
deal' oil in 6 8  % yield, wliich was seen to be homogenous by NMR. Full NMR 
analysis was caiTied out including *H, *H-*H COSY, HMQC, ^^ C and ^^ C DEPT 
experiments. The NMR peaks are assigned in table 2.5; these assignments are 
made subjectively and are based upon the ‘H, ^^ C and 2-D NMR experiments that 
have been carried out.
OH
HO
HO
COOH
CH
JVJ
PPM
Fig 2.13 — The NMR spectrum of Y-acetyl-p-D-glucopyi'anosyl-L-cysteine carried out in CD3OD at 
500 MHz,
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Assignment 5c (ppm) 5h (ppm) Multiplicity Integral
Coupling 
constant/  ^J  
(Hz)
CH-i-CO 23.1 2 . 0 2 s 3H -
C-3 33.9 3.00 bt IH 13.6 and 7.1
C-2’ 74.5 3.18-3.39 m IH -
C-3 33.9 3.18-3.39 m IH -
C-3’ 79.7 3.18-3.39 m IH -
C-4’ 71.6 3.18-3.39 m IH T
C-5’ 82.3 3.18-3.39 m IH -
C-6 ’ 63.0 3.65 dd IH 12.2 and 5.5
C-6 ’ 63.0 3.87 dd IH 1 2 . 0  and 1 . 6
C-1’ 87.3 4.38 d IH 9.9
C-2 56.3 4.47 m IH -
CH3-CO-N,
CO-OH
173.0,
177.6 .
Table 2.5 -  and NMR assignments of A/-acetyl-p-D-glucopyranosyl-L-cysteine carried out in 
CD3OD at 500 MHz for and 125 MHz for
2.2.7.1 Explanation of the NMR assignments
HO.
HO
OH
■COOHHN
Fig 2.14 - //-acetyl-P-D-glucopyranosyl-L-cysteine.
Some of the assignments in table 2.5 are assigned subjectively because o f difficulty in 
assigning the large multiplet centred at ca. 3.30 ppm. The COSY spectrum is poorly 
resolved in this area so it is not possible to clarify the exact coupling pattern. The 
DEPT spectrum reveals the two methylene groups of 7 in the spectrum, and with 
the aid of the HMQC also the peaks in the proton spectrum. Two double doublets at 
3.65 and 3.87 ppm are coupled geminally to each other and a double doublet at 3.00 
ppm is coupled to a component o f the multiplet at 3.18-3.39 ppm and a multiplet at
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4.47 ppm. In the NMR spectra of the precursors 5 and 6 , the peaks representing H- 
3 are found at ca. 3.00 ppm so the double doublet at 3.00 ppm is assigned to H-3 also. 
The proton H-2 is likely to be highly deshielded, being adjacent to both carbonyl and 
amide functional groups, so the signal at 4.47 ppm is assigned as H-2; furthermore 
this signal shows only small coupling as would be expected of the vicinal  ^rather than 
geminal partner of H-3. The other H-3 is assigned as the component of the multiplet at 
3.18-3.39 ppm. Following this rationale, the peaks at 3.65 and 3.87 ppm are those of 
H-6 ’; this is consistent as the protons of H-6 ’ are adjacent to a hydroxyl group and as 
a result are likely to be more deshielded than the H-3 of the cysteine moiety. The 
doublet at 4.38 ppm with a large coupling constant of V =  9.9 Hz is assigned to H-1’ 
as this is the only remaining proton in 7 that would be expected to be a simple 
doublet. The large coupling constant of V  = 9.9 Hz is indicative of the p-anomer. 
The three proton singlet at 2.02 ppm represents the acetyl group of cysteine. Signals 
due to the remaining proton of H-3 and also protons H-2’, H-3’, H-4’and H-5’ could 
not be easily distinguished due to the complexity of the multiplet between 3.18-3.19 
ppm. However the COSY spectrum allows us to identify the position of certain peaks 
within the multiplet. Proton H-2’ is the peak at ctz. 3.18 ppm, adjacent to the signal for 
the proton of H-3 at ca. 3.22 ppm. The signal corresponding to proton H-3’ is 
positioned at the opposite end of the multiplet at ca. 3.38 ppm. The signals of protons 
H-4’ and H-5’ make up the peaks in the multiplet at ca. 3.31 ppm. It is because of 
these assignments that it is possible to assign fully the ^^ C spectrum.
1.2.1.2 Discussion
The removal of the benzoate groups of 6  was reasonably straightforward, and after 
column chromatography a reasonable yield was obtained. Prior to deprotection of 6 , 
the removal o f benzoate was carried out on the ester A-acetyl-0-methyl-»S'-(2,3,4,6- 
tetra-0-benzoyl-p-D-glucopyranosyl)-L-cysteine 5, but a diastereomeric mixture was 
obtained with racemization occurring at the H-2 of the cysteine residue. This is 
consistent with the literature precedent for a related compound; A-acetyl-3-(j3-D- 
glucopyranosyl)-L-cysteine ethyl ester °^ and the actual details are outlined in section 
2 . 1.2 .
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2.2.8 Deprotection of the glycosyl portion: N-acetyl-a-D- 
glucopyranosyl-L-cystelne
O B z OH
N aO M e/M eO H O.
B zO
; x
HO
A c H N  COOH :xA c H N  COOH
16 17
Scheme 2.12 -  The synthesis ofiV-acetyl-a-D-glucopyranosyl-L-cysteine.
Reaction of iV-acetyl-«S'“(2,3,4,6-tetra-0-benzoyl-a-D-glucopyranosyl)-L-cysteine 16 
with freshly prepared sodium methoxide in methanol at room temperatuie, gave after 
work up and column chromatography A^-acetyl-a-D-glucopyranosyl-L-cysteine 17 as 
a deal' oil in 6 8  % yield. Full NMR analysis was carried out using *H, *H-^ H COSY, 
HMQC, ^^ C and ^^ C DEPT experiments. Examination o f the NMR spectrum, fig 
2.15, shows tiace impurity peaks and suggests the material is at least 91 mol % pure. 
The NMR peaks are assigned in table 2.6; these assignments are made subjectively 
and are based upon the ’H, ’ C^ and 2-D NMR experiments that have heen cairied out.
HO
HO
OH
HN COOH
PPM
Fig 2.15 -  *11 NMR spectrum of A^-acetyl-a-D-glucopyranosyl-L-cysteiiie carried out in DgO at 500 
MHz.
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Assignment ÔC (ppm) ÔH (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
OTs-CO 22.7 2.07 s 3H _
C-3 34.3 3.06 d 2H 6 . 0
C-4’ 70.2 3.44 t IH 9.2
C-3’ 74.3 3.56 t IH 1 0 . 0
C-2’ 71.8 3.79-3.86 m IH -
C-6 ’ 61.0 3.79-3.86 m 2H -
C-5’ 73.1 3.79-3.86 m IH -
C-2 55.9 4.44 t IH 6 . 0C-r 87.8 5.44 d IH 5.4
CH3-C0 -N,
CO-OH
173.4 and 
177.0
Table 2.6 -  and NMR assignments of A'^acetyl-a-D-glucopyranosyl-L-cysteine carried out in 
D2 O at 500 MHz for and 125 MHz for
2.2.8.1 Explanation of NMR assignments
HO
HO
OH
HN
C H 3
Fig 2.16 - A'^acetyl-a-D-glucopyranosyl-L-cysteine,
The assignments in table 2.6 are in part subjective because of difficulty in assigning 
the large multiplet at ca, 3.85 ppm. The DEPT spectrum identifies the two 
methylene groups of 17 in the spectrum, and with the aid of the HMQC also these 
peaks in the proton spectrum. A doublet, with an integration indicating two protons, at 
3.06 ppm is coupled vicinally ( V =  6 . 0  Hz) to a triplet at 4.44 ppm. In the NMR 
spectra of the precursors 4 and 16, the signal representing H-3 is usually found at ca. 
3.00 ppm, but it has generally been a double doublet. However, as the signal to which
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it couples at 4.44 ppm is not coupled to any other signal,  ^ the doublet at 3.06 ppm is 
assigned subjectively to H-3 of cysteine and the triplet at 4.44 ppm is assigned as H-2; 
H-2 is likely to be highly deshielded, being adjacent to both carbonyl and amide 
functional groups. Following this rationale, the DEPT and HMQC spectra show the 
other remaining methylene group as giving rise only to a signal in the ^H NMR 
spectrum centred at ca, 3.85 ppm which is a multiplet with an integration of three 
protons. The multiplet at 3.85 ppm must be made up of the two protons of H-6 ’ (this 
is consistent as the protons of H-6 ’ are adjacent to a hydroxyl group and as a result are 
likely to be more deshielded than the H-3 of the cysteine moiety) plus one other 
proton. From the COSY spectnnn we can see that the signal at 3.85 ppm couples to 
three other signals. Firstly it couples to a doublet at 5.44 ppm, which itself does not 
couple to anything else; this could mean that the remaining component of the 
multiplet at 3.85 ppm represents H-2’, and the doublet at 5.44 ppm, with the small 
coupling constant o f 5.4 Hz, is the signal due to H-1’; the only expected doublet 
remaining, A component of the multiplet at ca. 3.85 ppm couples to a component of 
the same multiplet at 3.85 ppm which is assigned to H-5’, which itself couples to H- 
4’, a triplet at ca. 3.44 ppm. The signal H-4’ is a triplet due to the axial position of 
itself and its two neighbouring protons H-3’ and H-2’. Proton H-4’ couples to a signal 
at 3.56 ppm which is assigned as H-3’; H-3’is a triplet for the same reason as H-4’, 
the axial position of itself and its neighbouring protons. The signal o f H-3’ couples to 
a component of the multiplet at 3.85 ppm, which was previously hypothesised to be 
H-2’. The coupling constant of 5.4 Hz for H-1’ at 5.44 ppm is indicative o f the a- 
anomer.^  ^ The three proton singlet at 2.07 ppm represents the acetyl group of the 
cysteine.
H-5’, to which H-6 ’ would couple, would be expected to show clear coupling to H-4’.
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2.2.9 An alternative route to N-acetyl-O-methyl-a-glucopyranosyl- 
L-cysteine. Blocking of the anomeric position: Methyl jS-D- 
glucopyranoslde
The above route was successful in yielding both a and p-anomers of iV-acetyl-6 '- 
glucosyl-L-cysteine. However the major product was the p-anomer. It was decided to 
design an alternative route to obtain a better yield of the a-anomer, as discussed in 
more detail in the introduction of this chapter.
O H  OH
H O  HO
Scheme 2.13 -  The synthesis of methyl P-D-glucopyranoside.
The reaction of glucose with MeOH/HCl, led after workup and recrystallisation of a 
crude oil to isolation of methyl p-D-glucopyranoside 8 , in ca. 42 % yield, which was 
homogenous by H^ NMR. A H^ NMR experiment showed the appearance of a methyl 
singlet at ca. 3.2 ppm and the melting point 106-109 °C is characteristic of the p- 
anomer which has a literature melting point of 107
2.2.10 Benzyl protection and deprotection of the anomeric position: 
2,3,4,6-tetra-O-benzyka-D-glucopyranoside
OH OBn O Ba
HO DMF BnO BnO 1OH8 9 10
Scheme 2.14 -  The synthesis of 2,3,4,6 -tetra-O-benzyl-a-D-glucopyranoside.
The reaction o f methyl p-D-glucopyranoside 8  with benzyl bromide and NaH in 
DMF, gave after work up l-0-methyl-(2,3,4,6-tetra-0-benzyl)-D-glucopyranoside 9, 
as a clear brown oil in approximately 82 % crude yield. H^ NMR showed peaks in the
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aromatic region and also a singlet at ca. 3.4 ppm, representing the O-Me group 
attached at C-1 of the glucose ring.
l-0-methyl-(2,3,4,6-tetra-0-benzyl)-D-glucopyranoside 9 was heated to reflux in 2M 
HCl/acetic acid, and after cooling, the white crystals formed were filtered and 
recrystallised fi:om methanol to give 2,3,4,6-tetra-O-benzyl-a-D-glucopyranoside 10 
in 23 % crude yield. The material was seen to homogenous by NMR. The NMR 
spectrum showed the absence of the methyl singlet which was present at ca. 3.4 ppm 
in the NMR spectinm of 9. A melting point of 148-149 °C was obtained, and is 
characteristic of the expected product.
2.2.11 Activation of the anomeric position: 1-0-p-nitrobenzoyi- 
(2,3,4,6-0-benzyi)-a-D-giucopyranoside
OBnOBn
p-nitrobenzoyl chloride/py
BnO"BnO NO;DCM BnOBnO OH
Scheme 2.15 -  The synthesis of l-C>-p-nitrobenzoyl-(2,3,4,6-0-benzyl)-a-D-glucopyranoside.
The reaction of 2,3,4,6-tetra-O-benzyl-a-D-glucopyranoside 10 with j^-nitrobenzoyl 
chloride in dichloromethane, in the presence of pyridine gave, after workup and 
recrystallisation firom methanol, l - 0 -/7-nitrobenzoyl-(2 ,3 ,4 ,6 -0 -benzyl)-a-D- 
glucopyranoside 11 as fine, white crystals in 52 % crude yield, which was 
homogenous by NMR. The NMR experiment showed new aromatic peaks 
assignable to the j9 -nitiobenzoyl group between 8.2 and 8.3 ppm. A doublet at 6.0 
ppm with a coupling constant of V  = 3.0 Hz is assignable to H-1. The H^ NMR 
spectrum and melting point, 127-128 °C are characteristic of the expected product.
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2.2.72 Activation of the anomeric position (bromination): 2,3,4,6- 
tetra-O-benzyl-a-D-glucopyranosyl bromide
OTn OBn
HBr/AcOH
1  ^  DCM BnO n  ^11 T 12o
Scheme 2,16-T h e  synthesis of 2,3,4,6 -tetra-O-benzyl-a-D-glucopyranosylbromide.
The reaction of l-0-^-mtrobenzoyl-(2,3,4,6-0-benzyl)-a-D-glucopyranoside 11, with 
hydrogen bromide in glacial acetic acid (45 % w/v HBr) in dichloromethane, after 
workup and recrystallisation gave 2,3,4,6-tetra-O-benzyl-a-D-glucopyranosyl 
bromide 12 in approximately 82 % crude yield. NMR suggests the material to be 
ca. 93 mol % pure. NMR analysis showed the absence of the /?-nitrobenzoyl 
aromatic peaks that were present in the spectrum of 1 1 , and a change in the position 
of H-1 at ca. 6.4 ppm, shifting from 6 . 6  ppm as seen in the spectrum of 11. According 
to the literature benzylated glycosyl bromides are relatively u n sta b le ,so  because o f  
this 12 was used directly in the coupling reaction with iV-acetyl-O-methyl-L-cysteine 
without any ftirther purification or characterisation.
2.2.73 Coupling reaction: N-acetyI-0-methyi-S-(2,3,4,6-tetra-0- 
benzyl-a-D-gIucopyranosyl)-L-cysteine
OBn HS N H A c SnCl4
BnO DCMBr
12
OBn
B ^
S
AcHN   CO2 CH3
BnO 1 
13 ' 1
Scheme 2.17 -  The synthesis ofiV-acetyl-(9-methyl-iS'-(2,3,4,6-tetra-0-benzyl-a-D-glucopyranosyl)-L- 
cysteine
Reaction of 2,3,4,6-tetra-O-benzyl-a-D-glucopyranosyl bromide 12 with A-acetyl-O- 
methyl-L-cysteirie 2, in dichloromethane in the presence of a SnCU catalyst led, after
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workup and column chromatogiaphy, to the isolation o f A/^acetyl-O-methyl-5'- 
(2,3,4,6-tetra-0-benzyl-a-D-glucopyi*anosyl)-L-cysteine 13, in 35 % crude yield. 
Recrystallisation from ethanol was successful, although decreasing the yield to 20 % 
and gave a sample homogenous by NMR, (fig 2.17). A range o f NMR experiments 
was carried out including ^H, ^H-*H COSY, HMQC, ^^ C and ^^ C DEPT experiments. 
An accurate mass spectrum gave the correct empfrical formula. The ‘H NMR 
spectrum (fig 2.17) shows a peak at 5.1 ppm with a coupling constant of V =  5.3 Hz, 
which is assigned to H-T indicating that the a-anomer has been isolated.
H-4' OBn
I H-6 ’ H-2’
BnO H-1’
BnO
OBn
H-3H-3'
HN
■CH,
T  I  I  I I I  I I  I  I  I  I  i  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I— I— I— I— I— I— I— I— I— I— I— I— I— r
8.0 8.0 6.0pm no 4.0 2.0 1.0
PPM
Fig 2.17 -  ‘H NMR spech um of A^-acetyl-0-methyl-iS'-(2,3,4,6-teh-a-0-benzyl-a-D-glucopyi-anosyl)-L- 
cysteine canied out in CDCI3 at 500 MHz for ‘H and 125 MHz for ‘^ C.
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Assignment 5c (ppm) ÔH (ppm) Multiplicity Integral
Coupling
constant/
(Hz)
Œ 3-CO 2 2 . 8 1.99 s 3H _
C-3 35.0 2.87 dd IH 14.4 and 3.5
C-3 • 35.0 3.30 dd IH 14.4 and 5.2
C-4’ 77.4 3.50 ■ t IH 9.9
C-6 ’ 68.7 3.67-3.71 m IH -
C-3’ 82.2 3.67-3.71 m IH -
CH2-OC 52.5 3.74 s 3H -
C-2’ 79.5 3.78 dd IH 9.7 and 5.3
C-5’ 71.4 4.15 m IH -
Ar-CT/g-O- - 4.47 m 2H -
Ar-C7 2^-0 - _ 4.59 d IH
Ar-C/Î2"0 - - 4.67 s 2H
Ar-C^2-0 - - 4.80 m 2H _
C-2 52.5 4.90 m IH
Ar-C%-0- - - 4.93 d IH -
c - r 86.3 5.14 d IH 5.3
- 7.00 d IH 8.3
AxCH 127.7-128.5 7.12-7.37 m 20H -
Ar-CH2-0 - 72.6-75.7 - - - -
ArC-CHz 137.6-142.1 - - -
CH3CO-N,
CO-CH3
170.8 and 
171.0
Table 2.7 -  'H and '^C NMR assignments 0 fY-acetyl-O-methyl-iS-(2 ,3 ,4 ,6 -tetra-O-benzyl-a-D- 
glucopyranosyl)-L-cysteine carried out in CDCI3 at 500 MHz for *H and 125 MHz for
2.2.13.1 Discussion
Repeat of this reaction also yielded only the a-anomer, it seems clear that this is the 
only anomer produced during the coupling reaction. The reaction was also attempted 
in acetonitrile, as a more polar solvent is thought to limit the “anomeric effect” and 
perhaps some of the p-anomer would form, however only the a-anomer was isolated. 
Kessler et al. synthesised an analogue of 13, with different cysteine protecting gi'oups, 
using a trichloroacetimidate glucosyl donor.  ^ Only the a-anomer of A-phthaloyl-6 "- 
(2,3,4,6-tetra-0-benzyl-a-D-glucopyranosyl)-L-cysteine allyl ester was produced in
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this reaction. As only the a-anomer is produced in this case, the formation of so much 
p when benzoyl protection is used might seem unusual. However this can be 
explained by participation of the ester group at C-2. The “side aim” of the carbonyl 
group forms an oitho-ester with the carbocation which is present after removal of the 
halide, this blocks the approach of the nucleophile to the lower face producing the p- 
anomer. With a benzyl group positioned at C-2, no participation can occur so only the 
a-anomer is formed. This is illustrated in scheme 2.18.
BzO
N ucleophile
Orthoester facilitates the formation o f  the p-anomer
Nu
BnO BnO
Orthoester unable to form
Scheme 2.18 -  Mechanism of ester group participation.
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2.2.14 Deprotection of the benzyl groups: N-acetyl-O-methyl-a-D- 
glucosyl-L-cysteine
OBn
BnO
13
AcHN X
OH
Pd/C, HCl
Tolucne,MeOH,H2 0  
CO2CH3
HO
14
S
AcHN XC0 2 CH3
Scheme 2.19 -  The synthesis ofiV-acetyl-O-methyl-a-D-glucosyl-L-cysteine.
The hydrogenation o f iV-acetyl-0-methyl-5'-(2,3,4,6-teti’a-0“benzyl-a-D- 
glucopyranosyl)-L-cysteine 13 in a two phase system o f toluene, methanol and water, 
in the presence o f palladium on cai'bon and HCl, after workup and column 
chromatography, gave A^-acetyl-O-methyl-a-D-glucosyl-L-cysteine 14 as a cleai' 
syi'up in 83 % crude yield. A sample was puiified by HPLC for mass spectrometiy. 
An accurate mass was obtained to confirm the empii ical formula. A range o f NMR 
experiments was caiTied out including ^H, ^H-^ H COSY, HMQC, ^^ C and ^^ C DEPT. 
The *H NMR spectrum showed H-1’ at 5.3 ppm with a coupling constant of V =  5.2 
Hz thus indicating that the anomeric conformation is still a.
H-6 '
HO H-rHO H-5' DH
H-3H-3'
HN
•CH,
P P M
Fig 2.18 -  ‘H NMR spectrum of A^-acetyl-O-methyl-a-D-glucosyl-L-cysteine canied out in CD3OD at
500 MHz for ‘H and 125 MHz for
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Assignment 5c (ppm) ÔH (ppm) Multiplicity Integi’al
Coupling
constant/
(Hz)
CH3-CO 22.4 1.97 s 3H
C-3 33.7 2.98 dd IH ■ 14.1 and 5.2
C-3 33.7 3.05 dd IH 14.1 and 7.8
C-4’ 71.7 3.26 bt IH -
C-3’ 75.6 3.43 t IH 9.8
C-6 ’ 62.5 3.64-3.69 m 2H -
C-2’ 73.1 3.64-3.69 m 2H _
CH2-OC 52.9 3.71 s 3H -
C-6 ’ 62.5 3.83 dd IH 1 1 . 8  and 2 , 0
C-5’ 74.5 3.89 m IH -
C-2 54.5 4.87 m IH -
C -r 88.9 5.30 d IH 5.2
CH3-C0 -N,
C0 -CH3
172.7 and 
173.4 . .
Table 2.8 — and NMR assignments of//-acetyl-0-methyl-a-D-glucosyl-L-cysteine carried out 
in CD3OD at 500 MHz for and 125 MHz for
2.2.14.1 Discussion
The removal of the benzyl groups was straightforwai*d and completes the synthesis of 
A-acetyl-O-methyl-a-D-glucosyl-L-cysteine 14. Although hydrolysis of the ester 
would have given the target molecule 17, this was not attempted. Reactivity studies 
(see chapter 4) suggested that acid hydrolysis might cleave the thioglycoside link or 
the amide of the cysteine portion, and alkaline hydrolysis leads to racemization of the 
cysteine moiety. Finally, this approach had been shown to be no easier or higher 
yielding than the previous route where the benzoyl protecting group was used.
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2.2.15 N-acetyl-O-methyl-gîucosyl cysteine diastereomeric mixture
OBz OH
Q NaOMe/MeOH PIO_ \  -s
BzO 1 HO 1 IAcHN-^COzCH) AcHN-^COzCH) HjCOzC'^NHAc
R-cysteine derivative S-cysteine derivative
18 19
Scheme 2.20 -  The synthesis of iV-acetyl-O-methyl-P-D-glucosyl cysteine diastereomeric mixture.
The reaction of iV-acetyl-(9-methyl-6'-(2,3,4,6-tetra-0-benzoyl-p-D-glucopyranosyl)- 
L-cysteine 5 with freshly prepared sodium methoxide in methanol at room 
temperature, gave after work up and column chiomatography an approximately 50:50 
diastereomeric mixture of A’-acetyl-O-methyl-p-D-glucopyranosyl cysteine 18 and 19 
as a clear oil in 65 % yield. and ^^ C NMR experiments were carried out. The ^^ C 
NMR spectrum shows far more than the number of expected peaks suggesting a 
mixture. A similar mixture was found by Uhrig et al. when 7V-acetyl-3-(2,3,4,6-tetra- 
(9-acetyl-P-D-glucopyranosyl)-L“Cysteine ethyl ester was treated with 10 % 
triethylamine in methanol, fig 2.19.^° This is supported by the NMR spectrum, fig 
2 .20 .
OAc
AcO IAcHN^COzEt
Fig 2.19 - A^-acetyl-3-(2,3,4,6-tetra-0-acetyl-P-D-glucopyranosyl)-L-cysteine ethyl ester.
Two doublets are present at ca. 4.5 ppm which are most likely to be proton H -l’ of 
the two diastereomers. This is assigned subjectively by comparison with the NMR 
spectrum of A'-acetyl-p-D-glucopyranosyl cysteine 7 (fig 2.13). Also noticeable is the 
multiplet at 4.7 ppm, this is likely to be the H-2 of the cysteine moiety. Two sets of 
signals are also present for what is, by analogy with other compounds, earlier, 
assigned as H-6 ’ at ca. 3.9 and 3.7 ppm.
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OH OH
o
HO
AcHN
0
10
HO
1 CO2CH3
%HaCOaC^NHAc
4
A'-acetyl-O -inethyl-p-D-glucopyranosyl-L-cysteine A -acetyl-O -m ethyl-p-D -glucopyranosyl-D -cysteine
y Ml
P P M
Fig 2.20 -  NMR spectrum of A^-acetyl-P-D-glucopyranosyl cysteine diastereomers cairied out in
0 ,0  at 500 MHz for ‘H and 125 MHz for ‘^ C.
2.2.15.1 - Discussion
Column chiomatography o f the crude product only succeeded in removing the by­
product methyl benzoate fr om the reaction. The diastereomers could not be separated. 
The stereochemical interconversion is due to the basic conditions created by the 
methoxide ion. Deprotonation occurs at C-2 and as this is adjacent to the carbonyl 
group, the negative charge is stabilised resulting in racemization on reprotonation. 
This is illustrated in scheme 2.21.
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AcH N
BH
A cH N , "^ "COgCH;
H
BH (+)
AcH N
Fast inversion
A cH N
Scheme 2.21 -  Mechanism of inversion.
As seen earlier the problem of interconversion was solved by conversion of the 
methyl ester group of cysteine to a carboxylic acid. This makes deprotonation at C-2 
more difficult because under basic conditions the carboxylic acid is deprotonated, and 
the resulting charge is stabilised by the carbonyl group. This makes inversion more 
difficult. This is illustrated in scheme 2.22
, .A  c i d i c  p r o t o n  
i f  B
R R O C H B H (+)
e
O C H
, E l e c t r o n  
w i t h d r a w i n g
.L e s s  a c i d i c
H'
R
O B H (+)
e
R
%
.. E l e c t r o n  
d o n a t i n g
Scheme 2.22 -  Mechanism showing the effect of removing the methyl ester of cysteine.
The removal of the benzoate groups of 5 was also attempted in aq. 3M HCl acid, 
while no benzoate esters were removed it was noticed from the NMR analysis that 
the methyl ester of cysteine was absent from the spectrum.
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2.3 Discussion and Conclusions
2.3.1 Discussion of the overail route
The synthesis of A^-acetyl-D-glucopyranosyl-L-cysteine, a and (3-anqmers, has been 
carried out successfully. The preparation of the glucosyl donor, 2,3,4,6-tetra-O- 
benzoyl-a-D-glucopyranosyl bromide 1 and the amino acid portion, A -^acetyl-O- 
methyl-L-cysteine 2 was carried out in good yield and purity. The coupling reaction 
yielded both a and p anomers in the same step. Some aspects of this route are still 
unclear; for example upon preparation of further batches of A^-acetyl-O-methyl-6 '- 
(2,3,4,6-tetra-0-benzoyl-D-glucopyranosyl)-L-cysteine, if  the reaction mixture was 
stirred for long periods it was usual for only the p-anomer to be isolated. Intermittent 
monitoring by NMR would perhaps show whether the a-anomer was formed and 
then converted to the p form, although the glucose-cysteine linkage is probably quite 
stable so this is unlikely. The removal of the methyl ester of //-acetyl-O-methyl-.S'- 
(2,3,4,6-teti'a-0-benzoyl-D-glucopyranosyl)-L“cysteine was relatively hee from 
problems. The preparation was carried out under acid conditions and a good yield was 
obtained. The removal of this gi'oup prior to the treatment with sodium methoxide was 
necessary to avoid the problem of racemization of the C-2 of the cysteine moiety. The 
removal of the benzoate groups was achieved in good yields.
Synthesis via the route carried out with the benzyl protecting group was less 
successful. The glycosyl donor was prepared in modest yield due to the number of 
steps required to arrive at the target compound. The coupling of 2,3,4,6-tetra-O- 
benzyl-a-D-glucopyranosyl bromide 12 and iV-acetyl-O-methyl-L-cysteine 2 gave 
only the a-anomer in a poor yield. Production of the p-anomer was not thoroughly 
investigated due to the success of the “benzoyl” route.
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2.3.2 Conclusions
The work in this chapter has been successful in completing one of the original aims of 
this project. The development of a novel route to //-acetyl-jS'-glucosyl-L-cysteine, a 
and P-anomers, has been successful under several headings. Firstly, the use of 
benzoate as a protecting group for the hydroxyl groups of the carbohydrate has been a 
success. The advantages of the use of the benzoyl group are:
i. Ease of preparation, i,e. good yields and cheap synthesis. The benzyl 
gi'OUp requires more preparation than the benzoate, leading to a reduction 
in overall yield.
ii. More robust than the acetate, and still conveniently removed with basic 
media, but stable enough to undergo further reactions in acidic media.
iii. Deprotection by sodium methoxide; there is no “aggressive” 
hydrogenation as with the benzyl group, where the acidic conditions 
perhaps lead to fuifher loss of yield by acid hydiolysis o f the glucose- 
cysteine linkage.
iv. Use of UY active protecting group means that separation of the products 
by column chromatography is easier.
Previous methods proved to be complex or incomplete. The route developed in this 
chapter uses conventional chemistry and modification of literature methods, yielding 
both a and p-anomers in the same step; in the literature, methods employing the use of 
the acetate gioup to protect the hydroxyl groups of glucose report isolation of the P- 
anomer.^’^ ’^ ’^ ® Work carried out using the benzyl group led to isolation of the a- 
anomer.  ^Monsigny et al.  ^ synthesised jS-p-glucosyl cysteine but the method involved 
the preparation of a 2,3,4,6-tetra-O-acetyl-p-D-glucopyranosylthiouronium salt and 
then the coupling with an iodo-serine derivative. Both these intennediates are difficult 
to prepare. Other simpler methods use 2,3,4,6-tetra-O-acetyl-p-D-glucopyranosyl 
bromide and 2,3,4,6-tetra-O-acetyl-p-D-galactopyranosyl bromide,^ p-D-galactose 
pentaacetate^ and p-D-glucose pentaacetate^® and different cysteine derivatives using 
various Lewis acids, SnCU  ^ and BFs-EtaO  ^ as coupling reagents. However some 
are incomplete only going as far as the coupled product.  ^Some workers obtained a 
diastereomeric m ixture.T he work carried out by Baran and Drabarek  ^ included no 
NMR characterisation, only microanalysis. The removal of the acetate groups is
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carried out using 10 % TEA in methanol, the same method of deprotection as used by 
Uhrig^ ® who observed racemization of the C-2 of the cysteine moiety. So it is likely 
that diastereomers were obtained, which would have been shown by adequate NMR 
analysis.
The methodology will be extended using galactose, mannose and ribose and this is 
reported in chapter 3.
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2.4 Experimental
2.4.1 General details and instrumentation
Melting point determination was carried out using a Kofler hot-stage apparatus and is 
uncorrected. Microanalysis was carried out by Ms. Nicola Walker and Ms. Judith 
Peters, University of Surrey using a Leeman Labs. Inc. CE4400 elemental analyser. 
H^, ^^ C and 2-D NMR spectroscopy was carried out on a Binker AC300 at 300 MHz 
and 75 MHz respectively and DRX-500 at 500 MHz and 125 MHz respectively. The 
majority of spectra were carried out using the Bruker DRX-500 at 500 MHz for H^ 
NMR and 125 MHz for ^^ C NMR, unless otherwise stated in the experiment. Spectra 
are referenced internally to TMS where possible or deuterated solvent signals. 
Chemical shift values are quoted in ppm while observed coupling constants (J) are 
reported in Hz. H^ NMR abbreviations are as follows: s = singlet, d = doublet, t = 
triplet, m = multiplet and b = broad. Mass specti'ometry was carried out by Mr. 
Richard Chaimdy, University of Surrey using a ThermoFinnigan spectrometer, 
MAT95 XP.
Solvents were used as supplied including anhydrous DMF which was purchased from 
Aldrich. Chemicals were either available in the lab or supplied by Acros Organics, 
Aldrich, Fisher Scientific, Fluka or Lancaster. All starting materials purchased from 
an external source were checked by TLC or H^ NMR where applicable, prior to use. 
TLC was canied out on MERCK Silicagel 60 F254 plates. Column chromatography 
was carried out using BDH Medical Supplies Silicagel 60, 33-70 pm. Sodium 
hydride, 60 % dispersion in mineral oil, was used without removal o f the mineral oil.
2.4.2 Purity of compounds
All characterisation data in the Experimental section refers to material ‘homogeneous 
by NMR’ unless explicitly stated otherwise.
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‘Homogeneous by NMR’ is defined here as “a proton-decoupled NMR spectrum 
or a well-resolved high field NMR spectrum showing at most only ‘trace’ peaks 
not attributable to the structure”.'^
For NMR a ‘trace’ peak is defined here as one with < 5 % the intensity of the 
strongest peak attributable to the structure; for NMR a ‘trace’ peak is defined here 
as a singlet, or its equivalent as a doublet, triplet, etc., with < 5 % the intensity o f a 
sharp one proton singlet, or its equivalent as a doublet, triplet, multi-proton singlet,^ 
etc.^
2.4.3 N-aœtyl-0-methyl-L-cysteine 2^ ®
2 H
To a stined solution of acetyl chloride (7.6 cm ,^ 8.4 g 0.053 mol) in methanol (150 
cm )^ at 0 °C, was added TV-acetyl-L-cysteine (10.0 g, 0.612 mol). The solution was 
then stirred for 3 hours at the same temperature. The solvent was removed in vacuo to 
leave a clear oil, which was dissolved in water ( 1 0 0  cm )^ and extracted with 
dichloromethane (5 x 100 cm )^. The organic layer was then dried over Na2S0 4 , 
filtered, and the solvent was removed in vacuo to leave 77-acetyl-O-methyl-L-cysteine 
2 as a white powdery solid, yield = 9.02 g, 90 %, which was homogenous by 
NMR. NMR (300 MHz) (CDCI3): 5 = 1.33 (t, IH, S^, 9.2 Hz), 2.08 (s, 3H,
CH3CO), 3.03 (m, 2H, H-3), 3.80 (s, 3H, C lh -0 \  4.89 (m, IH, H-2), 6.38 (b.s, IH, 
NTT). Melting point = 76-77 °C, lit. melting point = 79-80
2.4.4 a-D-glucose pentabenzoate
BzO 
BzO>
OBz
3
To a stirred solution of pyridine (38 cm )^ in dichloromethane (33 cm )^ at 0 °C, was 
slowly added a previously cooled solution of benzoyl chloride (32 cm ,^ 38.7 g, 0.275
° Purity criteria for new compounds in “Instructions for authors”, J. Org. Chem., 2004, 6 9 ,16A.
In this work, many compounds give a ^HNMR spectrum showing a sharp weU-resolved three-proton 
singlet from the Ac-NH methyl group. When this peak is used as reference, a ‘trace’ peak is defined 
as one with an intensity < 2 % (5/3 = 1.66 ~ 2 %) of this three-proton singlet.
® These criteria of purity are reasonable here. For example, since many of the products are oils 
(carbohydrates are notoriously difficult to crystallise), and since isomeric (a  and P-isomers) 
contamination is possible, combustion microanalysis is unsuitable; furüiermore, even HPLC might be 
less reliable with die possibility of contamination by materials of greatly differing UV-vis sensitivity 
(e.g. contamination of benzoylated products with non-benzoylated, and vice versa).
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mol) in dichloromethane (32 cm )^. The reaction was allowed to stir for five minutes. 
a-D-glucose (10.0 g, 0.056 mol) was added portion-wise so that the reaction 
temperature did not go above 10 °C. The flask was then stored in the refrigerator for 
24 hours. The reaction was worked up by diluting with dichloromethane (200 cm )^, 
washing with 2M H2SO4 (4 x 60 cm )^, water (4 x 60 cm )^, sat. aq. NaHCOs solution 
(4 X 60 cm )^ and water (4 x 60 cm )^. The organic layer was dried over Na2 S0 4 , 
filtered, and the solvent removed in vacuo to leave a slightly yellow waxy solid. The 
solid was ground up with IMS and washed thoroughly, filtered by suction and allowed 
to dry on the filter for two hours. The resultant white powder was recrystallised from 
acetone and water to give a-D-glucose pentabenzoate 3 as a bright white powder, 
yield = 24.81 g, 63 %, which was homogenous by NMR. NMR (300 MHz) 
(CDCI3): 5 = 4.48 (dd, IH, H-6 , 12.9 and 4.6 Hz), 4.63 (m, IH, H-6 ), 4.63 (m,
IH, H-5), 5.69 (dd, IH, H-2, V =  10.2 and 3.8 Hz), 5.87 (t, IH, H-4, V =  10.0 Hz), 
6.36 (t, IH, H-3, 1 0 . 1  Hz), 6 . 8 6  (dd, IH, H-1, V =  3.9 Hz) 7.26-8.19 (m, 25H,
AiH). Melting point = 178-180 °C, lit. melting point = 178-179 °C.
2 .4 .52 ,3 ,4 ,6-tetra-O-benzoyl-a-D-glucopyranosyl BzO'"Y^  -—Q
Br
BzO.
bromide z^o.
1
To solution of a-D-glucose pentabenzoate (25.0 g, 0.036 mol) in dichloromethane (50 
cm )^ was added hydrogen bromide in glacial acetic acid (45 % w/v HBr) (50 cm ,^ 
0.281 mol). The flask was sealed and left to stand overnight in the refrigerator. The 
mixtuie was then poured into iced water ( 1 0 0  cm^), and the flask rinsed with 
dichloromethane (20 cm )^. The organic layer was then separated, shaken with sat. aq. 
NaHC0 3  solution (4 x 50 cm )^ until the effervescence ceased, and finally washed with 
water (4 x 50 cm )^. The organic layer was dried over Na2 S0 4 , filtered, and the solvent 
was then removed in vacuo to give 2,3,4,6-tetra-O-benzoyl-a-D-glucopyranosyl 
bromide 1  as a creamy brown crystalline solid, recrystallisation from diethyl ether- 
petroleum ether gave white crystals, yield = 16.15 g, 70 %, which was homogenous 
by H^ NMR. H^ NMR (300 MHz) (CDCI3): 8  = 4.50 (dd, IH, H-6 , V =  12.9 and 4.3 
Hz), 4.73 (m, IH, H-6 ), 4.73 (m, IH, H-5), 5.33 (dd, IH, H-2, V =  9.9 and 3.8 Hz) 
5.86 (t, IH, H-4, V -  9.9 Hz) 6.30 (t, IH, H-3, V =  10.0 Hz), 6 . 8 6  (d, IH, H-1, V  =
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4.2 Hz), 7.26-8.08 (m, 20H, ArH). Melting point = 148-149 °C lit. melting point = 
148-149
2,4.0 N“dCBtyl~O“tïiôthyl“S-(2j3,4f6~totr3~0~ 
benzoyl-D-glucopyranosyl)-L-cysteine,
S" . AcHN-^COaCHja and fS-anomers 4 and 5 achn-^ co^ chs
4  S
To a solution of 2,3,4,6-tetra-O-benzoyl-a-D-glucopyranosyl bromide (5.0 g, 0.0068 
mol) and //-acetyl-0-methyl-L-cysteine (1.2 g, 0.0068 mol) in dichloromethane (100 
cm )^, stirred at room temperature, was added tin(IV)chloride (0.79 cm ,^ 1.77 g, 
0.0068 mol). The solution was allowed to stir for 24 hours. The reaction was diluted 
with dichloromethane (100 cm )^ and worked up by washing with aq. 3M HCl (5 x 50 
cm )^ and water (5 x 50 cm^), then drying the organic layer over Na2 S0 4  followed by 
filtration. A white crystalline solid was present after removal of the solvent in vacuo. 
Silica gel TLC (using 7:3 dichloromethane-ethyl acetate) showed four components. 
Silica gel column chromatography was carried out using 7:3 dichloromethane-ethyl 
acetate. The first component eluted was revealed to be umeacted starting material 
(805 mg, 16 %), brominated sugar 1 which was ca. 90 % pure. The next eluted was N- 
acetyl-0-methyl-5'-(2,3,4,6-tetra-0-benzoyl-a-D-glucopyranosyl)-L-cysteine 4 as a 
white crystalline solid, yield = 0.46 g, 9 %, which was homogenous by H^ NMR. H^ 
NMR (CDCI3 ): Ô = 2.03 (s, 3H, CTTj-CO), 3.08 (dd, IH, H-3, 14.5 and 2.3 Hz),
3.25 (dd, IH, H-3, V =  14.5 and 5.0 Hz), 3.75 (s, 3H, CH3OC), 4,50 (dd, IH, H-6 ’, V  
= 12.5 and 4.1 Hz), 4.77 (m, IH, H-5’), 4.92 (d, IH, H-6 ’, V =  12.5 Hz), 5.03 (m, IH, 
H-2), 5.45 (dd, IH, H-2’, 9.3 and 5.5 Hz), 5.75 (t, IH, H-4’, V =  9.8 Hz), 5.86 (d,
IH, H-1’, V =  5,7 Hz), 5.99 (t, IH, H-3’, V =  9.5 Hz), 6.79 (d, IH, NTT, V =  7.6 Hz), 
7.29-8.14 (m, 20H, ArH). NMR (CDCI3 ): 5 = 23.0 (CH3 -CO), 34.7 (C-3), 52.3 
(C-2), 52.7 (CH3 OC), 62.4 (C-6 ’), 69.0 (C-4’), 69.2 (C-5’), 70.5 (C-3’), 71.6 (C-2’),
84.7 (C-1’), 128.6, 128.7, 128.8, 128.9, 129.0, 129.2, 129.8, 130.0, 130.1, 130.2, 
130.3, (20xArCH)^, 133.5, 133.8, 133.9 (4 x Ai-C-COf, 165.4, 165.6,165.8, 166.4 (4 
X ArC-CO), 170.0, 170.7 (2 x CO). Anal, calcd. for C4 0 H3 7 O12NS (755.79); C, 63.57;
^The bigger peak at 128.8 ppm represents four carbons, peaks at 128.6, 128.7, 130.0, 130.1, 130.2 and 
130.3 ppm, two carbons, the remainder one carbon.
 ^The bigger peak at 133.5 ppm represents two carbons.
94
_________________________________________________________________ Chapter 2
H, 4.93; N, 1.85. Found; C, 62.49; H, 4.87; N, 1.77. LRMS (Cl) M+H = 756. HRMS 
(Cl) M+H, calcd., 756.2109; found, 756.2133. Melting point = 72-74 °C. The next 
polar eluted gave /7-acetyl-0-methyl-i5-(2,3,4,6-tetra-0-benzoyl-p-D- 
glucopyranosyl)-L-cysteine 5 as a white crystalline solid, which was recrystallised 
from ethanol, yield = 1.64 g, 32 %, and was homogenous by NMR. NMR 
(CDCI3 ): 5  = 1.96 (s, 3H, CH3-CO), 3.15 (dd, IH, H-3, V =  13.9 and 6 . 0  Hz), 3.25 
(dd, IH, H-3, V =  13.9 and 5.0 Hz), 3.70 (s, 3H, CHjOC), 4.24 (m, IH, H-5’), 4.46 
(dd, IH, H-6 ’, V =  12.4 and 4.9 Hz), 4.72 (d, IH, H-6 ’, 12.4 and 2.7 Hz), 4.84
(m, IH, H-2), 4.91 (d, IH, H-1’, ^J= 10.0 Hz), 5.51 (t, IH, H-2’, 9.7 Hz), 5.68 (t,
IH, H-4’, V =  9.8 Hz), 5.93 (t, IH, H-3’, 9.5 Hz), 6.45 (d, IH, Ni7, V =  7.9 Hz),
7.27-8.06 (m, 20H, ArH). '^ C NMR (CDCI3): 5 = 22.8 (CH3 -CO), 32.0 (C-3), 51.6 
(C-2), 52.7 (CH3 OC), 62.9 (C-6 ’), 69.1 (C-4’), 70.4 (C-2’), 73.8 (C-3’), 76.6 (C-5’),
83.8 (C-1’), 128.5, 128.6, 128.7, 128.8, 128.9, 129.1, 129.7, 129.9, 130.0, 130.1,
130.2 (20 X ArCH)'', 133.5, 133.6, 133.7, 133.8 (4 x ArC-CO), 165.4, 165.5, 165.9,
166.4 (4 X ArC-CO), 170.0, 171.0 (2 x CO). Anal, calcd. for C4 0 H3 7 O12N 8  (755.79); 
C, 63.57; H, 4.93; N, 1.85. Found; C, 63.14; H, 4.79; N, 1.72. LRMS (Cl) M+H = 
756. HRMS (Cl) M+H, calcd., 756.2109; found, 756.2118. Mp = 106-108 °C. The 
most polar product was a mixture o f materials, which could not be identified by *H 
NMR spectroscopy.
2.4.7 N-acetyl-S-(2,3,4,6-tetra-O-benzoyl-B-D- „
glucopyranosyl)-L-cysteine 6 aJI c^ooh
6
7V-acetyl-0-methyl-»S'-(2,3,4,6-tetra-0-benzoyl-P-D-glucopyranosyl)-L-cysteine 5 ( 1  g, 
0.0013 mol) was added to aq. 2M HCl (100 cm )^ in a flask fitted with a condenser. 
The mixture was heated to 90 °C and the reaction monitored by Silica gel TLC (7:3 
dichloromethane-ethyl acetate) over a period of 144 hours. Conversion of the less 
polar spot for 5 to a spot on the baseline showed reaction had occurred. The reaction 
mixture was allowed to cool; and extracted with dichloromethane (4 x 30 cm )^. The 
organic layers were combined, washed with H2 O (4 x 30 cm^), separated, dried with 
Na2 S0 4  and then filtered. The solvent was removed in vacuo to leave a clear syrup.
 ^The bigger peaks at 128.6 and 128.7 ppm represent three carbons, peaks at 128.5, 129.9, 130.0, 130.1 
and 130.2 ppm, two carbons and the remainder one carbon.
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TLC showed two components (7:3 dichloromethane-ethyl acetate). Silica gel column 
chromatography was carried out. The first component was eluted with 7:3 
dichloromethane-ethyl acetate and was 5, ca. 90 % pure, (0.28 g, 29 %), the second 
component was eluted with 9:1 dichloromethane-methanol and gave A-acetyl-S- 
(2,3,4,6-tetra-0-benzoyl-p-D-glucopyranosyl)-L-cysteine 6  as a white, powdery solid, 
yield = 0.50 g, 52 %, which was seen to be homogenous by 'H NMR. 'H NMR 
(CD3OD): 5 = 1.81 (s, 3H, CH3-CO), 3.05 (dd, IH, H-3, V =  13.6 and 8.3 Hz), 3.38 
(dd, IH, H-3, 13.8 and 4.7 Hz), 4.37 (m, IH, H-5’), 4.51 (m, IH, H-6 ’), 4.51 (m,
IH, H-2), 4.62 (dd, IH, H-6 ’, V =  12.4 and 3.2 Hz), 5.17 (d, IH, H-1’, 10.0 Hz),
5.53 (t, IH, H-2’, V =  10.0 Hz), 5.73 (t, IH, H-4’, \T=  9.8 Hz), 5.99 (t, IH, H-3’, V =
9.5 Hz), 7.16-7.99 (m, 20H, ArH). "C NMR (CD3OD): 5 = 22.9 (CH3-CO), 33.4 (C- 
3), 55.4 (C-2), 64.5 (C-6 ’), 71.2 (C-4’), 72.4 (C-2’), 75.9 (C-3’), 77.2 (C-5’), 84.5 (C- 
1’), 128.1, 128.3, 128.4, 128.5, 128.6, 128.9,129.1, 129.2, 129.4, 129.5, 129.6, 129.7,
129.8 (20 X AtQ', 133.2, 133.3, 133.5 (4 x ArC-COy, 165.5, 165.6, 165.9, 166.4 (4 x 
Ar-CO), 173.4, 177.73 (2 x CO). Melting point = 163-166 °C.
O B z2.4.8 N-acetyl-S-(2,3,4,6-tetra-O-benzoyl-a-D  
-glucopyranosyl)-L-cysteine 16 "
AcHN-^COOH
/T-acetyl-0-methyl-jS'-(2,3,4,6-tetra-0-benzoyl-a-D-glucopyranosyl)-L-cysteine 4 (0.5 
g, 0.0006 mol) was added to aq. 2M HCl (100 cm )^ in a flask fitted with a condenser. 
The mixture was heated to 90 °C and the reaction monitored by silica gel TLC (7:3 
dichloromethane-ethyl acetate) over a period of 96 hours. Conversion of the less polar 
spot for 5 to a spot on the baseline showed reaction had occurred. The reaction 
mixture was allowed to cool, and extracted with dichloromethane (4 x 30 cm^). The 
organic layers were combined, washed with H2O (4 x 30 cm^), separated, dried with 
Na2 S0 4  and filtered. The solvent was removed in vacuo to leave a clear syrup. TLC 
showed two components (7:3 dichloromethane-ethyl acetate). Silica gel column 
clnomatography was carried out. The first component was eluted with 7:3 
dichloromethane-ethyl acetate and was 4, ca. 90 % pure, (0.07 g, 15 %) the second
‘ The peaks 128.3, 128.4, 128.5, 128.6, 129.6, 129.7 and 129.8 represent two carbons; the remaining 
signals represent one carbon.
 ^The peak at 133.2 represents two carbons, the rem aining  signals represent one carbon.
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component was eluted with 9:1 dichloromethane-methanol and gave //-acetyl-5- 
(2,3,4,6-tetra-0-benzoyl-a-D-glucopyi*anosyl)-L-cysteine 16 as a white, powdery 
solid, yield = 0.36 g, 75 %, which was ca. 93 mol % pure by NMR. NMR 
(CD3 OD): 5  = 2.03 (s, 3H, CH3-CO), 3.07 (bt, IH, H-3, V =  14.1 Hz), 3.25 (bd, IH, 
H-3, V =  13.2 Hz), 4.58 (dd, IH, H-6 ’, 12.3 and 4.0 Hz ), 4.64 (bd, IH, H-2,
4.0 Hz), 4.70 (d, IH, H-6 ’, V =  12.3 Hz), 4.94 (m, IH, H-5’), 5.64 (dd, IH, H-2’, V =  
9.4 and 5.5 Hz), 5.82 (t, IH, H-4’, V =  9.8 Hz), 6.03 (t, IH, H-3’, V =  9.7 Hz), 6.07 
(bs, IH, H-1’), 7.30-8.13 (m, 20H, ArH). "C NMR (CD3 OD); 5 = 2 2 . 8  (CH3 -CO),
34.3 (C-3), 56.2 (C-2), 64.2 (C-6 ’), 69.8 (C-5’), 70.9 (C-4’), 72.6 (C-3’), 73.1 (C-2’),
85.4 (C-1’), 128.3, 128.4, 128.5, 128.5,128.9, 129.0,129.4,129.5,129.6,129.7 (20 x 
ArQ'', 133.2, 133.5, 133.6, 133.7 (4 x ArC-CO), 165.4, 165.5, 166.0, 166.5 (4 x Ai- 
CO), 173.6,176.0 (2 X CO).
2.4.9 N-acety!-S-p-D-glucopyranosyi-L-cysteine 7 9«
HO IAcHN-^COOH
7
To a stirred solution of A'-acetyl-6>-5'-(2,3,4,6-teti'a-0-benzoyl-p-D-glucopyranosyl)- 
L-cysteine 6  (0.5 g, 0.00072 mol) in methanol (5 cm )^, was added methanolic sodium 
methoxide ( 1  cm^), which was previously prepared by the cautious addition of sodium 
(0.05 g) to methanol (10 cm )^. The flask was sealed and stirred for 2 hours. The 
reaction was worked up by addition of Amberlite (IR 120 (ca. 2 g), until the 
solution was neutral to moist universal indicator paper and it was then filtered. The 
solvent was removed in vacuo to leave a pale white oil. Silica gel TLC (9:1 
dichloromethane-methanol) showed two spots, one of which was present on the 
baseline and became visible only by staining with 1% vapour. Silica gel column 
chromatography was carried out using 9:1 dichloromethane-methanol and after 
elution of the first component which was methyl benzoate, the eluent was changed to 
3:1 chloroform-methanol and the column was washed through. After removal of the 
solvent in vacuo the final component, //-acetyl-iS'-p-D-glucopyranosyl-L-cysteine 7, 
was obtained as an opaque syrup, yield = 0.15 g, 6 8  %, which was seen to be 
homogenous by ^H NMR. 'H NMR (CD3 OD): 5 = 2.02 (s, 3H, C%-CO), 3.00 (dd, 
IH, H-3, 13.6 and 7.1 Hz), 3.25-3.39 (m, 5H, H-3, H-2’, H-3’, H-4’, H-5’), 3.65
 ^Each peak represents two carbons.
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(dd, IH, H-6 ’, V =  12.2 and 5.5 Hz ), 3.87 (dd, IH, H-6 ’, V =  12.0 and 1.6 Hz), 4.38 
(d, IH, H-1’, V =  9.9 Hz), 4.47 (m, IH, H-2). ‘ C^ NMR (CD3 OD): 6  = 23.1 (CH3 - 
CO), 33.9 (C-3), 56.3 (C-2 ), 63.0 (C-6 ’), 71.6 (C-4’), 74.5 (C-2’), 79.7 (C-3’), 82.3 
(C-5’), 87.3 (C-1’), 173.0,177.6 (2x  CO).
2.4.10 N-acetyl-S-a-D-glucopyranosyl-L-cysteine 17
HO  i.
X .A c H N  C O O H
17
To a stiiTed solution of A^-acetyl-iS'-(2,3,4,6-tetra-0-benzoyl-a-D-glucopyranosyl)-L- 
cysteine 16 (0.05 g, 0.0674 mmol) in methanol ( 1  cm )^, was added methanolic sodium 
methoxide (0.14 cm )^, which was previously prepared by the cautious addition of 
sodium (0.05 g) to methanol (10 cm )^. The flask was sealed and stirred for 2 hours. 
The reaction was worked up by addition of Amberlite (IR 120 H )^ (ca. 0.5 g), until 
the solution was neutral to moist universal indicator paper and then filtered. The 
solvent was removed in vacuo to leave a clear oil. TLC (9:1 dichloromethane- 
methanol) showed two spots, one of which was present on the baseline and became 
visible only by staining with 1% vapour. Column chromatography was carried out 
using 9:1 dichloromethane-methanol and after elution of the first component which 
was methyl benzoate, the eluent was changed to 3:1 chloroform-methanol and the 
column was washed through. After removal of the solvent in vacuo the final 
component, //-acetyl-iS-a-D-glucopyranosyl-L-cysteine 17, was obtained as an opaque 
syrup, yield = 0.015 g, 6 8  %. Its purity was obtained by NMR as 91 mol %. 
NMR (D2 O): 5 = 2.07 (s, 3H, CiTj-CO), 3.06 (d, 2H, H-3, V =  6.0 Hz), 3.44 (t, IH, H- 
4’, V =  9.2 Hz), 3.56 (t, IH, H-3’, 10.0 Hz), 3.79-3.86 (m, 4H, H-2’, H-6 ’, H-5’),
4.44 (t, IH, H-2, V =  6.0 Hz), 5.44 (d, IH, H-1’, 5.4 Hz). ^^ C NMR (D2 O): 8 =
22.7 (CH3-CO), 34.3 (C-3), 55.9 (C-2), 61.0 (C-6 ’), 73.1 (C-5’), 70.2 (C-4’), 74.3 (C- 
3’), 71.8 (C-2’), 87.8 (C-1’).
2.4.11 Methyl-p-D-glucopyranoside 812a
O M e
a-D-glucose (20 g, 0.112 mol) was dissolved in methanol/HCl (140 cm^) and heated 
(80 °C) for 18 hours. Distilled water (60 cm )^ was added to the reaction and lead (II)
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carbonate to neutralise the HCl residue. The reaction mixture was filtered and the 
water removed in vacuo to leave a clear oil. Crystallisation was carried out with 
ethanol to give methyl-p-D-glucopyranoside 8  as a white powdery solid, yield = 9.128 
g, 42 %, which was homogenous by H^ NMR. H^ NMR (300 MHz) (CD3OD): 6  = 
3.18-3.89 (m), 3.20 (s, CTT3O-C) 4.16 (d), 4.66 (d). Melting point = 106-109 °C, lit. 
melting point = 106-108
2.4.12 1-0-methyl-(2,3,4,6-tetra-0-benzyl)-D- f
glucopyranoside 9'^ ^ OMe
Sodium hydride (60 % dispersion in mineral oil) (4.465 g, 0.112 mol) was dissolved 
in dimethylfoimamide (60 cm )^ and stirred under N2 at 0 °C for 30 minutes. To this 
solution was cautiously added methyl p-D-glucopyranoside 8  (5 g, 0.028 mol) and the 
reaction was stirred for 1 hour at 0 °C. Then with further cooling to 0 °C, benzyl 
bromide (13.3 cm ,^ 19.1 g, 0.112 mol) was added and the reaction stirred for 30 
minutes at 0 °C, then at room temperature for a further 2 days. The reaction was 
worked up by addition of distilled water ( 2 0 0  cm )^ and then extraction into diethyl 
ether (4 x 50 cm )^. The resultant organic layers were combined and washed with 
water (4 x 50 cm )^, then dried over Na2S0 4  and filtered. The solvent was then 
removed in vacuo to leave l-0-methyl-(2,3,4,6-tetra-0-benzyl)-D-glûcopyranoside 9 
as a yellow syrup, yield = 15.03 g, 82 %. The purity was assessed H^ NMR as ca. 90 
mol %. H^ NMR (300 MHz) (CDCI3): 8  = 3.39 (s, CTT3O-C), 3.55-3.77 (m, 5H, 
glucose ring), 4.00 (t, IH, glucose ring), 4.47-4.86 (m, 8 H, Ar-CiT2-0 ), 5.00 (bs, IH, 
H-1), 7.13-7.39 (m, 20H, ArTT-CHz).
2.4.13 2,3,4,6-tetra-0-benzyI-a-D’’glucopyranoside 10 13 Bn
®" OH 
10
1 -0-methyl-(2,3,4,6-tetia-0-benzyl)-D-glucopyranoside 9 (15.03 g, 0.023 mol) was 
dissolved in a mixture of aq. 2M HCl acid (120 cm )^ and glacial acetic acid (300 cm )^ 
in a flask fitted with a condenser. The mixture was then heated (80 °C) overnight. The 
flask was allowed to cool and crystals began to form, the reaction mixture was then 
refrigerated overnight to allow more crystals to form. The solid was then collected by
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vacuum filtration and the resulting filtrate removed. The crystals were washed well 
with water and dried on the filter. The filtrate was again refluxed as before, overnight. 
The flask was then cooled to 0 °C and treated with small amounts of water, this 
allowed the product to precipitate slowly, (if precipitation was rapid an oil would 
form). The flask was again refrigerated overnight and the new crystals collected and 
washed as before. The combined collections when recrystallised from methanol gave 
2,3,4,6-teti'a-O-benzyl-a-D-glucopyranoside 10 as white needle-like crystals, yield =
3.4 g, 23%. NMR (300 MHz) (CDCI3): 5 = 3.57-3.70(m, 4H, glucose ring), 3.96 (t, 
IH, glucose ring), 4.04 (m, IH, glucose ring), 4.47-4.98 (m, 8 H, Ar-CTTz-O), 5.23 (bs, 
IH, H-1), 7.14-7.37 (m, 20H, ArTT-CHg). Melting point = 148-149 °C, lit. melting 
point = 149 °C.^ ^
2.4.14 1-0-p-nitrobenzoyI-(2,3,4,6-0-benzyl)-a-D- 
glucopyranoside 11^ ^
To a stirred solution of pyridine (5 cm )^ in dichloromethane (100 cm^) at 0 °C, was 
slowly added ^ -nitrobenzoyl chloride (1.7 g, 0.092 mol). The solution was allowed to 
stir for five minutes before 2,3,4,6-tetra-O-benzyl-p-D-glucopyranoside 10 (3.0 g, 
0.0055 mol) was added portion wise so that the reaction temperature did not go above 
10 °C. The reaction was stirred at room temperature for 24 hours. The reaction was 
worked up by washing with aq. 3M HCl (3 x 30 cm )^, water (3 x 30 cm^), sat. aq. 
NaHC0 3  solution (3 x 30 cm )^ and water (3 x 30 cm )^. The organic layer was dried 
over Na2S0 4 , filtered, and the solvent removed in vacuo to leave a yellow waxy solid. 
Recrystallisation firom methanol gave l-0-p-nitrobenzoyl-(2,3,4,6-0-benzyl)-a-D- 
glucopyranoside 11 as white needle-needle like crystals, yield = 2.0 g, 52 %. The 
material was seen to homogenous by H^ NMR. H^ NMR (300 MHz) (CDCI3): Ô = 
3.64-4.05 (m, 6 H, glucose ring), 4.47-5.00 (m, 8 H, Ar-CTT2-0 ), 6.60 (d, IH, = 3.0 
Hz), 7.14-7.36 (m, 20H, A1TT-CH2), 8.20-8.32 (m, 4H, NO2-A1TT). Mp = 127-128 °C, 
lit. melting point = 128 °C.^ ^
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2.4.15 2,3,4,6-tetra-O-benzyl-a-D-glucopyranosyl 
bromide 12
Chapter 2 
1,
12
To solution of l-0-p-nitrobenzoyl-(2,3,4,6-0-benzyl)-a-D-glucopyranoside 11 (1 g, 
0.0014 mol) in dichloromethane (25 cm )^ was added hydrogen bromide in glacial 
acetic acid (45 % w/v HBr) (3.5 cm )^. The flask was sealed and left to stand for 2 
hours. The mixture was the poured into iced water (50 cm )^, and the flask rinsed with 
dichloromethane (25 cm"). The organic layer was then separated, shaken with sat. aq. 
NaHCOs solution (4 x 10 cm )^ until the effervescence ceased and finally water (4 x 
10 cm^). The organic layer was dried over Na2S0 4 , filtered and the solvent was 
removed in vacuo to give 2,3,4,6-tetra-O-benzyl-a-D-glucopyranosyl bromide 12 as a 
brown syrup, yield = 0.82 g, 94 %, ca. 93 mol % pure by H^ NMR. ^H NMR (300 
MHz) (CDCI3): 5 = 3.53 (dd, IH, glucose ring, 9.5 and 4.0 Hz), 3.65 (dd, IH, 
glucose ring, V =  11.0 and 2.1 Hz), 3.78 (m, 2H, glucose ring), 4.04 (t, 2H, glucose 
ring), 4.44-5.00 (m, 8 H, Ar-CiT2-0 ), 6.44, (d, IH, H-1, V =  4.1 Hz), 7.14-7.43 (m, 
2 0 H, ArTT-CHz).
2.4.16 N-acetyl-0-methyl-S-(2,3,4,6-tetra- OBn
Rnfl 10-benzyl-a-D-glucopyranosyl)-L-cysteine 13 n^o
AcHN CO2CH3
13
To a solution of 2,3,4,6-tetra-O-benzyl-a-D-glucopyranosyl bromide 12 (0.82 g, 
0.0015 mol) and /V-acetyl-O-methyl-L-cysteine (0.27 g, 0.0015 mol) in 
dichloromethane (25 cm )^, stirred at room temperature, was added tin (IV) chloride 
(0.18 cm ,^ 0.39 g, 0.0015 mol). The solution was allowed to sth* for 72 hours. The 
reaction was then diluted with dichloromethane (25 cm )^ and worked up by washing 
with aq. 3M HCl ( 5 x 1 0  cm )^ and water ( 5 x 1 0  cm )^, then drying the organic layer 
over Na2S0 4  followed by filtration. A white crystalline solid was present after 
removal of the solvent in vacuo. Silica gel TLC (7:3 dichloromethane-ethyl acetate) 
showed 3 spots. Silica gel column chromatography was canied out using 7:3 
dichloromethane-ethyl acetate. The first component isolated was a mixture of 
products, brominated sugar, yield = 0.19 g, 17 %, ca. 70 mol % pure by ^H NMR, and 
some other unidentifiable material. The second spot gave /7-acetyl-0-methyl~»S'- 
(2,3,4,6-tetra-0-benzyl-a-D-glucopyranosyl)-L-cysteine 13 which recrystallised from
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ethanol to give white, needle-like crystals, yield = 0 . 2 2  g, 2 1  %, and was seen to be 
homogenous by 'H NMR. 'H NMRCCDCls): 8  = 1.99 (s, 3H, C%-CO), 2.87 (dd, IH. 
H-3, V =  14.4 and 3.5 Hz), 3.30 (dd, IH, H-3, V =  14.4 and 5.2 Hz), 3.50 (t, IH, H- 
4’, V  = 9.9 Hz), 3.67-3.71 (m, IH, H-6 ’), 3.67-3.71 (m, IH, H-3’), 3.74 (s, 3H, 
CHiOC), 3.78 (dd, IH, H-2’, V =  9.7 and 5.3 Hz), 4.15 (m, IH, H-5’), 4.47 (m, 2H, 
Ax-CHt), 4.59 (d, IH, An-C%), 4.67 (s, 2H, Ar-C%), 4.80 (m, 2 H, Ar-Cft), 4.90 (m, 
IH, H-2), 4.93 (d, IH, Ax-CHz), 5.14 (d, IH, H-1’, 5.3 Hz), 7.00 (d, IH, HN, V =
8.3 Hz), 7.12-7.37 (m, 20H, ArH). "C NMR (CDCI3): 8  = 22.8 (CH3-CO), 35.0 (C-3),
52.5 (C-2), 52.5 (CH3OC), 68.7 (C-6 ’), 71.4 (C-5’), 72.6, 73.6, 75.2, 75.8 (Ar-CHaO),
77.4 (C-4’), 79.5 (C-2 ’), 82.2 (C-3’), 86.3 (C-1’), 127.7, 127.8, 127.9, 128.0, 128.1, 
128.2, 128.4, 128.4, 128.5, 128.5 (20 x ArCH)', 137.6, 138.0, 138.5, 142.1 (4 x ArC- 
CH2), 170.8, 171.0 (2 X CO).Anal. calcd. for C40H4 5 O8NS (699.86); C, 68.65; H, 6.48; 
N, 2.00. Found; C, 67.59; H, 6.52; N, 1.98. LRMS (Cl) M+H = 700. HRMS (Cl) 
M+H, calcd., 700.2939; found, 700.2939. Melting point = 105-107 °C. The most 
polar product was a mixtuie of materials, which could not be identified by NMR 
spectroscopy, yield = 0.05 g, 5 %.
2.4.17 N-acetyl-O-methyl-S-a-D-glucopyranosyl 
-L-cysteine 14
AcHN^ COjCH,
14
//■-acetyl-0-methyl-5'-(2,3,4,6-tetra-0-benzyl-a-D-glucopyranosyl)-L-cysteme 13
(0.05 g, 0.0714 mmol) was dissolved in a two-phase system which consisted of 
methanol (4 cm^), toluene (2 cm )^ and water (2 cm )^. Then with stirring was added
0.125 g of Pd on charcoal (30 % Pd, 50 % water) and hydrochloric acid (37 %) (3.5 
mm )^ and the suspension was hydrogenated at 1 bar for 24 hours at room temperature. 
The mixture was filtered and the solvent removed in vacuo to leave a clear oily 
residue which was dissolved in water ( 2 0  cm )^ and then extracted with 
dichloromethane (2 x 10 cm )^. The aqueous layer was separated and the water 
removed under vacuum to leave V-acetyl-O-methyl-iS'-a-D-glucopyranosyl-L-cysteine 
14 a clear oil, yield 0.02 g, 83 %, which was 95 % pure by HPLC, H^ NMR 
(CD3OD): Ô = 1.97 (s, 3H, CB3-CO), 2.98 (dd, IH, H-3, 14.1 and 5.2 Hz), 3.05
 ^Each peak represents two carbons.
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(dd, IH, H-3, 14.1 and 7.8 Hz), 3.26 (t, IH, H-4’, 9.8 Hz ), 3.43 (t, IH, H-3’,
9.5 Hz ), 3.64-3.69 (m, 2H, H-2’ and H-6 ’), 3.71 (s, 3H, CH3 -OC), 3.83 (dd, IH, 
H-6 ’, V =  11.8 and 2.0 Hz), 3.89 (m, IH, H-5’) 4.87 (m, IH, H-2) 5.30 (d, IH, H-1’, 
V =  5.2 Hz), "C NMR (CD3 OD): 5 = 22.4 (CH3 -CO), 33.7 (C-3), 52.9 (CH3 -OC),
54.5 (C-2), 62.5 (C-6 ’), 71.7 (C-4’), 73.1 (C-2’), 74.5 (C-5’), 75.6 (C-3’), 88.9 (C-1’), 
172.7, 173.4 (2 x CO). LRMS (El) M = 339 HRMS (Cl) M+H, calcd., 340.1020; 
found, 340.1061.
2.4.18 N-acetyl-O-methyl-S-p-D-glucopyranosyl f   ^
cysteine diastereomeric mixture 18 and 19 AcHN-^COjCHa
18+19
To a stirred solution of //-acetyl-0-methyl-iS'-(2,3,4,6-tetra-0-benzoyl-a-D- 
glucopyranosyl)-L-cysteine 5 (0.5 g, 0.662 mmol) in methanol (5 cm^), was added 
methanolic sodium methoxide ( 1  cm )^, which was previously prepared by the cautious 
addition of sodium (0.05 g) to metiianol (10 cm )^. The flask was sealed and sthred for 
2 hours. The reaction was worked up by addition of Amberlite (IR 120 H )^ (ca. 2 g) 
until the solution was neutral to moist universal indicator paper and then filtered. The 
solvent was removed in vacuo to leave a white, pale oil. Silica gel TLC (9:1 
dichloromethane-methanol) showed two spots, one of which was present on the 
baseline and became visible only by staining with I2  vapour. Silica gel column 
chromatography was carried out using 9:1 dichloromethane-methanol and after 
elution of the first component which was methyl benzoate, the eluent was changed to 
3:1 chloroform-methanol and the column was washed thiough. After removal of the 
solvent in vacuo the final components, a 50:50 diastereomeric mixture (by NMR 
approximation) of V-acetyl-0-methyl-5^-P-D-glucopyranosyl cysteine 18 and 19, was 
present as an opaque syrup, yield = 0.15 g, 65 %, which was ca. 91 mol % pure by 
NMR. *H NMR (CD3 OD); 5 = 2.02 (s, 6 H, 2 XCH3 CO), 2.92 (dd, IH, H-3), 3.07-3.38 
(m), 3.61-3.70 (m, 4H), 3.73 (s, 6 H, 2xCH,OC), 4.40 (dd, 2H, 2xH -l’), 4.71 (m, 2H, 
2xH-2).
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Chapter 3
S y n th es is  of A/-acetyl-S-glycosyl-L- 
cyste ines: M anno, G alacto  and  Ribo 
derivatives
3.1 Introduction
3.1.1 Rationalo
The focus of chapter 2 was the protection of the thiol group of NAC with D-glucose 
in a “prodrug” approach. The synthesis of A^acetyl-5-glucosyl-L-cysteine, a and P- 
anomers, was successfully carried out. The benzoyl group was successfully used in 
the protection of the carbohydrate hydroxyl groups of glucose; 2,3,4,6-tetra-O- 
benzoyl-a-D-glucopyranosyl bromide was a good glycosyl donor, and yielded both 
the a and P-anomers during the coupling reaction with A-acetyl-O-methyl-L-cysteine. 
Following the success in chapter 2, this route will be used to synthesise more S- 
glycosyl-L-cysteines using different carbohydrates.
The use of different carbohydrates to produce different glycosyl donors is necessary 
to establish the generality of the route used in chapter 2 . In terms of medicinal 
applications, different carbohydrate-cysteine linkages may vary in their stability, and 
as a result may behave differently in the body. Glycosylated peptides also participate
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in cell recognition;^ different glycosyl-cysteines may be more efficacious than others 
at reaching the active site in the body.
3.1.2 Aims and Objectives
The aim of the research described in this chapter was to carry out the synthesis of N- 
acetyl-«S-glycosyl-L-cysteines using the methodology developed in chapter 2. This 
will establish the generality and limitations of the route whilst providing a broader 
range of 5"-glycosyl-L-cysteines. The different carbohydrates chosen for this study are 
D-mannose, D-galactose and D-ribose. D-mannose and D-galactose have been chosen 
as they are two of the more common hexoses. D-ribose has been chosen due to its 
abundance in the body in different forms and as a representative pentose. S- 
galactosyl-L-cysteine has been reportedly synthesised before but its structure and 
isomeric purity are questionable.^
The route used is shown below in scheme 3.1, D-mannose is used as the example 
carbohydrate.
acetyl chloride/M eOH  
N H A c -----------------------   N H A c
OH O Bz O Bz
OH pyridine O Bz 3 Br
SnCL
O Bz
ÇO2CH3
N H A c
and/or
A cH N  C O 2 CH 3
A cH N  X O 2 CH 3 
4
O Bz _  O Bz
2M H C 1 BzO  
5    BzO N aO M e/M eO H:xA cH N  "COOH
OH
A cH N COOH
Scheme 3.1 - Synthesis o f AZ-acetyl-a-D-mannosyl-L-cysteine.
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3.2 Results and Discussion
The discussion of the preparation of 6"-glycosyl-cysteme analogues will be dealt with 
in the following order: D-galactose, D-mannose and D-ribose. The synthesis of N- 
acetyl-L-cysteine 1 was carried out as in chapter 2.
3.2.1 The glycosyl donor: 2,3,4,6-tetra-O-benzoyl-a-D-galactosyl 
bromide
Scheme 3.2 -  The synthesis of 2,3,4,6 -tetra-O-benzoyl-a-D-galactosyl bromide.
The reaction of a-D-galactose with benzoyl chloride in dichloromethane in the 
presence of pyridine, led after workup to a-D-galactose pentabenzoate 8 in 61 % 
yield. A NMR experiment, carried out in CDCI3 showed the postulated peaks were 
present. In particular, a peak at 6.95 ppm is assigned to H-1 and it appears as a 
doublet of V  = 2.9 Hz; this is typical of axial-equatorial coupling,^ indicating the a- 
anomer has been synthesised. The product was homogenous by H^ NMR.
The reaction of a-D-galactose pentabenzoate 8 with hydrogen bromide in glacial 
acetic acid (45 % w/v HBr) in dichloromethane, after work up gave 2,3,4,6-tetra-O- 
benzoyl-a-D-galactopyranosyl bromide 9 in approximately 69 % crude yield. A H^ 
NMR experiment showed that the postulated peaks were present. The product was 
homogenous by H^ and NMR and the purity deemed sufficient for further use.
Like a-D-galactose pentabenzoate 8, the H^ NMR spectmm showed a peak at 6.97 
ppm that is assigned to H-1 and has a coupling constant of V =  4.4 Hz; this is typical 
of axial-equatorial coupling^ which is indicative of the a-isomer. The chemical shift 
and coupling constant are the same as seen in the literature for H-l."^
As with 2,3,4,6-tetra-O-benzoyl-a-D-glucopyranosyl bromide, the a-anomer was the 
only product obtained in this reaction. The anomeric effect means that the 
electronegative Br substituent prefers ihô axial conformation. If the substituent is
107
_________________________________________________________________ Chapter 3
axially positioned, there is a favoured interaction between the lone pair of electrons 
located axially on the ring oxygen and the anti-bonding molecular orbital of the C-Br 
bond. This is discussed in section 1.2.2 of chapter 1.
3.2.2 Coupling reaction: N‘-acetyl-0-methyl-S-(2,3,4,6-tetra-0- 
benzoyl-P-D-gaIactopyranosyi)-L-cysteine
OBz/OBz
BzO IBr 
9
OCH
NHAc S11CI4HS
BzO X,BzODCM AcHN
Scheme 3.3 — The synthesis o f A/-acetyl-0-methyl-lS'-(2,3,4,6-tetra-0-benzoyl-p-D-galactopyranosyl)- 
L-cysteine.
Reaction of 2,3,4,6-tetra-O-benzoyl-a-D-galactopyranosyl bromide 9 with 7V^ acetyl- 
0-methyl-L-cysteine 1, in dichloromethane in the presence of a SnCl'4 catalyst led, 
after workup and column chromatography, to the isolation of A -^acetyl- O-methyl-6 '- 
(2,3,4,6-tetra-0-benzoyl-p-D-galactopyranosyl)-L-cysteine 10, in 19 % crude yield. 
Several NMR experiments were carried out, (^H, ^H-^ H COSY, HMQC, ^^ C and ^^ C 
DEPT), to determine the structure, assess purity and assign signals. The material was 
seen to be homogenous by NMR and accurate mass confirmed the empirical 
formula. The identification o f 10 is discussed below and the NMR is shown in fig
3.1 and the assignments given in table 3.1. The assignments are based on 2-D and 
^^ C NMR experiments. In particular, the peak at 4.90 ppm is assigned to H-1’ and it 
appears as a doublet of V =  9.7 Hz, coupled to H-2’; this shows axial-axial coupling,^ 
confirming stereochemistry.
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OBzOBz
H
BzO
OBz
HN
10
‘CO2CH3
jU L L j^ L L L -Jju i. A
Fig 3.1 -  ^HNMR spectrum of#-acetyl-0-methyI-,$'-(2,3,4,6-tetia-0-benzoyl-p-D-galactopyranosyl)- 
L-cysteine carried out in CDCI3 at 500 MHz.
Assignment ÔC (ppm) 5h (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
CH3-CO 22.9 1.95 s 3H
C-3 31.7 3.16 dd IH 13.9 and 6.4
C-3 31.7 3.38 dd IH 13.9 and 4.3
CH3-OC 52.7 3.71 s 3H _
C-6 ’ 62.3 4.43 m IH -
C-5’ 75.5 4.43 m IH -
C-6 ’ 62.3 4.63 dd IH 10.3 and 5.8
C-2 51.7 4.88 m IH -
C-1’ 83.6 4.90 d IH 9.7
C-3’ 72.4 5.67 dd IH 10.0 and 3.6
C-2’ 67.7 5.83 t IH 9.7
C-4’ 68.4 6.04 d IH 3.4
m - 6.47 d IH 7.6
ArCH 128.5-130.2 7.21-8.08 m 20H -
AiC-CO 133.5-134.0 - - - -
Ar-CO-O 165.6-166.7 - - - -
CH3-CO-N,
CO-OCH3 170.2-171.2 . .
Table 3.1 and *H NMR assignments of vV-acetyl-0-methyl-6'-(2,3,4,6-tetia-0-benzoyi-p-D-
galactopyranosyl)-L-cysteine carried out in C D C I 3  at 500 MHz for ‘H and 125 MHz for
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3.2.2.1 Explanation of the NMR assignments
A
Fig 3.2 - A'’-acetyl-0-methyl-5-(2,3,4,6-tetra-0-benzoyl-(3-D-galactopyranosyl)-L-cysteine.
The interpretation of the COSY, HMQC. ‘ C^ and "C DEPT spectra
allows assignment of the peaks in the *H NMR spectrum.
The DEPT spectrum identifies the two CH2- carbon signals present in the molecule. 
The HMQC spectrum allows us to identify the corresponding signals in the NMR 
spectrum. The two double doublets centred at ca. 3.20 ppm were identified as the H-3 
protons of the cysteine moiety. Using the COSY spectrum this was confirmed. Since 
these peaks are shown by the COSY spectrum to couple to a multiplet at 4.88 ppm, H- 
2, and a doublet at 6.47 ppm which is assigned as NH; this last peak is confirmed 
since there is no coupling to the ^^ C spectrum for this doublet in the HMQC, the only 
case where this occurs in the molecule. The proton signals for H-6 ’ are obtained via 
the DEPT and HMQC spectrum as a double doublet at 4.63 ppm and as a component 
of a multiplet at 4.43 ppm. The COSY spectrum shows H-6 ’ coupling to another 
component of the multiplet at 4.43 ppm, which is assigned as H-5’; the presence of 
another proton is confirmed by the integration. Proton H-5’ couples to a doublet at
6.04 ppm, this is proton H-4’. This is a doublet although it is positioned equatorially 
and is adjacent to two axial protons. The COSY shows H-4’ to couple to H-3’ which 
is a doublet of doublets; proton H-3’ is axially positioned and o f its neighbouring 
protons, one is positioned axially (H-2’), the other equatorially (H-4’). Proton H-3’ 
couples to H-2’ which is a triplet with a coupling constant o f V -  9.7 Hz; this proton 
is present in an axial-axial-axial sysXQm, which couples to H-1’, a doublet with a 
coupling constant of V  = 9.7 Hz. This large coupling constant is typically of axial- 
axial coupling confirming the p stereochemistry, the a-anomer would have a much 
lower coupling constant of ca. V  = 5 Hz, due to axial-equatorial coupling,^ The two
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singlets in the NMR spectrum at 1.95 and 3.71 ppm are the CHg-groups of the N- 
acetyl and the methyl ester o f the cysteine residue. As the CHa-group of the iV-acetyl 
is adjacent to a carbonyl group, it is likely to be far more shielded and is therefore the 
peak at 1.95 ppm, leaving the more deshielded methyl ester CHa-group as the singlet 
at 3.71 ppm. The multiplets from 7.21 to 8.08 ppm are assigned to the aromatic 
protons. The integration for this range shows twenty protons which is correct for the 
four benzoyl groups around the carbohydrate ring. No further assignments were made 
because of the complexity of these multiplets.
3.2.2.2 Discussion
The P-anomer was the main product isolated in this coupling reaction, this was also 
the case upon repeat of this reaction. In the first attempt of this reaction a small 
amount of an unidentified compound was isolated from the column prior to the 
elution of 10; it is possible that this could be the a-anomer. This differs from the gluco 
derivative where both a and P-anomers were isolated. It could be that no a-anomer is 
formed or perhaps the amount produced is small, making isolation by column 
chromatography difficult.
3.2.3 A ttem pted hydrolysis of the methyl ester of N-acetyl-O-
methyl-‘S-(2,3,4,6-tetra-0-benzoyl-IS-D’-galactopyranosyl)-L- 
cysteine
OBz OBz OBz OBz
l ^ - ^ O  a)2MHCI L C - 0
1  b)BBi-3 ,DCM BzO [BzO AcHN OO2 CH3  ' ■" AcHN'^COOH
10 11
Scheme 3.4 -  The attempted hydrolysis of the methyl ester ofi'/-acetyI-0-methyI-iS-(2,3,4,6-tetra-C>- 
benzoyl-P-D-galactopyranosyl)-L-cysteine,
The hydrolysis of the methyl ester of N-acetyl-0-methyl~5'-(2,3,4,6-tetra-0-benzoyl-
p-D-galactopyranosyl)-L-cysteine 10 was attempted in the same fashion as for the
1 1 1
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gluco derivative, by the heating o f 10 in aq. 2M HCl. After 144 hours, TLC showed 
two spots. One on the baseline indicated a reaction had taken place. After work up 
and column chromatogiaphy, the deshed product was not isolated. A repeat of this 
reaction yielded a small amount o f a product. A NMR experiment carried out, fig 
3.3, showed encouraging peaks similar to those required, e.g. double doublets at ca. 
3.0 and 3.5 ppm could be the H-3 o f cysteine. The mtegration o f the other peaks is 
accurate for the remaining protons. Despite this, there was difficulty in repeating this 
reaction.
PPM
Fig 3.3 -  ‘H NMR spectrum of a component isolated during the attempted acid hydiolysis of the 
methyl ester of JV-acetyl-0-methyl-5'-(2,3,4,6-teti'a-0-benzoyl-P-D-galactopyranosyl)-L-cysteine 
carried out in CD3OD at 500 MHz.
Further attempts to reproduce this reaction using weaker concentrations of acid were 
not successful. Removal o f the methyl ester was also attempted by the reaction o f 10 
with BBrs in dichloromethane. After workup and column chromatography, the 
product was not isolated. No further attempts at the hydiolysis o f the methyl ester of 
10 were carried out.
1 1 2
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3.2.4 The glycosyl donor: 2,3,4,6-tetra-'0-benzoyTa-D- 
mannopyranosyl bromide
OH OBz OBzI OH I O ^  1 OBz
H Q 'x ' t d L V  PhCOCl/py B z O '\" '" 2 % ^  HBr/AcOH B z O ' ' \ ^ ^  
OH OBz
Scheme 3.5 -  The synthesis of 2,3,4,6 -tetra-O-benzoyl-a-D-mannopyranosyl bromide.
The reaction of a and p-D-mannose with benzoyl chloride in dichloromethane in the 
presence of pyridine, led after workup to a mixture of a and P-D-mannose 
pentabenzoate 2 in 47 % yield. A NMR experiment, carried out in CDCI3 showed 
the postulated peaks were present. The separation of anomers was not required as the 
literature states that the reaction of an anomeric mixture of 2  to produce the 
corresponding halide will result in the production of the a-anomer only.^
The reaction of a and p-D-mannose pentabenzoate 2 with hydrogen bromide in glacial 
acetic acid (45 % w/v HBr) in dichloromethane, after workup and gave 2,3,4,6-tetra- 
0-benzoyl-a-D-mannopyranosyl bromide 3 in approximately 84 % crude yield. A 
NMR experiment showed that the postulated peaks were present. Some impurity 
peaks were present in the NMR spectrum but the product purity does not 
significantly affect further steps.
In this reaction the starting material was an anomeric mixture, but the a-anomer was 
the main product. This is a result of the anomeric effect discussed in section 1.2.2 of 
chapter 1 .
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3.2.5 Coupling reaction: N-acetyl-0-methyl-S-(2,3,4,6-tetra-O- 
benzoyi-a-D-mannopyranosyl)-L-cysteine
S n C I .
B r3 D C M  4 I
A c H N - ^ C O î C H a
Scheme 3.6 -  The synthesis ofiV-acetyl-0-methyl-5'-(2,3,4,6-tetra-0-benzoyl-a-D-maimopyianosyl)- 
L-cysteine.
Reaction of 2,3,4,6-tetra-O-benzoyl-a-D-mannopyranosyl bromide 3 with N-acetyl-O- 
methyl-L-cysteine 1, in dichloromethane in the presence of a SnCU catalyst led, after 
workup and column chromatography, to the isolation of A-acetyl-0-methyl-i5- 
(2,3,4,6-tetra-0-benzoyl-a-D-mannopyranosyl)-L-cysteine 4, in 13 % crude yield. 
Several NMR experiments were carried out, (^H, COSY, HMQC, ^^ C and ^^ C 
DEPT), to determine the structure, assess purity and assign signals. The material was 
seen to be homogenous by NMR and accurate mass confirmed the empirical 
formula. The identification of 4 is discussed below and the NMR spectrum is 
shown in fig 3.4 and the assignments given in table 3.2. The assignments are based on 
2-D and ^^ C NMR experiments. In particular, the peak at 5.44 ppm is assigned to 
H-1’ and it appears as a doublet of V  = 1.6 Hz, coupled to H-2’. Due to the axial 
orientation of the substituent at C-2 it is not clear as with previous examples ft-om 
analysis of the coupling constants alone, whether the a or P-anomer has been isolated. 
The coupling constants for axial-equatorial and axial-axial systems are generally 
quoted as between V  = 1-5 Hz.  ^ However, in the majority o f cases the coupling 
constants for axial-equatorial systems have been noted to be higher, nearer to 5 Hz, 
than coupling constants for equatorial-equatorial systems to which a value closer to 1 
Hz is mostly observed.^ Therefore on this basis it is the a-anomer that is proposed. 
The best way to confirm the stereochemistry would be through an X-ray 
crystallographic structure, but despite some attempts this could not be obtained.
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BzO
CO2CH3
i W L j L j u ^ ^
Fig 3.4 -  NMR spectrum of A'^-acetyl-0-methyl-jS'-(2,3,4,6-tetra-0-benzoyl-a-D-mannopyranosyl)- 
L-cysteine carried out in CDCI3 at 500 MHz.
Assignment ÔC (ppm) ÔH (ppm) Multiplicity Integral
Coupling
constant/
(Hz)
CH3-CO 23.3 2.04 s 3H
C-3 36.0 3.22 dd IH 14.4 and 3.8
C-3 36.0 3.34 dd IH 14.4 and 4.8
CH3-OC 53.1 3.82 s 3H _
C-6 ’ 62.6 4.48 dd IH 12.4 and 3.6
C-5’ 70.5 4.73 m IH -
C-6 ’ 62.6 4.93 dd IH 12.4 and 2.4
C-2 52.5 5.09 m IH -
c - r 84.4 5.44 d IH 1 . 6
C-3’ 70.3 5.72 dd IH 10.0 and 3.2
C-2’ 72.3 5.80 dd IH 3.3 and 1.4
C-4’ 6 6 . 8 6.18 t IH 1 0 . 1
m - 6.85 d IH 8.4
AiCH 128.6-130.1 7.25-8.16 m 20H -
Ai’C-CO 133.4-133.8 - - - -
Ar-CO-0 165.4-166.4 - - - -
CH3-CO-N,
CO-OCH3 170.4-171.0 . .
Table 3.2 -  and ’HNMR assignments o f 7V-acetyl-0-methyl-5'-(2,3,4,6-tetra-(9-benzoyl-a-D-
mannopyranosyl)-L-cysteine canied out in CDCI3 at 500 MHz for ‘H and 125 MHz for
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3.2.5.1 Explanation of the NMR assignments
O Bz
O Bz
BzO
BzO
HN
CHj
Fig 3.5 - W-acetyl-0-methyl-iS'-(2,3,4,6-tetra-0-benzoyl-a-D-maiinopyranosyl)-L-cysteine.
The interpretation of the COSY, HMQC, ^^ C and ^^ C DEPT spectra
allows assignment of the peaks in the NMR spectrum.
From the DEPT and the HMQC spectrum, tiie two double doublets centred at ca. 3.30 
ppm were identified as the H-3 signal of the cysteine moiety, this is confirmed using 
the COSY spectrum. The COSY shows that these peaks couple to a multiplet at 5.09 
ppm, H-2, and a doublet at 6.85 ppm which is assigned as NH; this is confirmed as 
there is no coupling to the ^^ C spectrum for this doublet in the HMQC. The proton 
signals for H-6 ’ are obtained via the DEPT and HMQC spectrum as two double 
doublet, one at 4.48 ppm and one at 4.93 ppm. The COSY spectrum shows the 
protons of H-6 ’ coupling to a multiplet at 4.73 ppm, which is the signal of H-5’; this 
signal is a multiplet fiom being adjacent to three protons in different environments. 
Proton H-5’ couples to a triplet at 6.18 ppm, this is proton H-4’; H-4’ is the only 
proton to produce a triplet as it is in an axial-axial-axial system. The COSY shows H- 
4’ to couple to H-3’ at 5.72 ppm which is a doublet of doublets; proton H-3’ is axially 
positioned and of its neighbouring protons, one is positioned axially (H-4’), the other 
equatorially (H-2’). Proton H-3’ couples to H-2’ at 5.80 ppm, which appears as a 
nanow doublet. Proton H-2’ couples to H-1’ at 5.44 ppm, another narrow doublet 
with a coupling constant of V  = 1.6 Hz. As mentioned above, the equatorial 
conformation of proton H-2’ makes it difficult to ascertain the stereochemistry of the 
compound as both axial-equatorial and equatorial-equatorial conformations have 
small coupling constants o f V =  1-5 Hz.  ^ In carbohydrates however, the majority of 
coupling constants for axial-equatorial systems have been noted to be higher, nearer 
to 5 Hz, than coupling constants for equatorial-equatorial systems to which a value
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closer to 1 Hz is mostly observed.^ Therefore, it can be assumed that the a-anomer has 
been isolated. The two singlets in the NMR spectrum at 2.04 and 3.82 ppm are the 
CHa-groups of the A -^acetyl and the methyl ester of the cysteine residue. The 
multiplets from 7.25 to 8.16 ppm are assigned to the aromatic protons.
3.2.5.2 Discussion
Repeating this reaction led only to the isolation of the same single a-product. Even 
though the P-anomer was the major product in both the gluco and galacto derivatives, 
it is reasonable to find the a-anomer in this case if an SnI mechanism is operative. As 
can be seen from the mechanism involving ester group participation, shown in scheme 
3.7, the axially positioned benzoyl group at C-2’ provides steric hindrance. Also, as 
mentioned in chapter 1 section 1.2.5, the formation of a \,l-trans glycosidic linkage is 
preferred in the case of reactions o f glycosyl halides with an ester group in the C- 2  
position, to that of a \,2-cis linkage.
BzO
OBz
BzO^#"""^*^  ^ No attack possible from this angle due to steric hindrance
AcHN^ COjCHs
OBz
BzO
BzO
AcHN'^COzCHj
OBz
l-QBzO
BzO
AcHN CO2CH3
Scheme 3.7 - Mechanism of formation of a-anomer.
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3,2.6 Hydrolysis of the methyl ester: N-acetyhS-'(2,3,4,64etra-0- 
benzoyhD-mannpyranosyl)-L-cysteine
OBz OBzI OBz 2M HCl I OBz
4 6
A cH N -^ C O aC H a A cH N -^ C O O H
Scheme 3.8 -  The synthesis ofiV“acetyl-iS-(2,3>4,6-tetra-alpha-0-benzoyl-a-D-mannopyranosyl)-L- 
cysteine.
The reaction of A^acetyl-0-methyl-6'-(2,3,4,6-tetra-0-benzoyl-a-D-mannopyranosyl)- 
L-cysteine 4 with aq. 2M HCl at 90 °C for 144 hours with workup and purification by 
column chromatography gave A^-acetyl-5'-(2,3,4,6-tetra-0-benzoyl~a-D- 
mannopyranosyl)-L-cysteine 6  as a white powder in ca. 45 % crude yield. The 
reaction was monitored by TLC, using dichloromethmie: ethyl acetate 7:3, appearance 
of a spot on the baseline indicating product formation. A range of NMR experiments 
were carried out, including H^, ^H-^ H COSY, HMQC, ^^ C and ^^ C DEPT, to confirm 
the structure. As with the gluco derivatives, solvent choice for the NMR was difficult, 
because although the product appeared soluble in CDCI3 the H^ NMR spectrum was 
never fully resolved. Solvent CD3OD gave good resolution but some peaks are 
grouped together in the H^ NMR spectrum. Examination of the ^H NMR spectrum 
(fig 3.6) showed trace impurity peaks and suggested that the material was ca, 90 % 
pure. The H^ NMR coupling patterns (fig 3.6) are similar to the precursor 4. Most 
noticeable, is the absence of the methyl peak. The large singlet at ca. 3.3 ppm is 
residual methanol present in the CD3OD. The other NMR experiments confirm the 
assignment of each peak, reasoned analogously to the case of 4. LRMS was carried 
out but the molecular ion could not be identified, as with the glucose derivatives.
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BzO
OH
JL
P P M
Fig 3.6 -  *H NMR spectiinn of A^-acetyl-iS-(2,3,4,6-tetra-0-benzoyl-a-D-maniiopyi'anosyl)-L-cysteine 
canied out in CDiOD at 500 MHz.
Assignment ÔC (ppm) ÔH (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
CH3-CO 21.5 2.03 s 3H .
C-3 34.1 3.19 dd IH 13.7 and 7.7
C-3 34.1 3.32 m IH (obscuied)
C-6 ’ 62.4 4.50 dd IH 11.9 and 2.2
C-2 53.6 4.73 m IH -
C-6 ’ 62.4 4.79 m IH (obscured)
C-5’ 69.7 4.82 m IH -
C -r 84.1 5.69 m IH -
C-3’ 71.0 5.69 m IH -
C-2’ 71,9 5.81 d IH 1 . 6
C-4’ 6 6 . 8 6.17 t IH 9.9
AyCH 128.2-129.7 7.22-8.12 m 20H -
AiC-CO 133.3-133.6 - - - -
Ar-CO 165.4-166.3 - - - -
CH3-CO-N 172.2, 175.1 - - - -
Table 3.3 -  and ’H NMR assignments of A^-acetyl~<S'-(2,3,4,6-tetia-0-benzoyl-a-D-
mannopyi’anosyl)-L-cysteine canied out in C D 3 O D  at 500 MHz for and 125 MHz for
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3.2.7 Deprotection of the glycosyl portion: N-acetyl-D- 
mannopyranosyl-L-cystelne
O B z O B z-O
OH
N aO M e/M eO H
zO
0%
6 S 
A cH N C 0 2 C H 3 XA c H N " ^ C O O H
Scheme 3.9 -  The synthesis of A^-acetyl-iy-a-D-mannopyranosyl-L-cysteine.
Reaction of iV-acetyl-iS'-(2,3,4,6-tetra-0-benzoyl-a-D-mannopyranosyl)-L-cysteme 6 
with freshly prepared sodium methoxide in methanol at room temperature, gave after 
work up and column chromatography A^-acetyl-S'-a-D-mannopyi*anosyl-L-cysteine 7 
as a clear oil in 76 % yield. Full NMR analysis was carried out including 
COSY, HMQC, ^^ C and ^^ C DEPT experiments. Examination of the NMR 
spectrum, fig 3.7, suggests the material is ca. 93 mol % pure. The NMR peaks are 
assigned in table 3.4; these assignments are made by interpretation of the *H, ^^ C and 
2-D NMR experiments that have been carried out.
OH
OH
HO
HO
HN COOH
L lA
PPM
Fig 3.7 — NMR spectium of A^-acetyl-fS'-a-D-mannopyi*anosyl-L-cysteine carried out in D2O at 500
MHz.
1 2 0
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Assignment ÔC (ppm) ÔH (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
CHz~CO 2 2 . 2 2.05 8 3H -
C-3 34.1 3.10 m 2H -
C-4’ 67.1 3.70 t IH 9.7
C-3’ 71.2 3.75 dd IH 9.7 and 3.2
C-6 ’ 60.1 3.79 dd IH 12.3 and 5.7
C-6 ’ 60.1 3.87 dd IH 12.3 and 2.2
C-5’ 73.4 3.96 m IH -
C-2’ 72.0 4.07 m IH -
C-2 55.2 4.44 m IH -
C -r 8 6 . 2 5.33 d IH 1 . 0
CH3-C0 -N,
CO-OH
Table 3.4 -  and NMR assignments of A''-acetyl-a-D-mannopyranosyl-L-cysteme carried out in
D2 O at 500 MHz for and 125 MHz for *^ C.
3.2.7.1 Explanation of the NMR assignments
OH
OH
HO
HO
HN COOH
ca
Fig 3.8 — iV-acetyl-a-D-mannopyranosyl-L-cysteme.
The interpretation of the ’H-’H COSY, HMQC, ^^ C and ^^ C DEPT spectra
allows assignment of the peaks in the NMR spectrum.
From the DEPT and the HMQC spectrum, two multiplets positioned at ca. 3.10 ppm 
were identified as the H-3 signals of the cysteine moiety, this is confirmed using the 
COSY spectrum as this peak couples to a multiplet at 4.44 ppm, H-2, which does not 
couple to any other peak. If a signal for the NH of the cysteine moiety was present in
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the spectrum, then it would couple to the H-2 of cysteine. The solvent used is CD3OD, 
because of this, no signal is seen for NH as this proton exchanges with the deuterium 
of CD3 OD. The proton signals for H-6 ’ are obtained via the DEPT and HMQC 
spectrum as two double doublets, one at 3.79 ppm and one at 3.87 ppm. The COSY 
spectrum shows the protons of H-6 ’ coupling to a multiplet at 3.96 ppm, which is the 
signal of H-5’; this signal is a multiplet from being adjacent to three protons in 
different environments. Proton H-5’ couples to a triplet at 3.70 ppm, this is proton H- 
4’; H-4’ is the only proton to produce a triplet as it is in an axial-axial-axial system. 
The COSY shows H-4’ to couple to H-3’ at ca. 3.75 ppm which is a doublet of 
doublets; proton H-3’ is axially positioned and of its neighbouring protons, one is 
positioned axially (H-4’), the other equatorially (H-2’). Proton H-3’ couples to H-2’ 
at 4.07 ppm, which appears as a narrow doublet. Proton H-2’ couples to H-1’ at 5.33 
ppm, another narrow doublet with a coupling constant of 1.0 Hz. Following the 
same rationale as for the precursors 4 and 6  one can assume that the a-anomer has 
been isolated, as coupling constants for axial-equatorial systems have been noted to 
be nearer to 5 Hz, whereas coupling constants for equatorial-equatorial systems a 
value closer to 1 Hz is mostly observed.^ The singlet in the H^ NMR spectrum at 2.0 
ppm is the CHs-group of the 7/-acetyl group.
3.2.8 The glycosyl donor: 2,3,4-tri-0-benzoyl-'D-ribopyranosyl 
bromide, a and (3-anomers
HO OBz Br
Phœ ci/py / C W  HBr/AcOH B z O ' V ^ ° \
„ r ô “ ^  x A ,
12 13a 13b
Scheme 3,10 -  The synthesis of 2,3,4-tri-O-benzoyl-ribopyranosyl bromide, a  and p-anomers.
The reaction of a-D-ribose with benzoyl chloride in dichloromethane in the presence 
of pyridine, led after workup and recrystallisation to p-D-ribose tetrabenzoate 12 in 75 
% yield. A ^H NMR experiment showed the required peaks were present with some 
impurity peaks, these were possibly the a-anomer. A comparison of the chemical 
shifts and coupling constants in the literature’ confirmed the P-stereochemistry of 12
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in the ^ € 4  conformation. The NMR experiment also confirmed that it was the 
pyranose ring structure which was present and not the furanose form. Even though the 
NMR spectrum showed some impurity peaks, no further purification was required 
as the purity of this product does not significantly affect the subsequent steps.
The reaction of p-D-ribose tetrabenzoate 12 with hydrogen bromide in glacial acetic 
acid (45 % w/v HBr) in dichloromethane, after work up and gave 2,3,4-tri-O-benzoyl- 
D-ribppyranosyl bromide a and p-anomers 13a and 13b in approximately 73 % crude 
yield. A NMR experiment showed that the required peaks were present. From 
comparison with the literature NMR values,^ it is clear that both a and p-anomer 
have been synthesised, the a-anomer in the '^ Ci conformation and the P-anomer in the 
^ € 4  conformation, shown below in fig 3.9. Some impurity peaks were present in the 
NMR spectrum but the product purity does not significantly affect further steps.
I OBz|
OBz Br OBz OBz
'*Ci - 2,3,4-tri-O-benzoyl-a-ribopyranosyI bromide - 2,3,4-tri-Obenzoyl-P-ribopyranosyl bromide
13a 13b
Fig 3.9 -  The chair coaformers of 2,3,4-tri-0-benzoyl-p-D-ribopyranosyl bromide.
3.2.9 Coupling reaction: N-acetyi-0-methyi-S-(2,3,4-tri-0-benzoyl- 
P-D-ribopyranosyi)-L-oysteine
OBz Br
AcHN-
OBzlOBzOBz
14
OBz ^^%Bz DCM
13a 13b
Scheme 3.11 -  The synthesis ofiV-acetyl-0-methyl-5-(2,3,4-tri-0-benzoyl-p-D-ribopyranosyl)-L- 
cysteine.
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Reaction o f 2,3,4-tri-O-benzoyl-D-ribopyranosyl bromide, a and p-anomers, 13a and 
13b with A^-acetyl-O-methyl-L-cysteine 2, in dichloromethane in the presence of a 
SnCU catalyst led, after workup and column chromatography, to the isolation of N- 
acetyl-0-methyl-5'-(2,3,4-tri-0-benzoyl-p-D-ribopyi*anosyl)-L-cysteine 14, in 47 % 
crude yield. A range o f NMR experiments were carried out, including (^H,
COSY, HMQC, ^^ C and ^^ C DEPT), to determine the structure, assess purity and 
assign signals. The material was seen to be homogenous by NMR and accurate 
mass confirmed the empirical formula. The identification of 14 is discussed below 
and the *H NMR is shown in fig 3.10 and the assignments given in table 3.5. The 
assignments are based on 2-D and ^^ C NMR experiments.
AcHN-^z^COzCHs
OBz I 
OBz OBz
14
II
PPM
Fig 3.10 -  *H NMR spectium of A-acetyl-(7-methyl-iS'-(2,3,4-ti*i-0-benzoyl-p-D-ribopyianosyl)-L- 
cysteine carried out in CDCI3 at 500 MHz.
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Assignment ÔC (ppm) ÔH (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
0 6 - 0 0 23.1 2.08 s 3H -
c-3 32.9 3.19 dd IH 14.3 and 5.1
C-3 32.9 3.31 dd IH 14.3 and 4.8
O 6-0C 52.9 3.81 s 3H -
C-5’ 63.2 4.08 dd IH 12.5 and 5.7
C-5’ 63.2 4.43 dd IH 12.6 and 3.4
C-2 52.1 4.96 m IH -
C -r 82.9 5.41 d IH 4.9
c-2’ 69.4 5.52 t IH 3.9
C-4’ 67.4 5.57 m IH -
C-3’ 67.3 5.88 bs IH -
m - 6.5 d IH 7.0
AxCH 128.6-130.2 7.28-8.11 m 15H -
AiC-CO 133.5-133.7 - - - -
Ar-CO-0 165.4-166.0 - - - -
CH3-CO-N,
CO-OCH3
170.3 and 
171.1 . . .
Table 3 .5 -  "C  and NMR assignments of A'"-acetyl-0-methyl-iS'“(2,3,4-tri-0-benzoyl-p-D- 
ribopyranosyl)-L-cysteine carried out in CDCI3 at 500 MHz for and 125 MHz for
3.2.9.1 Explanation of the NMR assignments
AcHN
H
OBzOBz OBz
14
Fig 3.11 -  A^-acetyI-0-methyl-*S'-(2,3,4-tri-0-benzoyl-p-D-ribopyranosyl)-L-cysteine.
In the case of the gluco and galacto derivatives the signals and, coupling constants 
give adequate confirmation of the stereochemistry. With the ribo derivative, it is 
difficult to determine whether the a or (3-anomer is present as there can be
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contributions from both the "^ Ci and C^4 conformations. The assignment of each peak 
is still possible and this is discussed below, and the interpretation of the actual 
structure will be discussed after this.
The interpretation of the COSY, HMQC, ^^ C and ‘ C^ DEPT spectra
allows assignment of the peaks in the NMR spectrum.
From the DEPT and the HMQC spectrum, the two double doublets centred at ca. 3.20 
ppm were identified as the H-3 of the cysteine moiety; this is confirmed using the 
COSY spectrum. The COSY shows that these peaks couple to a multiplet at 4.96 
ppm, H-2, and a doublet at 6.50 ppm which is assigned as NH; this is confirmed as 
there is no coupling to the ^^ C spectrum for this doublet in the HMQC. The proton 
signals for H-5’ are obtained via the DEPT and HMQC spectrum as two double 
doublet, one at 4.08 ppm and one at 4.43 ppm. The protons of H-5’ couple to a 
multiplet at 5.57 ppm, which is proton H-4’. The COSY shows H-4’ to couple to a 
broad singlet, H-3’, at 5.88 ppm. Proton H-3’ couples to H-2’ at 5.52 ppm, which 
appears as a narrow triplet. Proton H-2’ couples to H-1’ at 5.41 ppm, which is a 
doublet with a coupling constant of V  = 4.9 Hz. The two singlets in the H^ NMR 
spectrum at 2.08 and 3.81 ppm are the CHg-groups of the W-acetyl and the methyl 
ester o f the cysteine residue. The multiplets fiom 7.28 to 8.11 ppm are assigned to the 
aromatic protons.
3.2.9.2 Discussion
Coupling of 2,3,4-tri-O-benzoyl-D-ribopyranosyl bromide a and p-anomers 13a and 
13b with iV-acetyl-O-methyl-L-cysteine led to the isolation of only one product. There 
aie two possible chair conformers ^Ci and C^4 , for each of the a and P-anomers, and 
these are shown in fig 3.12. For substitution at C-1 of 13a and 13b the literature 
evidence is of a preference for the P-anomer, even fiom the P-bromide.^’^  Jeanloz et 
al. showed that 2,3,4-tri-O-benzoyl-p-D-ribopyranosyl bromide gave 2’-naphthyl 
2,3,4-tri-O-benzoyl-P-D-ribopyranoside.^ An Sn2 mechanism can only give the a- 
product, so the formation of the p-product suggests an SnI mechanism with the usual 
/ran^-antiperiplanar attack of the nucleophile on the C-1 oxonium ion intermediate, 
coupled with the blocking of the a-approach by the axial C-2 benzoyl group. Jeanloz 
et al. again showed that p-product (88 %) is also obtained fiom attack by methanol, 
and likewise ethanol (80 %).^  Furthermore, for both a and P-ribo tetrabenzoates the
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preferred conformation, and ^ € 4  respectively, is that where the substituent at C-1 
is axial?
BzO
H3CO2C— ^ N H A c
H
OBzOBz OBz
BzO
CO2CH3  
OBz S'
15 AcHN 'COjCHj
H
OBz
OBz OBz15
T
NHAc
Fig 3.12 -  The four possible chair conformers for //-acetyl-0-methyl-iS'-(2,3,4-tri-0-benzoyl-D- 
ribopyranosyl)-L-cysteme, P 14 and a  15.
Therefore the P-anomer is proposed for the product isolated here, and the preferential 
conformation as C^4 . The assignment as the P-anomer is supported by the NMR 
evidence since the a-anomer preferred conformer "^ Ci would show a large {ca. 10 Hz) 
V4 , 5 value, which is clearly not the case in the product here. Coupling constants Ji, 2 
for tribenzoyl-p-ribosyl halides, in which the strong anomeric effect of the C-1 
halogen would be expected to result in the predominance of the C^4 conformer, aie 
1.0-1.7 Hz (in CDCI3) typical of equatorial-equatorial couplings.^ However, for 
tribenzoyl-P-ribosyl benzoate the preference for C^4 is only 77 % (in de-acetone), with 
this conformer being in rapid equilibrium with the "^ Ci conformer and this equilibrium 
results in a higher Ji, 2 value of 3.1 Hz (in de-acetone)  ^ or 3.5 Hz (in CDCls)  ^
reflecting a contribution from the axial-axial coupling in the ^Ci conformer. Such an 
equilibrium is proposed here to account for the moderate J\^  2 coupling constant of 4 . 6  
Hz.
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O B z O B z G b P n ^ O * -
13a
B zO '
I H S A ttack  o f  n u cleo p h ile  to form  p-anom er on lyJLr - ' L  AcHN^^COîCHj
^  ^
bC^B?b. ^IZ
13b
H S
O B z, A cH NBr
B r
"^COzCHa
A ttack  o f  n u cleo p h ile  to form  P -anom er on ly
Scheme 3.12 -  The mechanism for tiie formation of /'/-acetyl-0-methyl-iS'-(2,3,4-tri-0-benzoyl-P-D- 
ribopyranosyl)-L-cysteine.
Assuming the mechanism of ester gioup participation at C-2, in scheme 3.12 it can be 
seen that the ortho-ester formation would facilitate the fonnation of the p-anomer if 
either 13 a or 13b is the starting bromide.
3.2.10 Hydrolysis of the methyl ester: N-acetyl-S-'(2,3,4-trhO- 
benzoyl-l3-D-rlbopyranosyl)-L-cystelne
AcHN-^ ^COzCH)
I
2MHC1
OBz iz 
14
AcHN- COOH
OBzJ,OBz OBz16
Scheme 3.13 - The synthesis of A-acetyl-iS-(2,3,4-tri-C>-benzoyl-P-D-ribopyranosyl)-L-cysteine.
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The reaction o f iV-acetyl-0-methyl-5'-(2,3,4-tri-0-benzoyl-P-D-rihopyianosyl)-L- 
cysteine 14 with aq. 2M HCl at 90 °C for 144 horns with workup and purification by 
column chromatography gave iV-acetyl-5'-(2,3,4-tri-0-benzoyl-p-D-ribopyi*anosyl)-L- 
cysteine 16 as a white powder in ca. 41 % crude yield, which was homogenous by 
NMR, fig 3.13. The reaction was monitored by TLC, using dichloromethane: ethyl 
acetate 7:3, appearance o f a spot on the baseline indicating product formation. A 
range of NMR experiments were carried out, ‘H-*H COSY, HMQC, ^^ C and ^^ C 
DEPT, to confirm the structure. LRMS gave a satisfactory molecular ion and an 
accurate mass confirmed the empirical formula. As with the gluco derivatives, solvent 
choice for the NMR was difficult, because although the product appeared soluble in 
CDCI3 the H^ NMR spectrum was not fully resolved, so CD3OD was chosen as the 
solvent. The *H NMR spectrum (fig 3.13) is similar to that of the precursor 14, except 
that as with the gluco and marmo derivatives the methyl peak is no longer present. 
The other NMR experiments confirm the assignment o f each peak, reasoned 
analogously to the case of 14.
AcHN...2^C00H
H
>Bz
OBz OBz
PPM
Fig 3.13 -  'H  NMR of A'-acetyl-iS'-(2,3,4-ti'i-0-benzoyl-P-D-ribopyranosyl)-L-cysteme carried out in
CD3OD at 500 MHz.
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Assignment ÔC (ppm) ÔH (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
CH3-CO 22.7 1.98 s 3H _
C-3 33.2 3.05 dd IH 14.3 and 8 . 6
C-3 33.2 3.37 dd IH 13.6 and 4.2
C-5’ 64.0 4.12 dd IH 12.9 and 4.2
C-5’ 64.0 4.52 dd IH 12.9 and 3.0
C-2 54.4 4.69 m IH -
C-1’ 83.4 5.57 bs IH -
C-2’ 70.7 5.57 bs IH -
C-4’ 69.1 5.57 bs IH -
C-3’ 68.9 5.86 bs IH -
AïCH 128.3-129.8 7.25-7.92 m 15H -
ArC-CO 133.3-133.5 - - - -
Ar-CO-0 165.4-166.0 - - - -
CH3-CO-N,
CO-OH 172.1
Table 3.6 -  and NMR assignments of A^-acetyl-i5-(2,3,4-tri-0“benzoyl-P-D-ribopyranosyl)-L- 
cysteine carried out in CD3OD at 500 MHz for and 125 MHz for
3.2.11 Deprotection of the glycosyl portion: N-acetyi-P-D- 
ribopyranosyi-L-cysteine
AcHN COOH
NaOMe/MeOH
OBz,OBz OBz
16
AcHN-^COOH
O'
OH ^^OH 
17
Scheme 3.14 -  The synthesis ofiV-acetyl-p-D-ribopyranosyl-L-cysteine.
Reaction of iV-acetyl-iS'-(2,3,4-tii-0-benzoyi-p-D-ribopyranosyl)-L"Cysteine 16 with 
freshly prepared sodium methoxide in methanol at room temperatuie, gave after work 
up and column chromatography 7V^acetyl-6'-(3-D-ribopyranosyl-L-cysteine 17 as a 
clear oil in 55 % yield, which was homogenous by NMR, fig 3.14. Full NMR 
analysis was carried out including ^H, COSY, HMQC, ^^ C and ^^ C DEPT
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experiments. The NMR peaks aie assigned in table 3.7; these assignments are 
made by interpretation o f the and 2-D NMR experiments that have been
canied out. LRMS gave a satisfactoiy moleculai* ion and an accurate mass confirmed 
the empirical formula.
AcHN~,2^CC0H
OH
OH OH
f p m '
Fig 3.14 -  ‘H NMR spectrum of A-acetyl-P-D-ribopyranosyl-L-cysteine earned out in CD3OD at 500 
MHz.
Assignment Sc (ppm) ÔH (ppm) Multiplicity Integral
Coupling 
constant/ V  
(Hz)
C//3-CO 22.9 2 . 0 1 s 3H -
C-3 33.9 2.90 dd IH 13.6 and 8.0
C-3 33.9 3.20 dd IH 13.5 and 4.1
C-2’ 72.7 3.63 m m -
C-5’ 6 6 . 2 3.63 m IH -
C-4’ 70.0 3.74 m IH -
C-3’ 69.4 3.86 t IH 2.9
C-5’ 6 6 . 2 3.95 dd IH 11.5 and 2.3
C-2 55.7 4.47 m IH -
C -r 85.7 5.02 d IH 4.9
CH3-C0 -N,
CO-OH
173.1 and 
177.0 .
Table 3.7 - and ‘H NMR assignments of A-acetyl-p-D-ribopyranosyl-L-cysteine carried out in
C D 3 O D  at 500 MHz for *H and 125 MHz for *^ C.
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3.2.11.1 -  Explanation o f the NMR assignments
AcHN^ ^Z^ COOH
H
OHOH OH
Fig 3.15 -7/-acetyl-5-a-D-ribopyranosyl-L-cysteine.
The interpretation of the COSY, HMQC, ^^ C and ^^ C DEPT spectra
allows assignment of the peaks in the NMR spectrum.
From the DEPT and the HMQC spectrum, the two double doublets centred at cc. 3.00 
ppm was identified as the H-3 of the cysteine moiety, this is confirmed using the 
COSY spectrum as this peak couples to a multiplet at 4.47 ppm, H-2, which does not 
couple to any other peak. The proton signals for H-5’ are obtained via the DEPT and 
HMQC spectrum as a component of the multiplet at 3.63 ppm and a double doublet at 
3.95 ppm. The COSY spectrum shows the protons of H-5’ coupling to a multiplet at 
3.74 ppm, which is the signal of H-4’; this signal is a multiplet fiom being adjacent to 
the two protons of H-5’ and the proton of H-3’. Proton H-4’ couples to a triplet at 
3.86 ppm, this is proton H-3’; H-3’ is a triplet with small coupling constants of V  = 
2.9 Hz which could be due its axial position and being adjacent to two equatorial 
protons. The COSY shows H-3’ to couple to H-2’ which is a component of the 
multiplet at 3.63 ppm. Proton H-2’ couples to H-1’ at 5.02 ppm, a doublet with a 
coupling constant o f V =  4.9 Hz. The singlet in the H^ NMR spectrum at 2.01 ppm is 
the CHa-group of the iV-acetyl group.
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3.3 Discussion and Conclusions
3.3.1 Discussion
iV-acetyl-P-D-ribopyranosyl-L-cysteine 17 and iV-acetyl-a-D-mannopyranosyl-L- 
cysteine 7 were successfully synthesised using the route developed in chapter 2 for N- 
acetyl-D-glucopyranosyl-L-cysteine, a and p-anomers. The galactose series was 
successful only as far as the coupled product: iV-acetyl-0-methyl-»S'-(2,3,4,6-tetra-0- 
benzoyl-p-D-galactopyranosyl)-L-cystéine 10. The mechanism of the coupling 
reaction appears to be SnI as suggested by the literature for reactions having an ester 
group at C-2 of the glycosyl donor. In chapter 2, both the a and P-anomers were 
isolated from the glucose-cysteine coupling reaction, so the isolation of single 
anomers for the galactose, mannose and ribose series from the coupling reaction may 
seem strange. Analysis of the cmde NMR spectra of each coupling reaction was 
conclusive in showing no other anomer present for the mannose and the ribose 
derivatives. The crude NMR spectrum of the galactose coupling showed another 
possible minor product present. In the case of the mannose series the axial substituent 
at C-2’ prevents the formation of the p-anomer due to steric hinderance. If an Sn2 
mechanism was in operation, only the P-anomer would be formed and as the a anomer 
was obtained this is further evidence for an SnI mechanism. The p-anomer isolated 
fiom the coupling reaction for the ribose series is in the C^4  conformation. This is both 
the favoured anomeric product and also the product favoured by participation of the 
benzoyl group at C-2’. The galactose series also yielded only the P-anomer. Although 
this is the expected major product, the isolation of an a and p-anomer for the glucose 
series suggests two anomers would be isolated for the galactose series. As mentioned 
in section 3.2.2 a small amount of an unidentified compound was isolated from the 
column of crude tetrabenzoyl galactosyl cysteine. This could possibly be the a- 
anomer. It could be that the amount of a-anomer formed during the reaction is so 
small that isolation is difficult. The acid hydrolysis of the methyl ester of A’-acetyl-O- 
methyl-jS-(2,3,4-tri-0-benzoyl-p-D-ribopyranosyl)-L-cysteine 14 and A-acetyl-0- 
methyl-iS'-(2,3,4,6-tetra-0-benzoyl-a-D-mannopyranosyl)-L-cysteine 4 was 
straightforward as for the glucose derivatives in chapter 2. However, the acid 
hydrolysis of A-acetyl-0-methyl-5'-(2,3,4,6-tetra-0-benzoyl-P-D-galactopyranosyl)-
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L-cysteine 10 yielded a small amount of a product thought to be iV-acetyl-iS'-(2,3,4,6- 
tetra-0-benzoyl-p-D-galactopyranosyl)-L-cysteine but this product was not isolated 
upon a repeat of the reaction. It may be that prolonged reaction times are needed due 
to the lack of solubility of the benzoylated products in aqueous acidic medium. The 
removal of the methyl ester of 10 was also attempted with BBrg but this choice of 
reagent appears to be too strong, resulting in a messy crude syrup. As with the glucose 
series, removal of the benzoate groups for the mannose and ribose series was achieved 
in good yields.
3.3.2 Conclusions
The work in this chapter has been successful in establishing the generality of the route 
to 6"-glycosyl cysteines developed in chapter 2. This is highlighted by the successful 
synthesis of A-acetyl-p-D-ribopyranosyl-L-cysteine 17 and iV-acetyl-a-D- 
mannopyranosyl-L-cysteine 7. A^-acetyl-0-methyl-iS'-(2,3,4,6-tetra-0-benzoyl-P-D- 
galactopyranosyl)-L-cysteine 10 has also been prepared. However, it appears 
uncertain why there is greater difficulty in completing the synthetic route for the 
galactose series.
A-acetyl-p-D-ribopyranosyl-L-cysteine 17 and iV-acetyl-a-D-mannopyranosyl-L- 
cysteine 7 were not found in the literature. The use of this route to produce ^'-glycosyl 
cysteines in reasonable yield, has not been observed with any of the previous routes to 
^'-glycosyl cysteines found in the literature, with the exception of the route employed 
by Baran and Drabarek.  ^These workers synthesised the galactose analogue of &P-D- 
glucosyl-L-cysteine, but the isomeric purity of these compounds is questionable, as I
other workers observed isomerization of a similar compound under the same basic |
conditions.Racemization was also shown in chapter 2 for the removal of the 
benzoate groups of iV-acetyl-0-methyl-5'-(2,3,4,6-tetra-0-benzoyl-P-D- ■
glucopyranosyl)-L-cysteine using sodium methoxide in methanol.
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3.4 Experimental
3.4.1 General details and Instrumentation
Melting point determination was carried out using a Kofler hot-stage apparatus and is 
imcorrected. Micro analysis was carried out by Ms. Nicola Walker and Ms. Judith 
Peters, University o f Surrey using a Leeman Labs. Inc. CE4400 elemental analyser. 
H^, and 2-D NMR spectroscopy was canied out on a Bruker AC300 at 300 MHz 
and 75 MHz respectively and DRX-500 at 500 MHz and 125 MHz respectively. The 
majority o f spectra were carried out using the Bruker DRX-500 at 500 MHz for H^ 
NMR and 125 MHz for NMR, unless otherwise stated in the experiment. Spectra 
are referenced internally to TMS ■ where possible or deuterated solvent signals. 
Chemical shift values are quoted in ppm while observed coupling constants (J) are 
reported in Hz. H^ NMR abbreviations are as follows: s = singlet, d = doublet, t = 
triplet, m = multiplet and b = broad. Mass spectrometry was carried out by Mr. 
Richard Chaundy, University of Surrey using a ThermoFirmigan spectrometer, 
MAT95 XP.
Solvents were used as supplied except including anhydrous DMF which was 
purchased from Aldrich. Chemicals were either available in the lab or supplied by 
Acros Organics, Aldrich, Fisher Scientific, Fluka or Lancaster. All starting materials 
purchased from an external source were checked by TLC or H^ NMR where 
applicable, prior to use. TLC was carried out on MERCK Silicagel 60 F254 plates. 
Column chromatography was carried out using BDH Medical Supplies Silicagel 60, 
33-70 pm.
3.4.2 Purity of compounds
All characterisation data in the Experimental section refers to material ‘homogeneous 
by NMR’ unless explicitly stated otherwise. ‘Homogeneous by NMR’ is defined 
here as “a proton-decoupled ^^ C NMR spectrum or a well-resolved high field H^ 
NMR spectium showing at most only ‘trace’ peaks not attributable to the structure”.^  
For ^^ C NMR a ‘trace’ peak is defined here as one with < 5 % the intensity of the
“ Purity criteria for new compounds in “Instructions for authors”, J. Org. Chem., 2004, 6 9 ,16A.
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strongest peak attributable to the structure; for ^HNMR a ‘ti*ace’ peak is defined here 
as a singlet, or its equivalent as a doublet, triplet, etc., with < 5 % the intensity of a 
sharp one proton singlet, or its equivalent as a doublet, triplet, multi-proton singlet,^ 
etc''
3.4.3 a-D-galactose pentabenzoa te 8 obzobz
BzO'
OBz8
To a stirred solution of pyridine (12.6 cm )^ in dichloromethane (10,5 cm )^ at 0 °C, 
was slowly added a previously cooled solution of benzoyl chloride (10.5 cm ,^ 12.7 g, 
0.0900 mol) in dichloromethane (10.5 cm )^. The reaction was allowed to stir for five 
minutes. a-D-galactose (5 g, 0.0280 mol) was added portion-wise so that the reaction 
temperature did not go above 10 °C. The flask was then stored in the refrigerator for 
24 hours. The reaction was worked up by diluting with dichloromethane (100 cm )^, 
washing with aq. 2M H2 SO4 (4 x 40 cm^), water (4x40 cm )^, aq. sat. NaHCO] 
solution (4 X 40 cm )^ and water (4 x 40 cm )^. The organic layer was dried over 
Na2S0 4 , filtered, '• and the solvent removed in vacuo to leave a-D-galactose 
pentabenzoate 8  as white crystals, yield = 1 2 . 0  g, 61 %, which was homogenous by 
NMR. NMR (300 MHz) (CDCI3): ô = 4.42 (dd, IH, H-6 , 11.1 and 6.7 Hz),
4.63 (dd, IH, H-6 , V =  11.0 and 6.2 Hz), 4.85 (t, IH, H-5, V =  6 . 8  Hz), 6.03 (dd, IH, 
H-2, V =  11.2 and 3.3 Hz), 6.13 (dd, IH, H-3, V =  11.2 and 3.2 Hz), 6.20 (m, IH, H- 
4), 6.95 (d, IH, H-1, V =  2.9 Hz), 7.24-8.18 (m, 25H,
In this work, many compounds give a *H NMR spectrum showing a sharp well-resolved three-proton 
singlet &om the Ac-NH methyl group. When this peak is used as reference, a ‘trace’ peak is defined 
as one with an intensity < 2 % (5/3 = 1.66 ~ 2 %) of this three-proton singlet.
° These criteria of purity are reasonable here. For example, since many of the products are oils 
(carbohydrates are notoriously difficult to crystallise), and since isomeric (a  and p-isomers) 
contamination is possible, combustion microanalysis is unsuitable; furthermore, even HPLC might be 
less reliable with the possibility of contamination by materials of greatly differing UV-vis sensitivity 
(e.g. contamination of benzoylated products with non-benzoylated, and vice versa).
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3 .4 .42 ,3 ,4 ,6-tetra-O-benzoyl-a-D- obzobz
galactopyranosyl bromide 9"^ bzo-
Br
9
To solution of a-D-galactose pentabenzoate 8 (12.0 g, 0.0170 mol) in 
dichloromethane (50 cm )^ was added hydrogen bromide in glacial acetic acid (45 % 
w/v HBr) (20 cm ,^ 0.1100 mol). The flask was sealed and left to stand overnight in 
the reflrigerator. The mixture was then poured into iced water (100 cm^), and the flask 
rinsed with dichloromethane (20 cm )^. The organic layer was then separated, shaken 
with aq. sat. NaHCOs solution, (4 x 50 cm^), until the effervescence ceased and 
finally washed with water (4 x 50 cm )^. The organic layer was dried over Na2S0 4 , 
filtered, and the solvent was then removed in vacuo to give 2,3,4,6-tetra-O-benzoyl-a- 
D-galactopyranosyl bromide 9 as a creamy brown crystalline solid, yield = 7.6 g, 69 
%. ^H NMR (300 MHz) (CDCI3): 6 = 4.46 (dd, IH, H-6, V =  11.5 and 6.1 Hz), 4.64 
(dd, IH, H-6, V =  11.6 and 6.3 Hz), 4.92 (t, IH, H-5, V =  6.3 Hz), 5.67 (dd, IH, H-2, 
V =  10.6 and 3.4 Hz), 6,05 (dd, IH, H-3, 10.5 and 3.4 Hz), 6.12 (m, IH, H-4),
6.97 (d, IH, H-1, V =  4.4 Hz), 7.24-8.18 (m, 20H, AriT).^
3.4.5 N-acefyl-0"rnethyhS-(2 ,3,4,6-tetra-O-
Bzo\— —benzoyl-13-D-galactopyranosyiyL-cystelne 10 achn-^ co,ch3
10
To a solution of 2,3,4,6-tetra-O-benzoyl-a-D-galactopyianosyl bromide 9 (3 g, 0.0046 
mol) and A/-acetyl-0-methyl-L-cysteine 1 (0.82 g, 0.0046 mol) in dichloromethane 
(30 cm^), stirred at room temperature, was added tin (IV) chloride (0.53 cm ,^ 1.19 g, 
0.0046 mol). The solution was allowed to stir for 24 hours. The reaction was diluted 
with dichloromethane (30 cm )^ and worked up by washing with aq. 3M HCl ( 3 x 3 0  
cm )^ and water (3 x 30 cm^), then diying the organic layer over Na2 S0 4  followed by 
filtration. A white crystalline solid was present after removal of the solvent in vacuo. 
Silica gel TLC (using 7:3 dichloromethane-ethyl acetate) showed four components. 
Silica gel column chromatography was carried out using 7:3 dichloromethane-ethyl 
acetate. The first component eluted was revealed to be unreacted starting material 
(0.520 g, 15 %), brominated sugar, which was ca. 90 mol % pure. The second 
component isolated was a minor component in a very low yield and as a result could 
not be identified by ^H NMR, this could possibly be the a-anomer. The next eluted
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was 7V-acetyl-0-methyl-.S-(2,3,4,6-tetra-0-benzoyl-P-D-galactopyranosyl)-L-cysteine 
10 as a white crystalline solid, yield = 0.66 g, 19 %, which was homogenous by *H 
NMR. ’H NMR (CDCI3): 8  = 1.95 (s, 3H, CH3-CO), 3.16 (dd, IH, H-3, 13.9 and
6.4 Hz), 3.38 (dd, IH, H-3, ^J= 13.9 and 4.3 Hz), 3.71 (s, 3H, C%OC), 4.43 (m, IH, 
H-6 ’), 4.43 (m, IH, H-5’), 4.63 (dd, IH, H-6 ’, V =  10.3 and 5.8 Hz), 4.88 (m, IH, H- 
2), 4.90 (d, IH, H -r , 9.7 Hz), 5.67 (dd, IH, H-3’, 10.0 and 3.6 Hz), 5.83 (t,
IH, H-2’, V =  9.7 Hz), 6.04 (d, IH, H-4’, V =  3.4 Hz), 6.47 (d, IH, Ni7, 7.6 Hz), 
7.21-8.08 (m, 20H, ArH). '^CNMR(CDCl3): 8  = 22.9 (CH3-CO), 31.7 (C-3), 51.7 (C- 
2), 52.7 (CH3OC), 62.3 (C-6 ’), 67.7 (C-2’), 68.4 (C-4’), 72.4 (C-3’), 75.5 (C-5’), 83.6 
(C-1’), 128.5, 128.6, 128.7, 129.0, 129.1, 129.5, 129.9, 130.0, 130.1, 130.2, (20 x 
ArCH)“, 133.5, 133.6, 133.7, 134.0 (4 x Ar-C-CO), 165.6, 166.7 (4 x ArC-CO)',
170.2, 171.2 (2 X CO). LRMS (Cl) M+H = 756. HRMS (Cl) M+H, calcd., 756.2109; 
found, 756.2134. Melting point = 78-80 °C. The most polai* component isolated was 
cmde and unidentifiable by NMR, yield = 220 mg.
3.4-. 6 N-dCGtylS~(2j 3,4,6-tGtrd~0-b&nzoyl ob^obz
-P-D-galactopyranosylj-L-cystGinG 11 B z Ô  ÎAcHN'^ COOH
11
A^-acetyl-0-methyl-»S-(2,3,4,6-tetra-0-benzoyl-p-D-galactopyranosyl)-L-cysteine 10 
(0.25 g, 0.0003 mol) was added to aq. 2M HCl (30 cm )^ in a flask fitted with a 
condenser. The mixture was heated to 90 °C and monitored by Silica gel TLC (7:3 
dichloromethane-ethyl acetate) over a period of 144 hours. The reaction mixture was 
allowed to cool, and extracted with dichloromethane (4 x 1 0  cm )^. The organic layers 
were combined, washed with H2O (4 x 1 0  cm^), separated, dried with Na2 S0 4  and the 
filtered. The solvent was removed in vacuo to leave a clear syrup, yield = 0.12 g. TLC 
showed three components (7:3 dichloromethane-ethyl acetate). Silica gel column 
chromatography was carried out. The final component was thought to be A''-acetyl-5'- 
(2,3,4,6-tetra-0-benzoyl-P-D-galactopyranosyl)-L-cysteine but a low yield of 3 mg 
was obtained. 6  = 1.96 (s, 3H), 3.05 (dd, IH, V  = 13.2 and 8.9 Hz), 3.49 (dd, IH, V =
13.4 and 4.0 Hz), 4.44 (dd, IH, 13.2 and 8.4 Hz), 4.60 (m, 3H), 5.20 (m, IH), 
5.78 (m, 2H), 6.05 (bd, IH), 7.22-8.08 (m, 20H, ArH).
 ^ The bigger peaks 128.6 and 128.7 ppm represent three carbons, peaks 129.1 and 129.5 ppm, one
carbon, the remainder two carbons.
® These peaks represent two carbons.
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3.4.7 a and fS-D-mannose pentabenzoa te 2 bzo,\O B z
OBz
To a stirred solution of pyridine (12.6 cm )^ in dichloromethane (10.5 cm )^ at 0 °C, 
was slowly added a previously cooled solution of benzoyl chloride (10.5 cm ,^ 12.7 g 
0.090 mol) in dichloromethane (10.5 cm )^. The reaction was allowed to sth for five 
minutes. A mixture of a and P-D-mannose (5.0 g, 0.0280 mol) was added portion- 
wise so that the reaction temperature did not go above 10 °C. The flask was then 
stored in the refrigerator for 24 hours. The reaction was worked up by diluting with 
dichloromethane (100 cm^), washing with aq. 2M H2SO4  (4 x 40 cm^), water (4 x 40 
cm )^, sat. aq. NaHCOs solution (4 x 40 cm )^ and water (4 x 40 cm^). The organic 
layer was dried over Na2S0 4 , filtered, and the solvent removed in vacuo to give a 
mixture of a and P-D-mannose pentabenzoate 2  as a white crystals, yield = 9.3 g, 47 
%, which was ca. 80 mol % pure by NMR. NMR (300 MHz) (CDCI3): Ô = 
4.24-4.82 (m), 4.48-4.71 (m), 5.01 (m), 5.81 (m, 3H), 5.92 (t, 3H), 5.09 (m, 3H), 6.29 
(t, IH), 6.55 (d, IH), 6.63 (d, IH), 7.26-8.22 (m).
3.4.8 2,3,4 ,6-tetra-O-benzoyl-a-D-mannopyranosyl 
brom ide 3
3 Br
To solution of a and p-D-mannose pentabenzoate 2 (9.3 g, 0.0133 mol) in 
dichloromethane (50 cm )^ was added hydrogen bromide in glacial acetic acid (45 % 
w/v HBr) (20 cm ,^ 0.11 mol). The flask was sealed and left to stand overnight in the 
refrigerator. The mixture was then poured into iced water (100 cm^), and the flask 
rinsed with dichloromethane (20 cm^). The organic layer was then separated, shaken 
with sat. aq. NaHCOs solution, (4 x 50 cm^), until the effervescence ceased and 
finally washed with water (4 x 50 cm )^. The organic layer was dried over Na2S0 4 , 
filtered, and the solvent was then removed in vacuo to give crude 2,3,4,6-tetra-O- 
benzoyl-a-D-mannopyranosyl bromide 3 as a creamy brown crystalline solid yield =
7.2 g, 84 %, showing some impurity peaks in the H^ NMR spectrum. H^ NMR (300 
MHz) (CDCI3); 8  = 4.34 (m, impurities), 4.44 (m, impurities), 4.52 (dd, IH, H-6 ,
12.2 and 3.7 Hz), 4.66 (m, IH, H-5), 4.74 (IH, H-6 , V =  12.6 and 2.4 Hz), 4.88 (dd, 
impurities), 4.98 (dd, impurities), 5.50 (m, impurities), 5.75 (m, impurities), 5.84 (m.
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impurities), 6.08 (m, impurities), 5.91 (m, IH, H-2 ), 6.24 (t, IH, H-4, V =  10.0 Hz), 
6.29 (dd, IH, H-3, V =  10.2 and 3.1 Hz), 6.59 (d, IH, H-1, V =  1.2 Hz), 7.26-8.14 (m, 
20H, ArH).
3.4.9 N-acetyl-0-methyl-S-(2,3,4,6-tetra-O- szo
benzoyl-'a-D-mannopyranosyl)-’L-cysteine 4
AcHN-^ COjCHa
To a solution of 2,3,4,6 -tetra-O-benzoyl-a-D-mannopyranosyl bromide 3 (3 g, 0.0046 
mol) and iV-acetyl-O-methyl-L-cysteine 1 (0.82 g, 0.0046 mol) in dichloromethane 
(30 cm^), stirred at room temperature, was added tin (IV) chloride (0.53 cm ,^ 1.19 g, 
0.0046 mol). The solution was allowed to stir for 24 hours. The reaction was diluted 
with dichloromethane (30 cm )^ and worked up by washing with aq. 3M HCl (3 x 30 
cm )^ and water (3 x 30 cm )^, then drying the organic layer over Na2 S0 4  followed by 
filtration. A white crystalline solid was present after removal of the solvent in vacuo. 
Silica gel TLC (using 7:3 dichloromethane-ethyl acetate) showed three components. 
Silica gel column chromatography was carried out using 7:3 dichloromethane-ethyl 
acetate. The first component eluted was revealed to be unreacted starting material 
(920 mg, 27 %), brominated sugar*, which was ca. 80 mol % pure. The next eluted 
was A-acetyl-0-methyl-5'-(2,3,4,6-tetra-(9-benzoyl-a-D-mannopyranosyl)-L-cysteine 
4 as a white crystalline solid, yield = 0.45 g, 13 %, which was homogenous by H^ 
NMR. *HNMR (CDCI3): 5 = 2.04 (s, 3H, CH3-CO), 3.22 (dd, IH, H-3, V =  14.4 and 
3.8 Hz), 3.34 (dd, IH, H-3, V =  14.4 and 4.8 Hz), 3.82 (s, 3H, CH3OC), 4.48 (dd, IH, 
H-6 ’, V =  12.4 and 3.6 Hz), 4.73 (m, IH, H-5’), 4.93 (dd, IH, H-6 ’, 12.4 and 2.4
Hz), 5.09 (m, IH, H-2), 5.44 (d, IH, H-1’, V =  1.6 Hz), 5.72 (dd, IH, H-3’, V =  10.0 
and 3.2 Hz), 5.80 (dd, IH, H-2’, 3.3 and 1.4 Hz), 6.18 (t, IH, H-4’, V =  10.1 Hz),
6.85 (d, IH, NH, 8.4 Hz), 7.25-8.16 (m, 20H, ArH). "C NMR(CDCl3): 5 = 23.3 
(CH3-CO), 36.0 (C-3), 52.5 (C-2 ), 53.1 (CH3OC), 62.6 (C-6 ’), 6 6 . 8  (C-4’), 70.3 (C- 
3’), 70.5 (C-5’), 72.3 (C-2’), 84.4 (C-1’), 128.6, 128.7, 128.8, 128.9, 129.0, 129.1,
129.3, 129.9, 130.0, 130.1 (20xArCH)‘^, 133.4, 133.6, 133.8 (4 x Ar-C-CO)®, 165.5,
 ^The bigger peaks 128,7 and 130.0 ppm represent three and four carbons respectively, peaks 129.0,
129.1 and 129.3 ppm, one carbon, the remainder two carbons.
® The bigger peak at 133.8 ppm represents two carbons. .
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165.6, 166.4 (4 x A iC-CO)\ 170.4, 171.0 ( 2  x CO). LRMS (Cl) M+H = 756. HRMS 
(Cl) M+H, calcd., 756.2109; found, 756.2083. Melting point = 92-94 °C. The most 
polar component isolated was crude and unidentifiable by NMR, yield = 95 mg.
3.4.10 N-acetyl-S-(2,3,4,0-tetra-O-benzoyl-a-D
-mannopyranosyl)-L-cysteine 6  ^ ^
AcHN^COOH
iV-acetyl-0-methyl-*S'-(2,3,4,6-tetra-0-benzoyl-a-D-mannopyranosyl)-L-cysteine 4 
(0.05 g, 0.066 mmol) was added to aq. 2M HCl (20 cm )^ in a flask fitted with a 
condenser. The mixture was heated to 90 °C and monitored by silica gel TLC (7:3 
dichloromethane-ethyl acetate) over a period of 144 hours. A spot on the baseline was 
characteristic of the product. The reaction mixture was allowed to cool, and extracted 
with dichloromethane (3 x 10 cm )^. The organic layers were combined, washed with 
H2O (3 X 10 cm )^, separated, dried with Na2 S0 4  and filtered. The solvent was 
removed in vacuo to leave a clear syrup. Silica gel TLC showed two components (7:3 
dichloromethane-ethyl acetate). Silica gel column chromatography was carried out. 
The first component was eluted with 7:3 dichloromethane-ethyl acetate, the yield was 
too low to identify, but the component was thought to be 4, the second component 
was eluted with 92:8 dichloromethane-methanol and gave 7V-acetyl-5'-(2,3,4,6-tetra-0- 
benzoyl-a-D-mannopyranosyl)-L-cysteine 6  as a white, powdery solid, showing some 
impurity peaks in the H^ NMR spectrum, (ca. 90 mol % pure), yield = 0.022 g, 45 %. 
H^ NMR (CD3OD): Ô = 1.20 (ethyl acetate), 1.30 (impurities), 1.80 (impurities), 2.00 
(ethyl acetate), 2.03 (s, 3H, CH3-COI 3.19 (dd, IH, H-3, 13.7 and 7.7 Hz), 3.32
(m, IH, H-3), 4.10 (ethyl acetate) 4.50 (dd, IH, H-6 % 11.9 and 2.2 Hz ), 4.73 (m,
IH, H-2), 4.79 (m, IH, H-6 ’), 4.82 (m, IH, H-5’), 5.69 (m, 2H, H-1’ and H-3’), 5.81 
(d, IH, H-2’, 1.6 Hz), 6.17 (t, IH, H-4’, V =  9.9 Hz), 7.22-8.12 (m, 20H, ArH).
^^ C NMR(CD3 0 D): 5 = 21.5 (CH3-CO), 34.1 (C-3), 53.6 (C-2), 62.4 (C-6 ’), 6 6 . 8  (C- 
4’), 69.7 (C-5’), 71.0 (C-3’), 71.9 (C-2’), 84.1 (C-1’), 128.2, 128.3, 128.5, 128.6,
 ^The bigger peak at 165.6 ppm represents two carbons.
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128.7,129.0, 129.1,129.4,129.5, 129.6,129.7 (20x A iQ \ 133.3, 133.4, 133.5, 133.6 
(4xArC-C0), 165.4,165.8,166,3 (4 x Ar-COÿ, 172.2,175.1(2 x CO).
3.4.11 N-acetyl-S-a-D-mannopyranosyl 
-L-cysteine 7
To a stirred solution of A -^acetyl-iS'-(2,3,4,6-teti‘a-0-benzoyl-a-D-mannopyranosyl)-L“ 
cysteine 6  (15 mg, 0.020 mmol) in methanol (2 cm )^, was added sodium methoxide 
(0.04 cm )^, which was previously prepared by the cautious addition of sodium (0.05 
g) to methanol (10 cm )^. The flask was sealed and stirred for 2 hours. The reaction 
was worked up by addition of Amberlite (IR 120 H )^ until the solution was neutral to 
moist universal indicator paper and then filtered. The solvent was removed in vacuo 
to leave a clear oil. TLC (9:1 dichloromethane-methanol) showed two spots, one of 
which was present on the baseline and became visible only by staining with 1% vapour. 
Column chromatography was carried out using 9:1 dichloromethane-methanol and 
after elution of the first component which was methyl benzoate, the eluent was 
changed to 3:1 chlorofoim-methanol and the column was washed through. After 
removal of the solvent in vacuo the final component, A-acetyl-iS-a-D- 
mannopyranosyl-L-cysteine 7, was present as a clear syrup, yield = 5 mg, 76 %, 
which was ca. 93 mol % pure by NMR. NMR (D2O): ô = 2.05 (s, 3H, CH3- 
CO), 3.10 (m, IH, H-3), 3.70 (t, IH, H-4’, 9.7 Hz), 3.75 (dd, IH, H-3’, V =  9.7
and 3.2 Hz), 3.79 (dd, IH, H-6 ’ V =  12.3 and 5.7 Hz), 3.87 (dd, 2 H, H-6 ’, V =  12.3 
and 2.2 Hz ), 3.96 (m, IH, H-5’), 4.07 (m, IH, H-2’), 4.44 (m, IH, H-2), 5.33 (d, IH, 
H-1’, V =  1.0 Hz). ^^ C NMR (D2O): 5=22.2 (CH3-CO), 34.1 (C-3), 55.2 (C-2), 60.1 
(C-6 ’), 67.1 (C-4’), 71.2 (C-3’), 72.0 (C-2’), 73.4 (C-5’), 86.2 (C-1’).
‘ The bigger peak at 129.6 represents four carbons, the peaks at 128.2, 129.0, 129.1 and 129,5 represent
one carbon, and the remainder represent two carbons.
 ^The bigger peak at 166.3 represents two carbons.
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3.4.12 p-D-ribose tetrabenzoate 12^ ?
OBz
12
To a stirred solution of pyridine (10.5 cm )^ in dichloromethane (10.5 cm )^ at 0 °C, 
was slowly added a previously cooled solution of benzoyl chloride (8 . 8  cm ,^ 1 0 . 6  g 
0.075 mol) in dichloromethane (8 . 8  cm )^. The reaction was allowed to stir for five 
minutes. a-D-ribose (4.2 g, 0.0280 mol) was added portion-wise so that the reaction 
temperature did not go above 10 °C. The flask was then stored in the refrigerator for 
24 hours. The reaction was worked up by diluting with dichloromethane (100 cm )^, 
washing with aq. 2M H2SO4  (4 x 40 cm^), water (4 x 40 cm )^, sat. aq. NaHCOs 
solution (4 X 40 cm )^ and water (4 x 40 cm )^. The organic layer was dried over 
Na2 S0 4 , filtered, and the solvent removed in vacuo to give p-D-ribose tetrabenzoate 
12 as a white crystals, showing some impurity peaks in the NMR spectrum, {ca. 80 
mol % pure), yield = 11.7 g, 75 %. NMR (300 MHz) (CDCI3): 4.10 (dd, 
impurities), 4.30 (dd, IH, H-5, 12.3 and 3.5 Hz), 4.42 (dd, IH, H-5, 12.3 and
2.3 Hz), 5.20 (m, impurities), 5.72 (t, IH, H-4, V =  3.6 Hz), 5.75 (t, IH, H-2 , V =  3.6 
Hz), 6.07 (t, IH, H-3, 3.6 Hz), 6.24 (bt, impurities), 6,62 (m, impurities), 6.63 (d,
IH, H -r, 3.3 Hz), 7.26-8.18 (m, 20H,
3.4.13 2,3,4-tri-O-benzoyl-D-ribopyranosyl  ^ f
bromide, a  and p-anomers 13a, 13b^ Ù o \
OBz 3 r  C «z OBz 
13a 13b
To solution of p-D-ribose tetrabenzoate 12 (11.7 g, 0.0210 mol) in dichloromethane 
(50 cm )^ was added hydrogen bromide in glacial acetic acid (45 % w/v HBr) (20 cm ,^ 
0.1100 mol). The flask was sealed and left to stand overnight in the refrigerator. The 
mixture was then poured into iced water ( 1 0 0  cm )^, and the flask rinsed with 
dichloromethane (20 cm )^. The organic layer was then separated, shaken with sat. aq. 
NaHC0 3  solution, (4 x 50 cm )^, until the effervescence ceased and finally washed 
with water (4 x 50 cm )^. The organic layer was dried over Na2S0 4 , filtered, and the 
solvent was then removed in vacuo to give 2,3,4-tri-O-benzoyl-D-ribopyranosyl 
bromide 13a and 13b, as an anomeric mixture, as a creamy brown crystalline solid 
yield = 8.1 g, 73 %, which was ca. 85 mol % pure by H^ NMR. H^ NMR (CDCI3): ô = 
4.10 (dd, IH, H-5a, V =  12.3 and 5.3 Hz), 4.32 (dd, IH, H-5a, 13.4 and 1.2 Hz),
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4.44 (dd, IH, H-5p, 12.4 and 3.4 Hz ), 4.51 (dd, IH, H-5p, V =  12.5 and 2.1 Hz),
5.47 (m, IH, H-2.), 5.50 (m, IH, H-4.), 5.77 (m, 2H, H-2p and H-4p), 5.98 (t, IH, H-
3., 3.3 Hz), 6 . 1 2  (t, IH, H-3p, V =  3.9 Hz), 6.67 (d, 2H, H-l.+p, = 1.0 Hz).''
3.4.14 N-acetyl-0-methyl-S-(2,3,4-tri-0-benzoyl ,— c^oiCh,
-a-D-ribopyranosy!)-L-cysteine 14
»  in .
To a solution of 2,3,4-tri-O-benzoyl-P-D-ribopyranosyl bromide 13 (3 g, 0.0057 mol) 
and A-acetyl-0-methÿl-L-cysteine 1 (1.01 g, 0.0057 mol) in dichloromethane (40 
cm )^, stirred at room temperature, was added tin (IV) chloride (0.66 cm \ 1.48 g, 
0.0057 mol). The solution was allowed to stir for 24 hours. The reaction was diluted 
with dichloromethane (50 cm )^ and worked up by washing with aq. 3M HCl (4 x 30 
cm )^ and water (4 x 30 cm^), then drying the organic layer over Na2 S0 4  followed by 
filtration. A white crystalline solid was present after removal of the solvent in vacuo. 
Silica gel TLC (using 7:3 dichloromethane-ethyl acetate) showed four components. 
Silica gel column chromatography was carried out using 7:3 dichloromethane-ethyl 
acetate. The first two components eluted together and were revealed to be a mixture 
of unreacted starting material, brominated sugar, and another crude component which 
could not be identified by H^ NMR, yield = 0.4 g. The next eluted was iV-acetyl-0- 
methyl-5'-(2,3,4-tri-0-benzoyl-a-D-ribopyranosyl)-L-cysteine 14 as a white 
crystalline solid, yield = 1.67 g, 47 %, which was homogenous by H^ NMR. H^ NMR 
(CDCI3): Ô =  2.08 (s, 3H, CH3-CO), 3.19 (dd, IH, H-3, V =  14.3 and 5.1 Hz), 3.31 
(dd, IH, H-3, V =  14.3 and 4.8 Hz), 3.81 (s, 3H, CH3OC), 4.08 (dd, IH, H-5’, V  = 
12.5 and 5.7 Hz), 4.43 (dd, IH, H-5’, V =  12.6 and 3.4 Hz), 4.96 (m, IH, H-2), 5.41 
(d, IH, H-1’, V =  4.9 Hz), 5.52 (t, IH, H-2’, 3.9 Hz), 5.57 (m, IH, H-4’), 5.88
(m, IH, H-3’), 6.50 (d, IH, V  = 7.0 Hz), 7.28-8.11 (m, 15H, ArH). ^^ C 
NMR(CDCl3): 6  = 23.1 (CH3-CO), 32.9 (C-3), 52.1 (C-2), 52.9 (CH3OC), 63.2 (C- 
5’), 67.3 (C-3’), 67.4 (C-4’), 69.4 (C-2’), 82.9 (C-1’), 128.6, 128.7, 129.4, 129.5,
13.0.0, 130.1, 130.2, (15xArCH)\ 133.5, 133.6, 133.7 (3xAr-C-C0), 165.4, 165.9,
166.0 (3xArC-CO), 170.3, 171.1 (2 x CO). LRMS (Cl) M+H = 622. HRMS (Cl) 
M+H, calcd., 622.1744; found, 622.1741. Melting point = 56-59 °C. The most polar
 ^The bigger peaks 128.6, 128.7 and 130.2 ppm represent three carbons, peaks 129.4 and 129.5 ppm, 
one carbon each, the remainder two carbons.
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compound eluted was a minor component in a very low yield and as a result could not 
be identified by NMR.
3.4.15 N-acetyl-S-(2,3,4-trhO-benzoyl-a-D- s-'^ ^cogh
16ribopyranosyl)-L-cystelne 16
OBz
A-acetyl-0-methyl-iS'-(2,3,4-tri-0-benzoyl“a-D-ribopyranosyl)-L-cysteine 14 (0.5 g,
0.804 mmol) was added to aq. 2M HCl (50 cm )^ in a flask fitted with a condenser. 
The mixture was heated to 90 °C and monitored by silica gel TLC (7:3 
dichloromethane-ethyl acetate) over a period o f 144 hours. A spot on the baseline was 
characteristic of the product. The reaction mixture was allowed to cool, and extracted 
with dichloromethane (3 x 20 cm )^. The organic layers were combined, washed with 
H2 O (3 X 20 cm^), separated, dried with Na2 S0 4  and filtered. The solvent was 
removed in vacuo to leave a clear syrup. Silica gel TLC showed two components (7:3 
dichloromethane-ethyl acetate). Silica gel column chiomatogiaphy was carried out. 
The first component was eluted with 7:3 dichloromethane-ethyl acetate and was 14, 
(50 mg, 10 %), ca. 90 mol % pure by H^ NMR, the second component was eluted 
with 92:8 dichloromethane-methanol and gave A-acetyl-5'-(2,3,4-tri-0-benzoyl-a-D- 
iibopyranosyl)-L-cysteine 16 as a white, powdery solid, yield = 0.2 g, 41 %, which 
was homogenous by H^ NMR. H^ NMR (CD3OD): 5 = 1.98 (s, 3H, CH3-CO), 3.05 
(dd, IH, H-3, 14.3 and 8 . 6  Hz), 3.37 (dd, IH, H-3, V =  13.6 and 4.2 Hz), 4.12
(dd, IH, H-5’, V =  12.9 and 4.2 Hz ), 4.52 (dd, IH, H-5’, 12.9 and 3.0 Hz), 4.69
(m, IH, H-2), 5.57 (bs, IH, H-1’), 5.57 (b.s, IH, H-2’), 5.57 (bs, IH, H-4’), 5.86 (bs, 
lH,'H-3’), 7.25-7.92 (m, 15H, ArH). ^^ C NMR(CD3 0 D): 5 = 22.7 (CH3-CO), 33.2 
(C-3), 54.4 (C-2), 64.0 (C-5’), 68.9 (C-3’), 69.1 (C-4’), 70.7 (C-2’), 83.4 (C-1’),
128.3, 128.4, 128.5, 129.5, 129.7, 129.8 (15xArC)% 133.3, 133.4, 133.5 (3xArC-C0), 
165.5, 165.7, 166.0 (3xAr-C0), 172.1, 172.1 (2 x CO). LRMS (Cl) M+H = 608. 
HRMS (Cl) M+H, calcd., 608.1557; found, 608.1585.
* The bigger peak 128.3 ppm represents four carbons, peaks 128.5 and 129.8 ppm represent three 
carbons, peaks 128.4 and 129.7 represent two carbons and the remaining peak represents one carbon.
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3.4.16 N-acetyl-S-a-D-ribopyranosyl s-^ p-cooH
r ^ Q - ^ y  NHAc-L-cysteine 17 _
i f °  in  "
To a stined solution of A-acetyl-*S-(2,3,4-tri-0-benzoyl-a-D-ribopyranosyl)-L- 
cysteine 16 (0.150 g, 0.247 mmol) in methanol (2 cm )^, was added sodium methoxide 
(0.42 cm^), which was previously prepared by the cautious addition of sodium (0.05 
g) to methanol (10 cm )^. The flask was sealed and stirred for 2 hours. The reaction 
was worked up by addition of Amberlite (IR 120 H )^ until the solution was neutral to 
moist universal indicator paper and then filtered. The solvent was removed in vacuo 
to leave a clear oil. TLC (9:1 dichloromethane-methanol) showed two spots, one of 
which was present on the baseline and became visible only by staining with I2 vapour. 
Column chromatography was carried out using 9:1 dichloromethane-methanol and 
after elution of the first component which was methyl benzoate, the eluent was 
changed to 3:1 chloroform-methanol and the column was washed through. After 
removal of the solvent in vacuo the final component, A-acetyl-iS-a-D-ribopyranosyl- 
L-cysteine 17, was present as a clear syrup, yield = 44 mg, 55 %, which was 
homogenous by NMR. 'H NMR (CD3OD): 5 = 2.01 (s, 3H, CH3-CO), 2.90 (dd, 
IH, H-3, 13.6 and 8.0 Hz), 3.20 (dd, IH, H-3, ^J= 13.5 and 4.1 Hz), 3.36 (m, IH,
H-2’), 3.36 (m, IH, H-5’), 3.74 (m, IH, H-4’), 3.86 (t, IH, H-3’, V =  2.9 Hz), 3.95 
(dd, IH, H-5’,V =  11.5 and 2.3 Hz), 4.47 (m, IH, H-2 ), 5 . 0 2  (d, IH, H-1 ’, 4.9
Hz). "C NMR (CD3OD): 5 = 22.9 (CH3-CO), 33.9 (C-3), 55.7 (C-2), 66.2 (C-5’),
69.4 (C-3’), 70.0 (C-4’), 72.7 (C-2’), 85.7 (C-1’), 173.1, 177.0 (2 x CO). LRMS (Cl) 
M+H = 296. HRMS (Cl) M+H, calcd., 296.0798; found, 296.0761.
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Chapter 4
T he Enzym ic and  C hem ical Reactivity of 
A /-acetyl-S-p-glucosyl-L-cysteine and  its 
derivatives
4.1 Introduction
4.1.1 Rationale
In previous chapters, a method for the synthesis of various V-acetyl-iS-P-glycosyl-L- 
cysteines was developed. The glycosylation of W-acetyl-L-cysteine was carried out 
using glucose, galactose, ribose and mannose, with the aim of improving the efficacy 
of W-acetyl-L-cysteine as a drug. The lability and acidic nature of the thiol group of 
cysteine derivatives has been documented throughout this thesis. One such problem is 
that after oral administration, no NAC is detectable in the blood plasma after 12 
hours, ^  indicating fast metabolism of the drug. The masking of the thiol group with a 
carbohydiate such as seen in chapters 2 and 3, should improve the stability of N- 
acetyl-L-cysteine as this has been shown by the glycosylation of other drugs.  ^ Once 
administered, the mechanism of action for W-acetyl-j'-P-glycosyl-L-cystemes is of 
interest. Would such W-acetyl-iS-p-glycosyl-L-cysteines be useful as drugs in their 
own right or would a cleavage of the carbohydrate-cysteine linkage have to occur for 
the drug to be effective? Would the W-acetyl group be removed preferentially? De-
148
_________________________________________________________________ Chapter 4
glucosylation could release iV-acetyl--L-cysteine allowing the drug to be present in the 
body for longer without oxidation of the thiol group. If this happens, by what means 
would this hydrolysis occur, and whereabouts in the body would this take place? It is 
possible that hydrolysis of this linkage occurs enzymically via an enzyme related to 
thioglucosidase (jnyrosinase). It could even be cleaved by a simple 0-glycosidase 
enzyme, or be cleaved chemically by mild acid hydrolysis.
Returning to thioglucosidase sensitivity, shown in fig 4.1 is the structural similarity 
between iV-acetyl-5-p-glucosyl-L-cysteine 2 and sinigrin 1, which is the natural 
substrate for the myrosinase enzyme. Both sinigrin and myiosinase are present in cells 
of plants such as sinapis alba (white mustard), and various thioglycosidases 
responsible for the cleavage of the sulfur-carbohydrate linkage are widely distributed 
in many organisms including man.^
Œ 9H
HO I HO _ j
ÿf OOCr^lSIHAc
O^SO
Fig 4.1 - A comparison of the structure of sinigrin against A-acetyl-^-P-D-glucosyl-L-cysteine.
Myrosinase cleaves the carbohydrate sulfur-linkage in sinigrin, giving D-glucose and 
an aglycone firagment which undergoes a rearrangement, as shown in scheme 4.1.
HS O S O 3(
H O  X  H 2 O  H O  ^ O H
O3SO g
HS. O^SO
N  ^   R - N = C = S  +  H S O 4
R
Scheme 4.1 -  The hydrolysis of sinigrin with tlie myrosinase enzyme.
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The main structural similarities o f 1 and 2, are the p-glucoside linkage and the anion, 
with this in mind the reactivity, either as a substrate or inhibitor, or the stability of N- 
acetyl-^-P-glucosyl-L-cysteine 2 towards myrosinase must be ascertained.
Lote and Weiss isolated a digalactosyl cysteine-linked peptide from human urine.'^  In 
that study they reported that the sulfur carbohydrate linkage is easily cleaved by mild 
acid hydrolysis. Baiun and Drabarek claimed to have synthesised N- 
benzyloxycarbonyl-*S-P-glucosyl and jS-p-galactosyl-L-cysteine methyl ester 3 and 4, 
fig 4.2, and then attempted to determine the stability of the sulfur-carbohydrate 
linkage.  ^ Mild acid hydrolysis was carried out at various temperatures and pH. The 
liberated monosaccharide was detected using paper chromatography and over a period 
of 24 hours at 37 °C, pH = 0.4, they report detection of 16 % of glucose. However, 
there is some uncertainty about that work, and 3 may well react differently to the N- 
acetylated derivative in this work.
OH OH^OH
Q
HO HO
ZHN"^C02Me COzMe
3 4
Z^CgHsCHzOCO
Fig 4.2 -  7V-benzyloxycarbonyl-5-P-glucosyl-L-cysteine methyl ester and iV-benzyloxycarbonyl-tS'-P- 
galactosyl-L-cysteine methyl ester.
With the availability of H^ NMR it should be possible to examine better the acid 
sensitivity of the 5-linked glycocysteines, providing a clearer picture of the 
mechanism and the structure of any other species involved. The acid conditions will 
be chosen to be close to the conditions of the stomach acid in the human body to see if  
hydrolysis is likely in the stomach following oral administration.
4.1.2 Aims and Objectives
The aim of the research in this chapter was to study the activity of W-acetyl-iS-p- 
glucosyl-L-cysteine 2 towards the myrosinase enzyme and aqueous hydrochloric acid.
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iV-Acetyl-iS-p-glucosyl-L-cysteine 2 was chosen, as the myrosinase enzyme is 
reported to be active to glucosinolates with a p configuration and to no other sugar. 
Compound 2 was prepared in chapter 2 and will provide a good basis for the 
establishment of the methodologies for both the enzyme and the acid hydrolysis 
studies.
The following key features will be:
• The activity of myrosinase towards TV’-acetyl-.S'-p-glucosyl-L-cysteine 2, and other 
analogues, shown in fig 4.3,  ^will be monitored by NMR in a phosphate buffer 
prepared with D2O. In addition to 2, compound 5 is selected as, in v/vo, the non­
polar benzoates may provide better access through the lipophilic cell wall. 
Compounds 6a and 6b, a mixture of diastereomers, were chosen to assess if the 
presence of the CO2' group is important.
• Sinigrin 1 and 1 -0-p-nitrophenyl-p-D-glucoside (PNPG) 7, (another substrate for 
myrosinase), will be used as substrates for the inhibition studies which will be 
monitored by UV spectrophotometery. Standardisation of the myrosinase enzyme 
will be carried out using sinigrin 1.
• Acid hydrolysis studies of A-acetyl-^-P-glucosyl-L-cysteine 2 will be monitored 
by NMR using a DCI/D2O solution which will be made to the appropriate 
concentration.
OBz OH
BzO I HO 1  _
A cH N ^^CO oM e AcHN " ^ 0 0 2
5 2
OH OH
- 0
HO 1AcHN " "COgMe
HOHO
HO
6 a and 6 b
Fig 4.3
“ Compound 7, is a known substrate for myrosinase and has been used as a standard in die enzyme 
studies.®
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4.2 Results and Discussion
4.2.1 Standardisation of Myrosinase: Sinigrin
Chapter 4
HO
O3SO
Myrosinase
HjO
OH
"%0
HO
8
OH
S OSO3
Scheme 4.2 -  The hydrolysis of sinigrin with the myrosinase enzyme.
In order to study the capability o f A^-acetyl-iS-p-glucosyl-L-cysteine as an inhibitor for 
myrosinase, standardisation o f the enzyme activity was carried out. The hydrolysis o f  
sinigrin was monitored by UV spectroscopy by observation o f the disappear ance o f  
the sinigrin 1 absorbance at 227 nm over time. Standard assay conditions were 
employed as used in a study by Sotting et aL,  ^pH 7.0, 33 mM phosphate buffer, 37 ± 
0.1 °C. The concentration o f 1 in the UV cell was 0.1 mM in a total volume o f 2 cm ,^ 
and monitoring was carried out at X = 227 nm, where Esinigrin = 6874. Three 
standardisations were carried out. A plot of absorbance vs. time for the three 
experiments is shown in fig 4.4 and the raw data are in Table 4.1.
0.84 -
0.82 -
S  0.78 - 
0.76 -
0.74 -
0.72 -
0.7
0 40 8020 60
Time/mim
Fig 4.4 -  Plot of Abs2 2 7  vj. time for the standardisation of myr osinase in 33 mM phosphate buffer, pH
7.0 at 37 °C. [sinigrin] = 0.1 mM, myrosinase = 1.6 //g in 2 cm  ^or 0.0000842 units/ cm .^ Blue = run 1, 
pink = run 2 and yellow = run 3.
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Time (min) AbsorbanceRun 1 Run 2 Run 3
1 0.833 0.801 0.829
3 0.828 - -
5 0.827 0.799 0.824
10 0.823 0.794 0.820
15 0.821 0.791 0.818
20 0.816 0.788 0.815
25 0.813 0.787 0.812
30 0.811 0.785 0.812
35 0.809 0.783 0.808
40 0.806 0.777 0.804
45 0.804 0.776 0.804
50 0.800 0.774 0.797
55 0.798 0.770 0.797
60 0.795 0.769 -
65 - 0.765 -
70 - 0.762 -
(/Abs / dt (min' )^ 5.96 X 10'^ 5.44x10'^ 5.62 X 10'“
mean (/Abs / dt 
(min^) 5,67 ± 0.22 X 10*^
Table 4.1 -  Abs vs. time for the standardisation of myrosinase with in 33 mM phosphate buffer, pH 7.0 
at 37 °C. [sinigrin] = 0.1 mM, myrosinase = 1.6 //g, in 2 cm  ^or 0,0000842 units/ cm .^
The standardisation is as follows:
• (/Abs / dt is given by the slope of the plot of absorbance vs. time.
Average:
(/Abs / (/? = 5.67 X 10“^ min ^
• Abs = [sinigrin] s j  from the Beer-Lambert law, where ex = molar absorptivity 
constant and 1 = path length
• Therefore: Vi = -(/[sinigrin] / dt = -(dAbs/dt) / 85784
5.67 X 10“^ / 6784 = 8.36 x 10'^  mol dm‘^  min'^
= 8.36 X 10'^  //mol dm‘^  min ^
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• The reaction was carried out in 2 cm ,^ and since “standard conditions” are related 
to 1 cm^  of solution, this is equivalent to 8.36 x 10"^  //mol min'  ^ (in 1 cm )^ of 
sinigrin consumed.
• In 2 cm^  there was 0.0016 mg of myrosinase, so in 1 cm^  there was 0.0008 mg. 
Therefore: if  0.0008 mg of myrosinase catalyses hydrolysis o f 8.36 x 10'^  /(mol 
min'  ^of sinigrin, to catalyse the standard 1 //mol min'  ^will require:
0,0008 / 8.36 X 10'^  = 9.5 mg of myrosinase 
So 1 unit = 9.5 mg^
4.2.2 Standardisation of p-Nitrophenyi-p-D-giucoside with 
Myrosinase
O H  OH
Scheme 4.3 -  The hydrolysis of PNPG with the myrosinase enzyme.
The glucoside PNPG 7 is a known substrate for myrosinase and an enzyme assay was 
carried out in a similar manner to that of 1. UV spectroscopy was used to monitor the 
appearance of the j9-nitrophenol absorbance at 430 nm over time, at pH 7.0, 33 mM 
phosphate buffer, 37 ± 0.1 °C. The experiment was carried out with concentrations of
2.0, 5.0 and 10.0 mM PNPG in a UV cell in a total volume on 2 cm ,^ and monitoring 
was carried out at X = 430 nm, where Gp-nitrophenoi = 7002 at pH 7.0. A plot of 
absorbance V5. time is given in fig 4.4 and the raw data in table 4.2.
This is some 6  times weaker then the nominal activity quoted on the label as 1 unit =1.6 mg.
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Fig 4.5 -  Plot of Abs4 3 o time for the hydrolysis by myrosinase of PNPG, 33 mM phosphate buffer, 
pH 7.0 at 37 °C. [PNPG] == 2, 5 and 10 mM, myrosinase = 1,3 mg in 2 cm  ^or 0.0684 units/ cm .^ Dark 
blue, pink = 2 mM, yellow, light blue = 5 mM and puiple, brown =10 mM,
Time
(min)
Absorbance at various [P SfPG]
2 mM 2 mM (duplicate) 5 mM
5 mM 
(duplicate)
10 mM 
(duplicate)
10 mM 
(duplicate)
1 0.0150 0.0204 0.0218 0.0262 0.0244 0.0249
6 0.0198 0.0249 0.0312 0.0345 0.0387 0.0394
11 0.0251 0.0308 0.0406 0.0429 0.0536 0.0531
16 0.0296 0.0356 0.0491 0.0516 0.0686 0.0674
21 0.0346 0.0412 0.0571 0.0604 0.0833 0.0820
26 0.0398 0.0463 0.0661 0.0689 0.0988 0.0968
31 0.0455 0.0517 0.0754 0.0776 0.1139 0.1116
36 0.0497 0.0567 0.0842 0.0865 0.1291 0.1263
41 0.0546 0.0621 0.0933 0.0952 0.1440 0.1408
46 0.0599 0.0675 0.1025 0.1039 0.1594 0.1554
51 0.0649 0.0727 0.1116 0.1127 0.1747 0.1703
56 0.0698 0.0779 0.1204 0.1215 0.1899 0.1847
61 0.0750 0.0830 0.1292 0.1297 0.2047 0.1994
66 0.0803 0.0885 0.1381 0.1386 0.2199 0.2141
71 0.0854 0.0936 0.1471 0.1471 0.2348 0.2289
76 0.0904 0.0990 0.1560 0.1558 0.2501 0.2435
81 0.0950 0.1040 0.1647 0.1645 0.2652 0.2578
86 0.1000 0.1091 0.1737 0.1730 0.2801 0.2723
91 0.1051 0.1145 0.1825 0.1814 0.2948 0.2870
96 0.1100 0.1197 0.1913 0.1903 0.3100 0.3014
Table 4.2 -  Abs vj. time for the standardisation of myiosinase with PNPG, 33 mM phosphate buffer, 
pH 7.0 at 37 ®C. [PNPG] = 2, 5 and 10 mM, myiosinase =1.3 mg in 2 cm  ^or 0.0684 units/ cm .^
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As for sinigrin, dAhs / dt is given by the slope of the plot of absorbance vs. time.
• For 2 mM PNPG:
dAhs I dt — 1 . 0 0  X 1 0 '^  min ^
• Abs = [PNPG] 8430
Vi = -4PNPG] / dt = -{dAhsldt) / 87002
1.00 X 10'^  /  7002 = 1.43 X lO"’ mol dm'^  min"'
= 1.43 X 10'* /;mol dm‘^  min'*
Vi data is summarised in table 4.3, and includes Fi(adj), the initial rate adjusted to 1 
unit of myrosinase in 1 cm  ^of solution. A plot of Fi(adj) vs. [PNPG] is in fig 4.6.
[PNPG]o
(mM)
10^  X
dAhs/dt 
(min )^
10^  X -d[dPmG]/dt 
(mol dm'  ^min' )^
10" X -4dPNPG]M
(mol dm'^  min') 
Average
lO SPj(adj)' 
(mol dm'^  min' )^
2
1 . 0 0 1.43 1.47 ±0.04 2.08 ± 0.051.05 1.50
5 1.78 2.55 2.51 ±0.04 3.55 ±0.051.73 2.47
1 0
3.02 4.31 4.24 ±0.07 6.00 ± 9.902.92 4.17
Table 4.3 -  Reaction rates for the standardisation of myrosinase with PNPG, 33 mM phosphate buffer, 
pH 7.0 at 37 °C. [PNPG] = 2, 5 and 10 mM, myrosinase = 1.3 mg in 2 cm  ^or 0.0684 units/cm^.
' Adjustment is for 1 unit of myrosinase in a 1 cm  ^solution.
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7 .0 0  -
6.00  -  
J  5 . 0 0 -"O
1  4 .0 0
Î 3 .0 0
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10^  X [PNPG]/moldm*
Fig 4.6 -  Fi (adj) V5 . [PNPG]o for the hydrolysis of PNPG with myi osinase, 33 mM phosphate buffer, 
pH 7.0 at 37 °C. [PNPG] = 2, 5 and 10 mM, Fi (adj) is corrected for 1 unit of myrosinase in 1 cm* of 
solution, the values ai e in table 4.3.
For standard Michaelis-Menten khietics/
k.=.[E][S]
Pmax is where the enzyme is saturated by the substrate [S] »K m , and is typically 
found by the top of the curve of a plot of Vi (adj) vs. substrate, where the curve 
flattens out.
Fmax = kcat[E]
[S]
Under these conditions, 
so, generally. VF =
However at [S] „ K m , Vpr _  max
(Km+[S]) 
[S]TC'M
and Vi vs. [S] should be linear with the slope = Fmax / Km 
Examination o f fig 4.6 shows that this is the case here and the slope gives,
Pmax /  K m  = 4.90 X 10"^  m in'^
The value o f 4.90 x 10"^  min'^  is lower than that which is reported in the literature, 
where a value o f 24.5 x 10"^  min'^  is reported for Fmax / Km-^
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4.2.3 N-acetyl-S-P-glucosyl~L-cysteine and derivatives as  
substrates for myrosinase
OR OH
RO ! HO I
AcHN-'^COaR’ AcHN-^CO^Me
5: R  = B z R' = CH3 6a and 6b
2 :R = R ' = H
F ig  4 .7  -  C om pounds tested  as substrates for the m yrosinase enzym e.
Various derivatives of i\r-acetyl-»S'-P-glucosyl“L-cysteine were tested as substrates for 
myrosinase. They are shown in fig 4.7, and listed as follows: V-acetyl-*S'-p-glucosyl- 
L-cysteine 2, V-acetyl-0-methyl-5'-(2,3,4,6-tetra-0-benzoyl-p-D-glucopyranosyl)-L- 
cysteine 5 and V-acetyl-O-methyl-5-p-glucosyl-L-cysteine and V-acetyl-O-methyl-5- 
P-glucosyl-D-cysteine 6 a and 6 b as a diastereomeric mixture. Each experiment was 
monitored by NMR over a period of ca. 168 hours. For the NMR solvent for 5, 
D2O was added to CD3OD until solubility was achieved, this was ca. 95:5 in favour of 
CD3OD. For the diastereomeric mixture of 6 a and 6 b, D2O was used as NMR 
solvent. The studies for 5 and 6 a and 6 b were treated as preliminary studies and were 
carried out at 25 °C. The NMR solvent for 2 was a phosphate buffer at pH 7.0 
prepared in D2O and the study was carried out at 37 °C and monitored over a similai* 
time period of ca. 168 hours. After a short period of an hour, substrates 5, 6 a and 6 b 
showed no change in the H^ NMR spectrum, and this was found for the remainder of 
the experiment. Substrate 2, 5 mg, 15 //moles in 0.5 cm ,^ also showed no change after 
24 hours. The H^ NMR spectrum of 2 with myrosinase after 24 hours is shown in fig 
4.9, and the H^ NMR spectrum of the starting material is shown in fig 4.8. The 
amount of enzyme was increased to a total of 5 times the original amount, and still no 
change was observed by H^ NMR after 24 hours. The sample was then monitored 
intermittently by H^ NMR for a period of ca. 4 days, with no change to the H^ NMR 
spectrum. This increase in enzyme amounts to a total of 0.8 mg of myrosinase in 0,5 
cm ,^ which is ca. 0.09 units or 0.018 units/cm^. This level of myrosinase would 
hydrolyse sinigrin at the rate of 0.18 //moles min‘^
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(or 0.09 /mmoles min’  ^ in 0.5 cm^), and would have hydrolysed 15 //moles in a few 
hours. Cleai'ly 2 is not a substrate on this time scale.
OH
AcHN ' ^ C O j H
HO
J
II2 PPM35 4
Fig 4.8 -  'H NMR spectrum of iV-acetyl-5-p-glucosyl-L-cysteine in a D2 O phosphate buffer at 300 
MHz.
\JL j l o i i U -
PPM
Fig 4.9 -  ‘HNMR spectium ofiV-acetyl-jS-P-glucosyl-L-cysteine with myiosinase in a D2 O phosphate 
buffer (0.1 M) after 24 houi's at 37 °C. Myrosinase = 0.018 units in 0.5 cm^ [2] = 0.0308 mol dm"^  at 
500 MHz.
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None of the substrates tested showed activity towards myrosinase. As no change was 
observed by NMR it was not possible to see if  any of the chosen substrates were 
bound to the enzyme. As no activity was obsei*ved for each of the substrates chosen 
the study was not extended to any other carbohydrates.
4.2.4 Inhibition of the Sinigrin-Myrosinase reaction: N-acetyl-S-p- 
glucosyl-L-cysteine
From the experiments carried out in section 4.2.3 it can be seen that 2 does not appear 
to behave as a substrate for the myrosinase enzyme. Whether any of the substrates 
chosen bound to the enzyme it unclear from NMR spectiometry. It is possible that 
N-acetyl-iS-p-glucosyl-L-cysteine 2 may behave as an inhibitor to myrosinase. It is 
possible that 2 is bound to the enzyme, and it is blocking the active site, but not 
permanently. This is competitive inhibition. Or it may bind elsewhere on the enzyme, 
making a conformational change to the active site of the enzyme; this is known as 
non-competitive inhibition.
iV-aoetyl-5'-|3-glucosyl-L-cysteine 2 was tested as an inhibitor of the myrosinase- 
sinigrin reaction. The inhibition experiment was monitored by UV spectroscopy, 
monitoring the effect of added 2 on the rate of the disappearance of sinigrin 1 
absorbance at X = 227 nm over time. The conditions used were as before; the 
concentration of sinigrin was 0.1 mM, pH 7.0, 33 mM phosphate buffer, at 37 ± 0.1 
°C. The experiment was carried out with two concentrations of 2, 2.5 and 5 mM in the 
UV cell in a total volume on 2 cm^  containing 0.00016 units of myrosinase, and 
monitoring was carried out at 1 = 227 nm, where esinigriti = 6874. The plots of 
Absorbance vs. Time are given in figs 4.10 and 4.11. The results are gathered in table 
4.4, where V\ is initial rate over 60 minutes, Vi is the rate with inhibitor added and Vq 
is the rate without inhibitor.
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Fig 4.10 -  Plot of Abs2 2 7  vj. time for the hydrolysis of sinigrin by myiosinase in the presence of N- 
acetyl-p-D-glucosyl-L-cysteine, 33 mM phosphate buffer, pH 7.0 at 37 °C. [sinigrin] = 0.1 mM, [N- 
acetyl-P-D-glucosyl-L-cysteine] = 2.5 mM, myrosinase = 1.6 //g in 2 cm  ^or 0.0000842 units/cm^.
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Fig 4.11 -  Plot of Abs2 2 7  vs. time for the hydrolysis of sinig in by myrosinase in the presence of N- 
acetyl-P-D-glucosyl-L-cysteine, 33 mM phosphate buffer, pH 7.0 at 37 °C. [sinigrin] = 0.1 mM, [N- 
acetyl-P-D-glucosyl-L-cysteine] = 5.0 mM, myiosinase = 1. 6  //g in 2 cm  ^or 0.0000842 units/cm^.
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[Inhibitor]
(mM)
lO^^Xi/Abs/
dt
(mins'^)
lO^xFi 
(mol dm'^  min' )^ VilVo
0 5.67 8.36 1
2.5 4.93 7.17 0.86
5 3.60 5.24 0.63
Table 4.5 -  Reaction rates for the hydrolysis of sinigrin catalysed by myrosinase in the presence of iV- 
acetyl-p-D-glucosyl-L-cysteine, 33 mM phosphate buffer, pH 7.0 at 37 °C. [sinigrin] = 0.1 mM, [jV- 
acetyl-P-D-glucosyl-L-cysteine] = 0, 2.5 and 5.0 mM, rnyrosinase = 1.6 jMg, in 2 cm  ^or 0.0000842 
units/cm^.
The values of Fi / Vo for the two concentrations of 2 suggest some partial inhibition of 
the sinigrin-myrosinase reaction. In a study by Botting et al.  ^ non-competitive 
inhibition of the sinigrin-myrosinase reaction is obseiwed with glucono-S-lactone 11, a 
known inhibitor of p-glucosidases, shown in fig 4.12. They report a Vi/ Vq of 0.4 at a 
10 mM concentration of 11. The Vi / Vo of 0.6 for a 5 mM concentration of 2 here is 
comparable. However, there is a rather large scatter of the results in fig 4.11. The 
absorbance of 2 is , in the same UV-visible region as sinigrin; therefore increased 
concentrations of 2 raised the level of absorbance in the area of interest to a rather 
higher value. This restricted fiuther study at higher concentrations o f inhibitor, e.g. up 
to 10 mM as with the glucono-ô-lactone 11.
OH
H%0 HO "O 
11
Fig 4.12 -  Glucono-5-lactone.
To further study the inhibition properties o f iV-acetyl-iS-P-glucosyl-L-cysteine 2 
experiments were carried out using PNPG with myrosinase in the presence of 2. The 
absorbance area of interest in this study is A, = 430 nm where 2 does not absorb, so the 
presence of 2 will not obscure observations. This study is explained in section 4.2.5.
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4.2.5 Inhibition of the PNPG-Myrosinase reaction: N-acetyl-S-p- 
glucosyl-L-'Oysteine
A/-acetyl-5'-P-glucosyl-L-cysteine 2 was tested for inhibition o f the myrosinase-PNPG 
reaction. UV-Vis spectroscopy was used to monitor the appearance o f the p- 
nitrophenol absorbance at 430 mn over time, at pH 7.0, 33 mM phosphate buffer, 37 ± 
0.1 °C. The experiment was cairied out with concentrations of 2.0, 5.0 and 10.0 mM 
PNPG and three concentrations o f 1.0, 2.5 and 5.0 mM A^-acetyl-5'~P-glucosyl-L- 
cysteine 2 in the UV cell, in a total volume o f 2 cm ,^ and monitoring was carried out 
at 1 = 430 nm, where Sp.nitrophenoi = 7002 at pH 7.0. The plots o f abs vs. time are shown 
in fig 4.13-4.15 and the rates are summarised in table 4.5 where each value is a mean 
of two independent experiments.
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Fig 4.13 -  Plot of Abs vs. time for the hydrolysis of PNPG by myrosinase in the presence of A -^acetyl- 
P-D-glucosyl-L-cysteine, 33 mM phosphate buffer, pH 7.0 at 37 ®C. [PNPG] = 2 mM, [iV-acetyl-p-D- 
glucosyl-L-cysteine] = 1.0,2.5 and 5.0 mM, myiosinase = 1.3 mg in 2 cm  ^or 0.0684 units/cm^.
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Fig 4.14 -  Plot of Abs vs. time for the hydrolysis of PNPG by myrosinase in the presence of A^-acetyl- 
P-D-glucosyl-L-cysteine, 33 mM phosphate buffer, pH 7.0 at 37 ^C. [PNPG] = 5 mM, [iV-acetyl-P-D- 
glucosyl-L-cysteine] = 1.0,2.5 and 5.0 mM, myrosinase = 1.3 mg in 2 cm  ^or 0.0684 units/ cm .^
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Fig 4.15 — Plot of Abs vj. time for the hydi olysis of PNPG by myi osinase in the presence of iV-acetyl- 
P-D-glucosyl-L-cysteine, 33 mM phosphate buffer, pH 7.0 at 37 °C. [PNPG] = 10 mM, [/V-acetyl-p-D- 
gUicosyl-L-cysteine] = 1.0,2.5 and 5.0 mM, myiosinase =1.3 mg in 2 cm  ^or 0.0684 units/ cm .^
[PNPGJo
(mM)
10^  X (/Abs / dt (min' )^
Inhibitor concentration
0 mM 1 mM 2.5 mM 5 mM
2 1.03 ±0.025 0.979 ± 0.005 0.952 ± 0.034 1.00 ±0.00
5 1.76 ±0.025 1.79 ±0.020 1.86 ±0.01 1.78 ±0.015
10 2.97 ± 0.050 3.01 ±0.165 2.98 ±0.100 2.94 ± 0.050
Table 4.5 -  Reaction rates for the hydi olysis of PNPG by myrosinase in the presence of /V-acetyl-P-D- 
glucosyl-L-cysteine, 33 mM phosphate buffer, pH 7.0 at 37 °C. [PNPG] = 2.0, 5.0 and 10 mM, [iV- 
acetyl-P-D-giucosyl-L-cysteine] = 1.0, 2.5 and 5.0 mM, myrosinase =1.3 mg in 2 cm  ^or 0.0684 units/
cm^ .
As can be seen fi*om the information displayed in table 4.5, the rate of hydiolysis of 
PNPG by myrosinase is not affected by the addition of valions amounts o f A -^acetyl-P- 
D-glucosyl-L-cysteine 2.
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4.2.6 Acid Stability of N-acetyi-p-D-giucosyi-L-cysteine
Possible acid hydrolysis pathways of 2 are outlined in scheme 4.4.
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OH
HO
A c H N  COOH
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HO
H a N -^ C O ,
13 +
AcOH
HCI/H2O
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H^O HO
OH
OH
"%0 HO
H S —- 
A c H N " ^ C O O H  
12
H C I / H 2 O
OH
HS-
H j N'' ' C O ,
13
AcOH
Scheme 4.4 -  Possible acid hydrolysis pathways of A/-acetyl-p-D-glucosyl-L-cysteine.
Previous work claiming the acidic hydrolysis of iS-glysosyl cysteine derivatives 
involved the use o f iV'-benzyloxycarbonyl-5'-p-glucosyl and 5'-p-galactosyl-L-cysteine 
methyl ester 3 and 4.  ^ Some aspects of this work are unclear: adequate NMR analysis 
was not carried out on 3 and 4 and following evidence of isomerization in chapter 2 
(during deprotection of iV-acetyl-0-methyl-«S'-(2,3,4,6-tetra-0-benzoyl-P-D- 
glucopyranosyl)-L-cysteine) and in the study by Uhrig et al.f' it cannot be certain that 
a single diastereomer of 3 or 4 was obtained by the workers.
R’ .OH
R
HO
HC1 /H 2 0
HO ^
ZHN COzMe
3:R  = 0 H ,R '= H  
4:R  = H,R' = 0H
hoA—
HO ^ O H
8 :R  = 0H ,R ' = H 
14:R  = H.R' =  0H
HS
ZHNX C02Me
Scheme 4,5 -  The acid hydrolysis of A-benzyloxycarbonyl-5-P-glucosyl and 5"-P-galactosyl-Lcysteine 
methyl ester.^
 ^ In chapter 2, deprotection of A’-acetyl-0-methyl-.S-(2,3,4,6-te1xa-0-benzoyl-P-D-glucopyranosyl)-L- 
cysteine under basic conditions led to racemization occurring at H-2 of the cysteine moiety. 
Racemization was also reported by Uhrig et al. in Carbohydr. Res., 2000, 325, 72, where the 
deprotection of A'’-acetyl-3-(2,3,4,6-tetra-0-acetyl-P-D-glucopyranosyl)-L-cysteine ethyl ester with 10 
% methanolic trietliylamine was carried out. Similar conditions were used by Baran and Drabarek in 
Pol. J. Chem., 1978, 52, 941 suggesting their product was in fact a diastereomeric mixture.
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In addition to doubts about the synthesis of 3 and 4, the acid hydrolysis experiments 
carried out by Baran and Drabarek/ involved the quantification of glucose by UV-vis 
determination of its derivative with aniline, following isolation of glucose by paper 
chromatography. Over a 24 hour period, at pH 0,4 at 37 °C, they reported detection of 
16 and 20 % yields of glucose and galactose respectively. At pH 1.5 at 100 °C, over a 
24 hour period, it is reported that they detected 28 and 33 % yields of glucose and 
galactose respectively. In a report by Lote and Weiss^ on the identification of 
digalactosyl-cysteine from a glycopeptide in urine, acid hydrolysis of the sulfur- 
carbohydrate linkage was reported under conditions of 0.5 M HCl, under vacuum at 
105 °C 8 hours, again with detection after paper chromatography. However, some 
observations in the current work suggested that the lability of the thioglycoside link 
was greatly over estimated in these earlier studies. For example, a good yield of 
thioglycoside was obtained for acidic hydrolysis of iV-acetyl-0-methyl-*S'-(2,3,4,6- 
tetra-(9-benzoyl-P-D-glucopyranosyl)-L-cysteine 5, 7/-acetyl-0-methyl-6'-(2,3,4,6-
tetra-0-benzoyl-a-D-glucopyranosyl)-L-cysteme 14, 7/-acetyl-0-methyl-5'-(2,3,4-tri- 
0-benzoyl-P-D-ribopyranosyl)-L-cysteine 15 and #-acetyl-0-methyl-5'-(2,3,4,6-tetra- 
0-benzoyl-a-D-mannopyi'anosyl)-L-cysteine 16 to convert the C02Me of the cysteine 
side chain to CO2H, illustrated in fig 4.16, see chapter 2 section 2.2.5 and 2.2.6 and 
also, chapter 3, sections 3.2.6 and 3.2.10, with no evidence of significant cleavage.
^OBz ,OBz
BzO^ BzO"T'<)^--'RBzO-\----7''**<^ S---^  BzO--*-^ /
BzO ! BzO gAcHN'^ COjMe ^
5 14 AcHN ■ 'COjMe
AcHN-^COzMo
s T
R i 'OBz %Bz
15
OBz-I'QBzO
BzO
AcHN
16
Fig 4.16 -  A/-acetyl-C>-methyl-iS'-(2,3,4,6-tetra-0“benzoyl-P-D-glucopyranosyl)-L-cysteine and some 
derivatives.
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Given these reported levels of carbohydrate obtained after acid hydrolysis, it was 
deemed useful to use similar conditions for a study on the acid hydrolysis of 7V-acetyl- 
P"D-glucosyl-L-cysteine 2 as proposed in scheme 4.4. It would be interesting to see if  
the presence of the acetyl group on the N of the amino functional group of cysteine 
would affect the stability o f the molecule. Would a cleavage of the sulfur-glucose 
linkage occur first, or would the acid remove the acetyl group before cleavage of the 
glucosyl linkage?
The acid stability of A'-acetyl-P-D-glucosyl-L-cysteine 2 was monitored by NMR 
spectroscopy. Compound 2 was dissolved in a mixture of DCl / D2O, at 
concenti’ations of 1.0, 2.0 and 3.0 M DCI/D2O, and NMR spectra were acquired 
hourly over a period of 24 hours at 37 °C. Fig 4.18 shows the NMR spectrum of 
the stai'ting material in 3 M DCl at 37 °C. The inset picture of fig 4.18 highlights the 
peaks that correspond to H-1’ and H-2 of 2, the doublet at 3.50 ppm and the multiplet 
at 3.64 ppm respectively. In the red inset can be seen the appearance of a doublet 
alongside that of H-1’ at 3.54 ppm, and also a multiplet upfield at 3.34 ppm.
HO
X
HO
OH
H HN COOH
O CH3
Fig 4.17 -  //-acetyl-P-D-glucosyl-L-cysteine.
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After 0 hours
3.70 3.60 3.50 3.40 3.30 3.70 3.60 3.50 3.40 3.30ppm ppm
After 24 hours
After 0 hours
ppm(tl) 3.50 3.00 2.50 2.00 f.50 1.00
Fig 4.18 -  'H NMR spectrum of yV-acetyl-P-D-glucosyl-L-cysteine in 3 M DCI/D2O at 0 and 24 hours 
at 37 °C.
The peak corresponding to the acetyl group of 2 is seen in fig 4.18 at 1.07 ppm; in the 
spectrum after 24 hours, a second singlet appears at 1.00 ppm. One signal which 
represents one H-3 is seen as a double doublet at 2.03 ppm, and again the red 
spectrum shows a new double doublet, but positioned at 2.19 ppm. The appearance of 
the spectrum does not suggest that hydrolysis o f the glucose-cysteine linkage has 
occurred. For such a hydrolysis, peaks corresponding to a and P-D-glucose under 
rapid mutarotation conditions in the 'H NMR spectrum would be visible, i.e. H-1’ 
would appear as a doublet with a small coupling constant of ca. 5 Hz or less 
downfield o f a doublet with a larger coupling constant of ca. 10 Hz, clearly the 
hydrolysis product is exclusively p. The loss o f the acetyl group would account for 
these observations and for the chemical shift o f the peaks noted previously. A final 'H 
NMR spectrum of the 3 M DCI/D2O reaction after ca. 168 hours, fig 4.19, showed the 
completion o f the hydrolysis o f the fV-acetyl group. No doublet which would be
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expected of H-T o f a-D-glucose at mutarotation was seen in the NMR spectrum/ 
To ensme that the signal(s) which would represent the H-T o f D-glucose were not in 
anyway obscur ed or hidden, a simulated product mixture of D-glucose and A -^acetyl- 
L-cysteine was prepared. Thus a small amount of a-D-glucose and iV-acetyl-L- 
cysteine was dissolved in 3 M DCl and a 'H NMR spectrum taken at 37 °C. These 
simulated conditions revealed the peaks expected for D-glucose at mutarotation in 3 
M DCI/D2 O, i.e. 4.20 and 3.64 ppm, for a-H-1 and (3-H-l respectively. Based on this 
evidence it is proposed that the new singlet that appears at 1 . 0 0  ppm in the red 
spectrum in fig 4.18 corresponds to the CH3 group o f acetic acid, and that the acid 
hydrolysis products of 2 with 3 M DCl are 5-p-D-glucosyl-L-cysteine 13, and acetic 
acid, not D-glucose and A/-acetyl-L-cysteine.
OH
HO
HO
COO
1 PP M24 35
Fig 4.19 -  *H NMR spectrum of A^-acetyl-P-D-glucosyl-L-cysteine in 3 M DCl at 500 MHz after ca. 
168 hours at 37 °C.
The experiments carried out at 1 and 2 M DCl gave similar results but they were 
expectedly slower. After ca. 2 months, the sample used for the 2 M study was 
evaporated to dryness and another ‘H NMR spectrum was carried out in D2O. This is
® A transient singlet was seen in some spectra at 4.55 ppm. It is not clear what this is; although it is in 
roughly the conect position for H-1’ (a) no evidence of a second set of peaks for H-2’, H-3’ etc. is seen 
as would be expected of an o/p-D-glucose mixture.
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shown in fig 4.20 and is identical to fig 4.19 except that the acetic acid peak is no 
longer present and again peaks expected for D-glucose at mutarotation are also not 
present. This confirms the cleavage of the acetyl group by hydrolysis of the amide and 
not the cleavage of the suUm-glucose linkage.
PPM
Fig 4.20 -  'H NMR spectrum of S-p-D-glucosyl-L-cysteine in D2 O at 500 MHz.
Interestingly, the peaks in this product are almost identical to those of 13 claimed by 
Monsigny.^ Based on peak assignments for 2, the assignments for 13 are now more 
reliably made in this thesis and are given in table 4.6. These differ (in assignment) to 
those o f Monsigny^ whose assignments ar e probably wrong.
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Assignment ÔH (ppm) Multiplicity Integral Coupling constant/ V (Hz)
C-3 3.00 dd IH 15.3 and 7.8
C-2’ 3.37-3.52 m IH -
C-3 3.37-3.52 m IH -
C-3’ 3.37-3.52 m IH -
C-4’ 3.37-3.52 m IE -
C-5’ 3.37-3.52 m IH -
C-6 ’ 3.72 dd IH 12.7 and 5.6
C-6 ’ 3.92 dd IH 1 2 . 8  and 1 . 6c-r 4.56 d IH 9.7
C-2 4.22 m IH -
Table 4.6 -  NMR assignments of iS-P-D-glucosyl-L-cysteine in DgO at 500 MHz.
As mentioned previously, Baran and Drabarek report hydrolysis of N- 
benzyloxycarbonyl-6 '-p-glucosyl-L-cysteine, claiming detection of 16 % of glucose at 
pH 0.4 and 37 Also Lote and Weiss claimed hydrolysis of a digalactose-cysteine 
linkage after 8  horns using 0.5 M HCl at 105 °C under vacuum."^  A rough calculation 
for how long their hydrolyses would take at 25 °C,"^  working on the principle that a 10 
°C decrease in temperature leads to a halving o f the rate, suggested ca. 2048 hours 
(ca. 85 days) would be required to achieve cleavage of the carbohydrate-cysteine 
linkage had 25 °C been used. The results obtained in this study show that using a 
stronger concentration of acid and keeping the mixture at 37 °C for ca. 35 days and 
then at room temperature for a furlher 70 days, still no hydrolysis of the glucose- 
cysteine linkage occurs.
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4.2.7 Kinetic study: The hydrolysis of the acetyl group of N-acetyl- 
p-D-glucosyhL-cystelne
H OH
aq. HCl
HOHO OH
H N ' COOH
2
H OH
HOHO OH
HzN
13
COOH
Scheme 4.6 -  The acid hydrolysis of A'-acetyl-P-D-glucosyl-L-cysteine to iS-P-D-glucosyl-L-cysteine.
With the acetyl group being removed by aqueous acid hydrolysis, a kinetic study at 
various concentrations of aqueous HCl acid was carried out. Such information is 
useful as the rate of deacetylation of TV-acetyl-p-D-glucosyl-L-cysteine 2 would be 
required knowledge if  the compoimd were to find use in the pharmaceutical industry. 
So, 1.0, 2.0 and 3.0 M concentrations of DCI/D2O were used and NMR spectra 
acquired hourly over a period of 24 hours at 37 °C. Integration of the product peaks 
H-1’ and H-2 and their corresponding starting material peaks gave the rate of 
appearance of 13. The data are given in tables 4.7-4,12, and the plots in figs 4.21- 
4.26.
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Time
(hours) Asm A p ( A s M + A p )
A sm 10^x[SM]t 
(mol dm' )^ hi(Asm Ap ) (Asm Ap )
1 22403.1 0 22403.1 1 . 0 0 2.31 0
2 22178.7 0 22178.7 1 . 0 0 2.31 0
3 22362.9 0 22362.9 1 . 0 0 2.31 0
4 21919.3 954.9 22874.2 0.96 2 . 2 1 -0.043
5 21321.6 1173.6 22495.2 0.95 2.19 -0.054
6 21707.0 1331.0 23038.0 0.94 2.17. -0.060
7 21513.4 1560.7 23074.0 0.93 2.15 -0.070
8 20530.4 1589.6 22119.9 0.93 2.14 -0.075
9 21171.4 1786.0 22957.4 0.92 2.13 -0,081
1 0 20510.8 1923.0 22433.8 0.91 2 . 1 1 -0.090
1 1 20366.4 2070.1 22436.5 0.91 2 . 1 0 -0.097
1 2 20981.9 2523.8 23505.7 0.89 2.06 -0.114
13 20120.7 2598.6 22719.4 0.89 2.04 -0 . 1 2 1
14 20474.7 2722.8 23197.5 0 . 8 8 2.04 -0.125
15 2 0 2 0 1 . 2 3034.5 23235.6 0.87 2 . 0 1 -0.140
16 19384.9 2773.1 22158.1 0.87 2 . 0 2 -0.134
17 19648.1 3096.4 22744.6 0 . 8 6 1.99 -0.146
18 19887.3 3274.8 23162.1 0 . 8 6 1.98 -0.152
19 19581.8 3433.0 23014.8 0.85 1.96 -0.162
2 0 19840.3 3758.6 23598.9 0.84 1.94 -0.173
2 1 19134.7 3747.0 22881.7 0.84 1.93 -0.179
2 2 18967.7 3517.3 22485.0 0.84 1.95 -0.170
23 18630.6 3764.3 22394.8 0.83 1.92 -0.184
24 18638.9 3918.4 22557.3 0.83 1.91 -0.191
Table 4.7 -  Raw data for tlie hydrolysis of iV-acetyl-6'-p-D-glucosyl-L-cysteine to iS-P-D-glucosyl-L- 
cysteine using IM DCI/D2 O at 37 °C over 24 hours. Asm = area of starting material (arbitrary units), Ap 
= area of product (arbitrary units). Asm and Ap are obtained by integration of the peak H-1’ on the 
starting material and product, respectively.
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Time
(hours) A s m A p ( A s M + A p )
A sm 10^x[SM]t 
(mol dm' )^ In "^ sM( A sm  Ap ) ( A sm  Ap)
1 22829.6 0 22829.6 1 . 0 0 2.31 0
2 22495.3 0 22495.3 1 . 0 0 2.31 0
3 22301.0 0 22301.0 1 . 0 0 2.31 0
4 22160.6 1098.1 23258.7 0.95 2 . 2 0 -0.048
5 22003.2 1211.5 23214.7 0.95 2.19 -0.054
6 21882.2 1323.1 23205.3 0.94 2.18 -0.059
7 22118.1 1730.0 23848.1 0.93 2.14 -0.075
8 21334.1 1738.4 23072.5 0.92 2.13 -0.078
9 21427.6 1902.6 23330.3 0.92 2 . 1 2 -0.085
1 0 21375.2 1924.2 23299.4 0.92 2 . 1 2 -0.086
1 1 20898.7 1878.4 22777.1 0.92 2 . 1 2 -0.086
1 2 21431.2 2618.9 24050.1 0.89 2.06 -0.115
13 20799.5 2365.5 23165.0 0.90 2.07 -0.108
14 20873.5 2767.0 23640.5 0 . 8 8 2.04 -0.124
15 21094.6 2798.6 23893.3 0 . 8 8 2.04 -0.125
16 19834.2 2209.6 22043.7 0.90 2.08 -0.106
17 20209.3 3178.2 23387.5 0 . 8 6 1.99 -0.146
18 20332.8 3650.0 23982.8 0.85 1.96 -0.165
19 19965.4 3323.8 23289.2 0 . 8 6 1.98 -0.154
2 0 20157.3 3987.8 24145.1 0.83 1.93 -0.181
2 1 19591.4 3876.7 23468.1 0.83 1.93 -0.181
2 2 19272.6 3410.3 22682.9 0.85 1.96 -0.163
23 19100.1 3496.8 22597.0 0.85 1.95 -0.168
24 18999.9 3948.4 22948.3 0.83 1.91 -0.189
Table 4.8 -  Raw data for the hydrolysis of N-acetyl-iS-P-D-glucosyl-L-cysteine to 5'"P-D-glucosyl-L- 
cysteine using IM DCl/DgO at 37 °C over 24 hours. Asm “  area of starting material (arbitrary units), Ap 
= area of product (arbitrary units). Asm and Ap are obtained by integration of the peak H-2 on the 
starting material and product, respectively.
The kinetics are as follows. 
Therefore:
[SM], A SM
[SM]q (Agj^+Ap) 
so, assuming pseudo first-order loss of SM
o r [SM ]j = "SIM(Asm Ap )
[SM]t = [SM]o or = e“[SM],
x[SM ], (1)
(2)
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so taking a natural log: In [SM],[SM],
and substitute (1) into (3) gives In
=  - k o b s t
A,"SM
(^ SM ^p)./ =  - k o b s t
which gives -kobs as the slope of a plot o f In
(^ SM ^p)
V5 . time.
(3)
(4)
3.0
2.5 -
1 2.0
1
1 5 -
S£.
T=. 1.0
0.5
0.0 -
...................
10 15
Time / hours
20 25
Fig 4.21 -  A plot of [SM], \s. time, for the acid hydrolysis of A^-acetyl-P-D-glucosyl-L-cysteine to 5-P- 
D-glucosyl-L-cysteine with IM DCl/EXO at 37 °C over 24 hours. [SM]o = 2.31 x 10  ^mol dm'^. Blue = 
H-1 pink = H-2.
0 .0 0 0  »»»
<
+  - 0.100
5 -0.150 -
- 0.200
-0.250
Time / Hours
Fig 4.22 -  A plot of the ln(AsM/AsM + Ap) vs. time, for the acid hydrolysis of A^-acetyl-P-D-glucosyl-L- 
cysteine to 5-P-D-glucosyl-L-cysteine with IM DCI/D2 O at 37 °C over 24 hours. [SMjo = 2.31 x 10'^  
mol dm Blue = H-1’, pink -  H-2.
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Time
(hours) Asm Ap (AsM+Ap)
S^M ) 10^  X [SM]t 
(mol dm"^ ) hi "SM(^ SM -^ P ) (-^ SM -^ P )
1 69.99 L  0 69.99 1 . 0 0 1.39 0
2 69.99 0 69.99 1 . 0 0  . 1.39 0
3 67.77 0 67.77 1 . 0 0 1.39 0
4 6 8 . 2 2 6.57 74.79 0.91 1.26 -0.092
5 64.48 9.01 73.49 ■ 0 . 8 8 1 . 2 2 -0.131
6 67.45 7.22 74.67 0,90 1.25 -0 . 1 0 2
7 68.16 12.13 80.29 0.85 1.18 -0.164
8 65.98 11.59 77.57 0.85 1.18 -0.162
9 63.62 11.7 75.32 0.84 1.17 -0.169
1 0 62.5 10.62 73.12 0.85 1.18 -0.157
1 1 65.4 13.44 78.84 0.83 1.15 -0.187
1 2 64.02 13.45 77.47 0.83 1.14 -0.191
13 56.95 11.28 68.23 0.83 1.16 -0.181
14 63.67 15.38 79.05 0.81 1 . 1 2 -0.216
15 57.64 14.66 72.3 0.80 1 . 1 0 -0.227
16 58.14 14.68 72.82 0.80 1 . 1 1 -0.225
17 59.1 13.36 72.46 0.82 1.13 -0.204
18 57.79 16.95 74.74 0.77 1.07 -0.257
19 57.67 15.53 73.2 0.79 1.09 -0.238
2 0 52.78 16.08 6 8 . 8 6 0.77 1.06 -0.266
2 1 55.94 17.03 72.97 0.77 1.06 -0.266
2 2 53.91 17.15 71.06 0.76 1.05 -0.276
23 54,61 17.31 71.92 0.76 1.05 -0.275
24 53.76 19.63 73.39 0.73 1 . 0 1 -0.311
Table 4.9 -  Raw data for the hydrolysis of A^-acetyl-iS-p-D-glucosyl-L-cysteine to .S-P-D-glucosyl-L- 
cysteine using 2M DCI/D2O at 37 °C over 24 hours. Asm = area of starting material (arbitrary units), Ap 
= area of product (arbitrary units). Asm and Ap are obtained by integration of the peak H-1’ on the 
starting material and product, respectively.
176
Chapter 4
Time
(hours) Asm Ap (AsM+Ap)
■^SM 10^  X[SM]t 
(mol dm‘^ )
1_ .  -^SM
(^ S M  -^P ) ( A s M + A p )
1 71.15 0 71.15 1 . 0 0 1.39 0
2 71.15 0 71.15 1 . 0 0 1.39 0
3 69.26 0 69.26 1 . 0 0 1.39 0
4 71.93 5.87 77.8 0.92 1.28 -0.078
5 70.7 10.77 81.47 0.87 1 . 2 0 -0.142
6 68.9 11.81 80.71 0.85 1.18 -0.158
7 71.15 15.63 86.78 0.82 1.14 -0.199
8 68.75 15.3 84.05 0.82 1.13 -0 . 2 0 1
9 66.97 11.58 78.55 0.85 1.18 -0.159
1 0 64.99 11.63 76.62 0.85 1.17 -0.165
1 1 68.13 16.82 84.95 0.80 1 . 1 1 -0 . 2 2 1
1 2 67.38 14.67 82.05 0.82 1.14 -0.197
13 58.9 11.34 70.24 0.84 1.16 -0.176
14 67.64 17.51 85.15 0.79 1 . 1 0 -0.230
15 61.09 18.65 79.74 0.77 1.06 -0.266
16 59.73 15.92 75.65 0.79 1.09 -0.236
17 62.99 19.84 82.83 0.76 1.05 -0.274
18 60.32 19.99 80.31 0.75 1.04 -0.286
19 59.48 18.07 77.55 0.77 1.06 -0.265
2 0 56.79 15.27 72.06 0.79 1.09 -0.238
2 1 59.9 19.47 79.37 0.75 1.05 -0.281
2 2 57.3 19.89 77.19 0.74 1.03 -0.298
23 55.21 18.12 73.33 0.75 1.04 -0.284
24 54.76 24.63 79.39 0.69 0.96 -0.371
Table 4.10 -  Raw data for the hydrolysis of TV-acetyl-iS-P-D-glucosyl-L-cysteine to iS-P-D-glucosyl-L- 
cysteine using 2M DCI/D2 O at 37 °C over 24 hours. Asm = area of starting material (arbitrary units), Ap 
= area of product (arbitrary units). Asm and Ap are obtained by integration of the peak H-2 on the 
starting material and product, respectively.
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Fig 4.23 -  A plot of [SM], vs. time, for the acid hydrolysis of A^-acetyl-P-D-glucosyl-L-cysteine to 5-P- 
D-glucosyl-L-cysteine with 2M DCI/DzO at 37 °C over 24 hours. [SM]o = 1.39 x 10  ^mol dm Blue 
= H-1’, pink = H-2.
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Fig 4.24 -  A plot of ln(AsM/AsM + Ap) vs. time, for the acid hydrolysis of A^-acetyl-P-D-glucosyl-L- 
cysteine to 5-P-D-glucosyl-L-cysteine with 2M DCI/D20 at 37 °C over 24 hours. [SM]o = 1.39 x 10  ^
mol dm Blue = H-1’, pink = H-2.
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Time
(hours) Asm A p ( A s M + A p )
Asm 10^x[SM]t 
(mol dm' )^ In'(Asm Ap) (Asm Ap)
1 31950.2 0 31950.2 1 . 0 0 1.23 0
2 28038.61 1723.78 29762.39 0.94 1.16 -0.060
3 27919.63 2413.39 30333.02 0.92 1.13 -0.083
4 28034.93 2697.61 30732.54 0.91 1 . 1 2 -0.092
5 27648.83 3626.15 31274.98 0 . 8 8 1.09 -0.123
6 26492.26 3975.49 30467.75 0.87 1.07 -0.140
7 27075.74 4282.86 31358.6 0 . 8 6 1.06 -0.147
8 25520.56 4698.23 30218.79 0.84 1.04 -0.169
9 25994.58 6235.25 32229.83 0.81 0.99. -0.215
1 0 25049.88 6128.24 31178.12 0.80 0.99 -0.219
1 1 24559.01 5900.1 30459.11 0.81 0.99 -0.215
1 2 24339.98 7078.12 31418.1 0.77 0.95 -0.255
13 25278.13 7310.37 32588.5 0.78 0.95 -0.254
14 23096.56 7081.43 30177.99 0.77 0.94 -0.267
15 23241.32 7468.15 30709.47 0.76 0.93 -0.279
16 22613.37 8375.11 30988.48 0.73 0.90 -0.315
17 23197.83 9795.84 32993.67 0.70 0.87 -0.352
18 21535.83 9164.13 30699.96 0.70 0 . 8 6 -0.355
19 21011.59 9262.31 30273.9 0.69 0.85 -0.365
2 0 21699.44 9820.16 31519.6 0.69 0.85 -0.373
2 1 21416.81 10136.72 31553.53 0 . 6 8 0.84 -0.388
2 2 21331.51 10711.44 32042.95 0.67 0.82 -0.407
23 21060.39 11426.84 32487.23 0.65 0.80 -0.433
24 18983.28 10718.07 29701.35 0.64 0.79 -0.448
Table 4.11 -  Raw data for the hydrolysis of//-acetyl-5-P-D-gIucosyl-L-cysteine to 5-P-D-glucosyl-L- 
cysteine using 3M DCI/D2 O at 37 over 24 hours. Asm = area of starting material (arbitrary units), Ap 
= area of product (arbitrary units). Asm and Ap are obtained by integration of the peak H-1’ on the 
starting material and product, respectively.
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Time
(hours) A sm A p (A s M + A p )
A sM 10^  X [SM]t 
(mol dm' )^ hi s^M( A sm Ap ) ( A sm '*■ Ap )
1 32127.99 0 32127.99 1 . 0 0 1.23 0 . 0 0 0
2 28705.63 0 28705.63 1 . 0 0 1.23 0 . 0 0 0
3 29001.1 2135.53 31136.63 0.93 1.15 -0.071
4 29795.64 3927.91 33723.55 0 . 8 8 1.09 -0.124
5 28208.18 4230.26 32438.44 0.87 1.07 -0.140
6 27596.31 3967.54 31563.85 0.87 1.08 -0.134
7 279320 4602.44 32534.44 0 . 8 6 1.06 -0.153
8 26970.75 5308.62 32279.37 0.84 1.03 -0.180
9 26835.7 5646.17 32481.87 0.83 1 . 0 2 -0.191
1 0 26822.0 6994.28 33816.28 0.79 0.98 -0.232
1 1 25404.13 6 0 9 0 . 8 8 31495.01 0.81 0.99 -0.215
1 2 25478.77 7632.29 33111.06 0.77 0.95 -0.262
13 25624.34 8359.19 33983.53 0.75 0.93 -0.282
14 24237.65 8185.84 32423.49 0.75 0.92 -0.291
15 23881.65 8201.34 32082.99 0.74 0.92 -0.295
16 24280.74 10564.06 34844.8 0.70 0 . 8 6 -0.361
17 24403.72 10327.18 34730.9 0.70 0 . 8 6 -0.353
18 21184.99 9315.3 30500.29 0.69 0 . 8 6 -0.364
19 21791.07 10659.61 32450.68 0.67 0 .8 3 -0.398
2 0 22134.89 10375.04 32509.93 0 . 6 8 0.84 -0.384
2 1 21166.66 11495.96 32662.62 0.65 0.80 -0.434
2 2 22499.04 11172.24 33671.28 0.67 0.82 -0.403
23 21349.38 12219.21 33568.59 0.64 0.78 -0.453
24 19470.71 10826.83 30297.54 0 . 6 4 0.79 -0.442
Table 4.12 -  Raw data for the hydrolysis of JV-acetyl-j'-P-D-glucosyl-L-cysteine to -S-P-D-glucosyl-L- 
cysteine using 3M DCl/DgO at 37 °C over 24 hours. Asm = area of starting material (arbitrary units), Ap 
= area of product (arbitrary units). Asm and Ap are obtained by integration of the peak H-2 on the 
starting material and product, respectively.
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Fig 4.25 -  A plot of [SM], vs. time, fw the acid hydrolysis of ^ -acetyl-P-D-glucosyl-L-cysteine to 5-P- 
D-glucosyl-L-cysteine with 3M DCI/D2O at 37 °C over 24 hours. [SM]o = 1.23 x 10'^  mol dm Blue 
= H-1’, pink = H-2.
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Fig 4.26 -  A plot of ln(AsM/AsM + Ap) vs. time, for the acid hydrolysis of /V-acetyl-|3-D-glucosyl-L- 
cysteine to 5-P-D-glucosyl-L-cysteine with 3M DCI/D2O at 37 °C over 24 hours. [SM]o = 1.23 x 10"^  
mol dm Blue = H-1’, pink = H-2.
A  comparison of the kobs values for the three acid concentrations is shown as a plot in 
fig 4.27 and the values given in table 4.13.
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Acid 
concentration 
(mol dm' )^
1 0  ^X kobs (hours’ )^
H -r H-2
0 0 0
1 8.34 8 . 0 0
2 11.80 12.70
3 17.90 19.10
Table 4.13 -  Pseudo first order rate constants for the hydrolysis o f JV-acetyl-^-p-D-glucosyl-L-cysteine 
to 5-P-D-glucosyl-L-cysteine using 1,2 and 3M DCI/D2 O at 37 °C over 24 hours.
2.5
J
0.5
I 20 3 4
Concentration [D^ / mol dm^
Fig 4.27 -  A plot of kobs vs. concentration for the hydrolysis ofiV-acetyl-iS-p-D-glucosyl-L-cysteine to 
jS-p-D-glucosyl-L-cysteine using 1,2 and 3M DCI/D2 O at 37 °C over 24 hours. Blue = H-1’, pink = H- 
2.
The kobs obtained fi*om monitoring the appearance and disappearance of H-T and H-2 
is shown in fig 4.27 to be in good agreement. A linear relationship is seen relative to 
nominal concentration and k% = 5.96 ± 0.24 x 10'^  dm^  mol'  ^ homs'\
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4.3 Discussion and Conclusions
4.3.1 Discussion
The following compounds, shown in fig 4.28,. showed no activity when tested as 
substrates for the myrosinase enzyme: A^-acetyl-iS-P-glucosyl-L-cysteine 2, A-acetyl- 
0-methyl-iS'-(2,3,4,6-tetra-0-benzoyl-p-D-glucopyranosyl)-L-cysteine 5 and A -^acetyl- 
0-methyl-5'-p-glucosyl-L-cysteine and 7V-acetyl-0-methyl-5-P-glucosyl-D-cysteine 6 a 
and 6 b as a diastereomeric mixture.
OR OH
RO Î HO 1
AcHN-^COjR' AcHN'^COzMe
5:R=Bz R' = CH3  6 a and 6 b
2:R = R' = H
Fig 4.28 -  Compounds tested as substrates for the myrosinase enzyme.
It is most likely that iV-acetyl-L-cysteine is too poor a leaving group to be hydrolysed 
by the myrosinase enzyme. Sinigrin itself has a good leaving group which rearranges 
to form an isothiocyanate. In the case of PNPG, the ^ -nitrophenol group is also a good 
leaving group and as PNPG is a substrate for the myrosinase enzyme, it appears that 
the ability of the aglycone firagment to behave as a leaving group is critical for 
hydrolysis to occur.
The smigrin-myrosinase reaction appears to be inhibited by the addition of A-acetyl- 
S'-P-D-glucosyl-L-cysteine 2. Sotting et al. report a Fi / Fb of 0.4 for glucono-6 - 
lactone 1 1 ,^  a known non-competitive inhibitor, compared to a Fi / Vo of 0 . 6  for 2  in 
the sinigrin-myrosinase reaction, although it is likely to be competitive inhibition that 
is observed here. Unfortunately further studies of 2 as an inhibitor for the sinigrin- 
myrosinase reaction proved difficult Using UV spectrophotometry as 2 is observable 
in the same UV region as sinigrin. Compound 2  was also tested for inhibition of the 
PNPG-myrosinase reaction, but none was observed in contrast to the sinigrin 
hydrolysis. It is reported by Sotting^ that ascorbic acid enhances the rate of hydrolysis 
of sinigrin by myrosinase, but not that of PNPG. The result here, that 2 inhibits
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sinigrin but not PNPG hydrolysis is complementary. This different behavioui* of 
sinigrin vs. PNPG hydrolysis towards both activation and inhibition might, with 
speculation be ascribed to different active sites on the enzyme for the different 
substrates. Sotting has suggested that ascorbic acid activates by binding at a different 
site and bringing about a conformational change in the active site of myrosinase 
beneficial to sinigrin, but not PNPG, hydrolysis. In the same study Sotting suggests 
the binding of the inhibitor used in his studies occurs at this site. It is possible that 2 
may bind at this alternative site in a way that causes a confoimational change which is 
detrimental to sinigrin hydrolysis, but not hydrolysis of PNPG.
Experiments carried out on the acid stability of V-acetyl-S'-p-D-glucosyl-L-cysteine 2 
showed interesting results. The sulfur-carbohydrate linkage of 2 was stable to 
hydrolysis in 3 M DCI/D2O even after 35 days at 37 °C and a further 70 days at room 
temperature. This is very different to studies reported in the literatme where 
hydrolysis of a digalactosyl-cysteine linkage is claimed to require only 8  hours using 
0.5 M aq. HCl,'^  which is estimated to be ca. 85 days at room temperature. Also, it is 
contrary to a report of the 16 % hydrolysis of V-benzyloxycarbonyl-iS'-P-glucosyl-L- 
cysteine; at pH 0.4 and 37 °C over a 24 hour period.  ^ Both these studies relied on 
paper chromatography for the isolation of galactose and glucose respectively prior to 
detection. The study carried out here using NMR spectioscopy showed no such 
hydrolysis to occur even with a stronger concentration of acid. Bearing in mind that 
the substrates used in the literature differ from the ones used in this study, it is still 
unlikely that hydrolysis of the carbohydrate-sulfur linkage would occur. Hydrolysis of 
the iV-acetyl group of 2 was the only visible change observed in the H^ NMR 
spectrum, leaving apparently acid-stable iS-p-D-glucosyl cysteine 13. Given that 
hydrolysis of 2 to 6 "-p-D-glucosyl cysteine using 3 M DCI/D2 O was complete after ca. 
6 8  hours, if  hydrolysis of the carbohydrate-sulfur Imkage as observed in the literature 
by paper chromatography," ’^^  was to occur, it is certain that it would be seen by 
NMR, but in fact no further change was noted even after 105 days. These findings 
confirm the stability of the p-thioglycosidic linkage, contrary to earlier literature 
reports.  ^The acid hydrolysis of 2 to ^S-p-D-glucosyl cysteine was studied kinetically 
and found to cleave under acid catalysis with a second order rate constant of 5.96 ±
0.24 X 10'^  dm^  mof^ hours'^
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4.3.2 Conclusions
• The enzymic stability of the thioglycosidic bond is high. V-acetyl-.S'-p-D-glucosyl- 
L-cysteine 2, V-acetyl-0-methyl-jS'-(2,3,4,6-tetra-0-benzoyl-P-D-glucopyranosyl)- 
L-cysteine 5, iV-acetyl-O-methyl-^-p-glucosyl-L-cysteine 6 a and iV-acetyl-O- 
methyl-iî-P-glucosyl-D-cysteine 6 b do not appear to be substrates for the 
myrosinase enzyme. Whether a different enzyme such as an O-glucosidase would 
cleave the Imkage is uncertain, but it cannot be discounted that some enzyme 
based in the body would hydrolyse 2 .
• iV-acetyl-S'-p-D-glucosyl-L-cysteine 2 is a weak inhibitor of the sinigrin- 
myi'osinase hydrolysis with an inhibition strength comparable to other inhibitors. 
However, it is not an inhibitor of the PNPG hydrolysis. It is thought that two 
active sites are present on the myrosinase enzyme, and that perhaps 2  does not 
inhibit the active site at which PNPG is hydrolysed.
• In acidic media, the acetyl group of 2  is removed to produce iS-P-D-glucosyl-L- 
cysteine, but neither before or after the hydrolysis of this side chain has occurred, 
is chemical hydrolysis of the thioglycosidic link observed. This contrasts with 
earlier literature,where acid hydrolysis of similar linkages is reported.
The studies carried out in this chapter on the stability of 7V-acetyl-6'-P-D-glucosyl-L- 
cysteine 2  to the myrosinase enzyme and towards acidic media have been largely 
successfiil in that they have started the lengthy process of understanding the reactivity 
of 2  towards certain media which it might encoimter when administered into the body. 
The inactivity of 2 towards myrosinase, both as a substrate and an inhibitor, suggests 
that in the body 2 would be quite stable towards similar thioglycosidases. However, it 
is not certain how 2 would behave in the presence of other enzymes such as certain O- 
glycosidases which appear to be less selective. The stability o f 2 towards acidic media 
is somewhat surprising given the results reported by other workers."^ '^  It is likely that 2 
would remain at least partially intact when arriving in the stomach as an extended 
period in contact with acid media is required for cleavage of even the acetyl group.
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4.4 Experimental
4.4.1 General details
UV spectroscopy was carried out on a Cecil 8000 series UV-visible spectrometer for 
the sinigrin analysis, and a Unicam UVl spectrometer for the PNPG analysis using 10 
mm cells. The NMR analysis of V-acetyl-6 "-P-glucosyl-L-cysteine 2, iV-acetyl-O- 
methyl-»S'-(2,3,4,6-tetra-0-benzoyl-P-D-glucopyranosyl)-L-cysteine 5 and V-acetyl-O- 
methyl-5"-p-glucosyl-L-cysteine and V-acetyl-G-methyl-iS'-p-glucosyl-D-cysteine 6 a 
and 6 b was carried out on a Bruker AC300 at 300 MHz. The acid hydrolysis kinetics 
of V-acetyl-^S-P-glucosyl-L-cysteine 2 were carried out on a Bi*uker DRX-500 at 500 
MHz. Chemicals were either available in the lab or supplied by Acros Organics, 
Aldrich, Fisher Scientific, Fluka or Lancaster. All starting materials purchased fi*om 
an external source were checked for purity by TLC or NMR prior to use.
4.4.2 Preparations of standard solutions
The following stock solutions were prepared and used. Sinigrin solution (8 . 6  mmol 
dm' )^ was prepared by the addition of water (5 cm )^ to sinigrin (17.9 mg, 0.0431 
mmol) in a 5 cm  ^ volumetric flask. Aqueous K2HPO4 solution (0.1 mol dm"^ ) was 
made by the addition of water (50 cm )^ to K2HPO4 (1.1411 g, 5 mmol) in  ^ 50 cm  ^
volumetric flask. Aqueous KH2PO4 solution (0.1 mol dm' )^ was made by the addition 
of water (50 cm )^ to KH2PO4 (0.68045 g, 5 mmol) in a 50 cm  ^ volumetric flask. 
Aqueous potassium phosphate buffer (OT mol dm' )^ was made to pH 7 by mixing 
aqueous solutions of 0.1 M K2HPO4 and 0.1 M KH2PO4 and monitoring with a pH 
meter at 25 °C until a pH of 7 was reached. The PNPG solution (57.1 mmol dm‘^ ) was 
made by the addition of water (10 cm )^ to PNPG (172 mg, 0.571 mmol) in a 10 cm^  
volumetric flask, V-acetyl-jS-P-D-glucopyranosyl-L-cysteine solution (20.6 mmol dm' 
)^ was prepared by the addition of water (10 cm^) to V-acetyl-6 '-p-D-glucopyranosyl- 
L-cysteine (67 mg, 0.206 mmol) in a 10 cm^  volumetric flask.
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4.4.3 Standardisation of myrosinase: Sinigrin
To a 2 cm  ^quartz UV cuvette was added 23 mm  ^of a sinigrin solution (8 . 6  mmol dm' 
)^, 660 mm  ^ of potassium phosphate buffer at pH 7 (0.1 mol dm' )^ and 1300 mm  ^ of 
water. The UV cell was equilibrated at 37 ± 0.1 °C in the thermostatted cell of the UV 
spectrometer. The reaction was initiated by addition of 20 mm  ^ of a myrosinase 
solution, which was previously prepar ed by dissolving 0.08 mg of myrosinase in 1 
cm^  of water, taking the total volume in the UV cell to 2 cm .^ The concentrations of 
sinigrin and phosphate buffer in the UV cell are 0.1 and 33 mM respectively and that 
of myrosinase is 0 . 8  jug cm' .^ After addition of the enzyme, the reaction was 
monitored by observing the decrease in absorbance at 227 nm (e = 6784 M'^  cm' )^ due 
to sinigrin every 5 mins over a period of 70 mins. This experiment was carried out in 
triplicate.
4.4.4 Reaction of myrosinase: p-nitrophenyi-f^-giucoside
To a 2 cm  ^quartz UV cuvette was added 70 mm  ^of a PNPG solution (57.1 mmol dm' 
\  660 mm  ^of potassium phosphate buffer at pH 7 (0.1 mol dm' )^, and 1230 mm  ^ of 
water. The UV cell was equilibrated at 37 ± 0.1 °C in the thermostatted cell of the UV 
spectrometer. The reaction was initiated by addition of 40 mm  ^ of a myrosinase 
solution, which was previously prepared by dissolving 32.5 mg of myrosinase in 1 
cm^  o f water, taking the total volume in the UV cell to 2 cm .^ The concentrations of 
PNPG and phosphate buffer in the UV cell are 2 and 33 mM respectively and that of 
myrosinase is 650 //g cm' .^ After addition of the eirzyme, the reaction was monitored 
by observing the increase in absorbance at 430 nm (e = 7002 M'^  cm' )^ due to p- 
nitrophenol every 3 mins over a period of 96 mins. The experiment was repeated for 
concentrations of PNPG 5 and 10 mM in the UV cell, hr the case of the 5 mM, the 
following volumes were used, 175 mm  ^ of PNPG stock solution (57.1 mmol dm' )^, 
660 mm  ^ of phosphate buffer and 1125 mm  ^ of water. For 10 mM, the following 
volumes were used, 350 mm  ^ of PNPG stock solution (57.1 mmol dm' )^, 660 mm  ^of 
phosphate buffer and 950 mm  ^ of water. Both reactions were initiated by the addition 
of 40 mm  ^of enzyme stock solution, taking the total volume to 2 cm  ^ in the UV cell.
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Each experiment was carried out in duplicate at the same time in a UV cell multi­
changer.
4.4.5 N-acetyl-0-methyl-S-(2,3 ,4,6-tetra-O-benzoyl 
-P-D-glucopyranosyiyL-cysteii 
as a substrate for myrosinase
CBz
ne ad
iV-acetyl-0-methyl-»S'-(2,3,4,6-tetra-0-benzoyl-P-D-glucopyranosyl)-L-cysteine 5 ( 1 5  
mg, 0.0198 mmol) was dissolved in CD3OD/D2 O, ca. 95:5, (0.5 cm^), to which was 
added myrosinase (2 mg). The mixture was added to an NMR tube and a NMR 
spectrum was carried out after ca, 30 mins at room temperature, then again after 2 
hours and then after 25 hours. No change was noted by NMR.
4.4.6 N-acetyl-O-methyl-S-p-D-glucopyranosyl ?"
cysteine, R and S  diastereomers, as substrates
AcHN-^CXDjMefor myrosinase 6a and «b
iV-acetyl-0-methyl-5'-P-D-glucopyranosyl)cysteine, as a mixtuie of 2 -R and 2-S 
diastereomers 6 a and 6 b (20 mg, 0.0589 mmol) was dissolved in D2 O (0.5 cm )^, to 
which was added myiosinase (2 mg). The mixture was added to an NMR tube and a 
NMR spectrum was carried out after ca. 30 mins at room temperature, then again 
after 2 hours and then after 21 hours. No change was noted by NMR.
4.4.7 N-acetyi-S-p-D-glucopyranosyl-L-cysteine,
as a substrate for myrosinase ' ™ achn^ c^xxdh
jV-acetyl-^P-D-glucopyranosyl-L-cysteine 2 (5 mg, 0.0154 mmol) was dissolved in 
500 mm  ^ of D2O potassium phosphate buffer at pH 7 (100 mM) .^ The solution was 
transferred to an NMR tube and equilibrated at 37 ± 0.1 °C in a water bath. The 
reaction was initiated by addition of 5 mm" of myrosinase solution, which was
^The potassium phosphate buffer was made to pH 7 by mixing solutions of 0.1 M K2HPO4  and 0.1 M 
KH2PO4  which had been made up using D2 O instead of H2 O, and monitoring with a pH meter at 25 °C 
until a pH of 7 is reached.
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previously prepared by dissolving 32.5 mg of myrosinase in 1 cm  ^ of water (to give 
myrosinase at 325 fj.% cm' .^ A NMR experiment® was run after 30 mins and again 
after 2 and 20 hours. The amount of enzyme was increased at this point by addition of 
a further 20 mm  ^of myrosinase solution (32.5 mg/ cm )^. A NMR experiment was
then carried out after 1 hour and then after 24 hours. No change was noted by 
NMR.
4.4.8 Inhibition of the sinigrin-myrosinase reaction: N-acetyi-S-p-D- 
glucopyranosyl-L-cysteine
To a 2 cm  ^quartz UV cuvette was added 23 mm  ^of a sinigrin solution (8 . 6  mmol dm" 
)^, 660 mm  ^ of potassium phosphate buffer at pH 7 (0.1 mol dm' )^, 500 mm  ^ of a N- 
acetyl-*S'-p-D-glucopyranosyl-L-cysteine 2 solution (20 mM) and 797 mm  ^ of water. 
The UV cell was equilibrated at 37 ± 0.1 °C in the thermostatted cell of the UV 
spectrometer. The reaction was initiated by addition of 20 mm  ^ of a myrosinase 
solution, which was previously prepaied by dissolving 0.08 mg of myrosinase in 1 
cm  ^ of water, taking the total volume in the UV cell to 2 cm .^ The concentrations of 
sinigrin and phosphate buffer in the UV cell are 0.1 and 33 mM respectively, and the 
concentration of 2 is 5 mM and of myrosinase is 650 jug cm"^ . After addition of the 
enzyme, the reaction was monitored by observing the decrease in absorbance at 227 
nm (s = 6784 M"^  cm"^ ), due to sinigrin every minute over a period o f 65 mins. The 
experiment was also carried out using a 2.5 mM concentration of 2, for this the 
following adjustments were necessary, addition of 250 mm  ^ of iV-acetyl-iS-p-D- 
glucopyranosyl-L-cysteine 2 (20 mM) and 1047 mm  ^of water.
4.4.9 inhibition of the PNPG-myrosinase reaction: N-acetyi-S-p-D- 
giucopyranosyi-L-cysteine
To a 2 cm  ^quartz UV cuvette was added 70 mm  ^of a PNPG solution (57.1 mmol dm" 
)^, 660 mm  ^ of potassium phosphate buffer at pH 7 (0.1 mol dm' )^, 97 mm  ^ of a N- 
acetyl-iS-p-D-glucopyranosyl-L-cysteine 2 solution (20 mM) and 1133 mm  ^ of water.
® Although the water bath kept the temperature of the solution at 37 °C, the actual NMR experiments 
were acquired at 25 ®C.
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The UV cell was equilibrated at 37 ± 0.1 °C in the thermostatted cell of the UV 
specti'ometer. The reaction was initiated by addition of 40 mm  ^ of a myrosinase 
solution, which was previously prepared by dissolving 32.5 mg of myrosinase in 1 
cm^  of water, taking the total volume in the UV cell to 2 cm .^ The concentrations of 
PNPG and phosphate buffer in the UV cell are 2 and 33 mM respectively and the 
concentration of 2, 1 mM and of myrosinase 650 //g cm' .^ After addition of the 
enzyme, the reaction was monitored by observing the increase in absorbance at 430 
nm ( 8  = 7002 M’  ^ cm' )^, due to ^-nitrophenol every 3 mins over a period of 96 mins. 
This experiment was carried out with 2.5 and 5 mM concentrations of V-acetyl-iS-P- 
D-glucopyranosyl-L-cysteine 2. The adjustments for the 2.5 mM experiment were 243 
mm  ^ of 2 (20 mM) and 1022 mm  ^ of water, and for the 5 mM experiment, 485 mm  ^
of 2 (20 mM) and 780 mm  ^ of water. Each experiment was carried out in duplicate at 
the same time in a UV cell multi-changer. The concentration of PNPG was adjusted to 
5 and 10 mM and both the 5 and 10 mM experiments were carried out with 1, 2.5 and 
5 mM concentrations of A-acetyl-iS-P-D-glucopyranosyl-L-cysteine 2.
4.4.10 Acid hydrolysis of N-acetyl-S-p-D-giucopyranosyi-L-cysteine 
to S-p-D-giucopyranosyl-L-cysteine, the kinetic study
In a sample vial, deuterium chloride (100 mm ,^ 35 % w/w) was added to D2O (900 
mm^) making a 1 M DCI/D2O solution, to which was added A-acetyl-6 ’-P-D- 
glucopyranosyl-L-cysteine 2 (7.5 mg, 0.0231 mmol) giving an “in tube” concentration 
of 0.0231 M. The solution was then transferred to an NMR tube and equilibrated to 37 
±0.1 °C in the NMR machine. After one hour a NMR spectrum was acquired and 
then one every hour for a further 23 hours. Two further experiments were caiTied out 
using 2 and 3 M DCI/D2O solution. The 2 M DCI/D2O was made by the addition of 
DCl (200 mm ,^ 37 %) to D2O (800 mm )^ and then addition to A-acetyl-5-p-D- 
glucopyranosyl-L-cysteine 2 (4.5 mg, 0.0139 mmol). The 3 M DCI/D2O was made by 
the addition of DCl (300 mm ,^ 37 %) to D2O (700 mm )^ and then addition to N- 
acetyl-5'-p-D-glucopyranosyl-L-cysteine 2 (4.0 mg, 0.0123 mmol). The analysis of 
data is described in the results section.
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Chapter 5
C onclus ions  and  Further Work
5.1 Conclusions
5.1.1 Summary of synthesis
In chapter 2 a simple and effective synthetic route to W-acetyl-iS-D-glucopyranosyl-L- 
cysteine, both a and P-anomers, was developed and this methodology was extended in 
chapter 3 to the synthesis of two other 6 "-glycosyl cysteines, iV-acetyl-6 '-p-D- 
ribopyranosyl-L-cysteine and W-acetyl-5-a-D-mannopyranosyl-L-cysteine along with 
the benzoylated methyl ester of W-acetyl-iS-P-D-galactopyranosyl-L-cysteine. 
Previous methods for the synthesis of 5"-glycosyl cysteines were long, tedious and 
incomplete, and the W-acetyl derivatives here appear to be novel. The chemistry 
employed in this thesis gives a more general synthetic pathway to glycosyl cysteines. 
The new route involves the use of a benzoylated glycosyl bromide as the glycosyl 
donor and W-acetyl-O-methyl-L-cysteiue as the glycosyl acceptor. The coupling 
reaction is canied out in the presence of SnCU giving both a and P-anomers in the 
case of glucose, but single anomers for the other carbohydrates used. The removal of 
the methyl ester is carried out using aqueous acid and is successful for all 
carbohydrates with the exception of galactose. The deprotection of the benzoate 
groups is canied out using methanolic sodium methoxide. The use of benzoates as the 
protecting group in the synthesis of jS-glycosyl cysteines is not reported in the 
literature. The benzoate group has many distinct advantages; the ease of preparation,
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stability in acidic media but conveniently removed under basic conditions and UV 
active making column chromatography easier. The acetate group is the most common 
group found in the preparation of jS-glycosyl cysteines but it is not UV active. The 
benzyl group has been successfully used but the preparation of the glycosyl donor is 
more involved, and, as a result, lowers yields. The couphng reaction can, in ideal 
cases, yield both a and P-anomers which is not observed in the literature. The acid 
hydrolysis of the methyl ester of the benzoylated glycosyl cysteines prior to base- 
catalysed de-benzoylation avoids the problem of isomerization at the cysteine 
stereogenic centre as reported in the literature by some workers.
5.1.1 Conclusions
The mechanism for the coupling reaction of benzoylated glycosyl bromides to N- 
acetyl-L-cysteine is clearly S^l. In the case of the glucose series, the tetrabenzoyl-a- 
glucosyl bromide yields both a and P-anomers in the coupling reaction, if  an Sn2 
mechanism were in operation then only the p anomer would be formed. The 
predominance of the p-anomer was expected as a benzoate ester at C-2 of the glycosyl 
halide leads to formation of an ortho ester blocking the site at which the HS- 
nucleophile attacks to form the a product. The isolation of significant amounts of a- 
anomer suggests that the HS- nucleophile must also be attacking on the non-ortho 
ester carbocation inteimediate.
The evidence for the SnI mechanism is further strengthened by the isolation of only 
the a-anomer for the mannose coupling. The ester group participation at C-2 favours 
the a-anomer in this case, whereas an Sn2  mechanism would yield only p.
In the galactose series, only the p-anomer was isolated. It is not certain whether this is 
because no a-anomer is formed, or that the amount of a-anomer formed is so small, 
that isolation is difficult.
In the ribose series the p-anomer is formed in the favoured ^ € 4  conformation. The ^ € 4  
P-anomer is both the anomeric product and also the product that is favoured by the 
mechanism of ester gi*oup participation.
With the exception of the galactose analogue, the acid hydrolysis of the methyl ester 
of the various glycosyl cysteines was straightforward giving the required products in
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good yields. The reason for the lack of success of the galactose derivative is uncertain, 
perhaps prolonged reaction times are required.
The use o f aqueous acid for the removal of the ester group is advantageous as base 
must be avoided or racemization of the cysteine moiety can occur. This has been seen 
in the literature and was discussed in chapter 2. As was subsequently shown, the 
glycosidic sulfur linkage is resistant to acid hydrolysis; rather surprisingly the 
presence of benzoyl groups seems to inhibit the acid hydrolysis of the A-acetyl group 
under these conditions; this may be due to the low solubility of the benzoylated 
glycosyl cysteine methyl ester and the product in aqueous medium.
De-benzoylation of the glucose, mannose and ribose series was straightforward but 
again the A-acetyl group was stable under the basic conditions.
The benzyl route carried out in chapter 2 for the synthesis of W-acetyl-O-methyl- 
glucosyl cysteine yielded the a-anomer as seen in the literature, but this was the sole 
product. The overall route was more involved and lower yielding.
The standard myrosinase substrate sinigrin, a thioglycoside with an acidic aglycone 
fragment that can rearrange spontaneously, was readily hydrolysed by a commercial 
myrosinase sample, although activity was low. A further established substrate, p- 
nitrophenyl-P-D-glucoside (PNPG), also with a relatively acidic aglycone fragment, 
was also hydrolysed, but Fm3x/Km was foimd to be lower than that reported in the 
literature. iV-Acetyl-iS-p-D-glucosyl-L-cysteine was resistant to hydrolysis by 
myr osinase, suggesting that the nucleofugacity of the aglycone fragment is the key to 
reactivity. This is reinforced by the indication that despite it not being a substrate 
some binding of iV-acetyl-*S'-p-D-glucosyl-L-cysteine does occur, reflected in the 
competitive inhibition of the sinigrin-myrosinase reaction. No inhibition of the 
PNPG-myrosinase reaction was detected. As inhibition of the sinigrin-myrosinase 
reaction was observed using A-acetyl-6 '-P-D-glucosyl-L-cysteine but not inhibition of 
the PNPG-myrosinase reaction, it is possible that two active sites are present on the 
myrosinase enzyme, with A-acetyl-iS-p-D-glucosyl-L-cysteine only binding at the site 
responsible for the sirrigrin hydrolysis. The hydrolysis of sinigrin by myrosinase is 
reported to be activated by ascorbic acid, which binds at an alternative site on 
myrosinase. This binding is thought to cause a conformational change which enhances 
sinigrin hydrolysis, but not that of PNPG. It is a possible that A-acetyl-6 '-p-D- 
glucosyl-L-cysteine binds at this site.
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In contrast to literature reports, the thioglycosidic linkage of W-acetyl-iS-p-D-glucosyl- 
L-cysteine is resistant to acid hydrolysis, although hydrolysis of the iV-acetyl group 
occurs with ky  ^= 5.96 x 10'^  dm^  mol'  ^houis'\ Interestingly, this suggests that under 
some extreme physiological conditions, e.g. in stomach acids,. thioglycosylated 
peptides would be more likely to be cleaved at the amide link, rather than the 
thioglycoside link.
5.2 Further work
Using the synthetic route to ^'-glycosyl cysteines it should be possible to extend the 
study to other carbohydrates. Carbohydrates with furanose ring structures and also 
disaccharides would perhaps be good choices as these have not been attempted in this 
thesis. It would also be interesting to attempt the S-glycosylation of peptides.
It may also be beneficial to carry out the monitoring of the coupling reactions in this 
thesis by NMR to allow a full kinetic study. This would perhaps clear up any 
questions regarding the mechanism, such as does any a-anomer form in the galactose 
coupling reaction?
Further studies on iS'-glycosyl cysteines as substrates for other enzymes would be 
interesting. Examples could include 0-glucosidases and galactosidases, some of these 
enzymes are reportedly less selective than myrosinase.
An experiment on the inhibition of the sinigrin-myrosinase by PNPG would also be 
interesting. If two active sites are in operation on the enzyme as previously postulated, 
then inhibition of the sinigiin myrosinase reaction would in fact be minor.
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